2018-05-26 12:38:43,086:INFO: Disease Protein Prediction in the PPI Network
2018-05-26 12:38:43,086:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-26 12:38:43,086:INFO: ======================================
2018-05-26 12:38:43,087:INFO: Loading PPI Network...
2018-05-26 12:38:53,901:INFO: Loading Disease Associations...
2018-05-26 12:38:53,926:INFO: Loading PPI Matrix...
2018-05-26 12:39:19,454:INFO: Running Experiment...
2018-05-26 12:39:19,469:INFO: Experiment Progress: 0.0% -- 0/519
2018-05-26 12:39:20,372:INFO: Experiment Progress: 0.2% -- 1/519
2018-05-26 12:39:20,897:INFO: Experiment Progress: 0.4% -- 2/519
2018-05-26 12:39:21,355:INFO: Experiment Progress: 0.6% -- 3/519
2018-05-26 12:39:22,365:INFO: Experiment Progress: 0.8% -- 4/519
2018-05-26 12:39:22,909:INFO: Experiment Progress: 1.0% -- 5/519
2018-05-26 12:39:23,333:INFO: Experiment Progress: 1.2% -- 6/519
2018-05-26 12:39:23,768:INFO: Experiment Progress: 1.3% -- 7/519
2018-05-26 12:39:24,347:INFO: Experiment Progress: 1.5% -- 8/519
2018-05-26 12:39:25,903:INFO: Experiment Progress: 1.7% -- 9/519
2018-05-26 12:39:26,332:INFO: Experiment Progress: 1.9% -- 10/519
2018-05-26 12:39:29,564:INFO: Experiment Progress: 2.1% -- 11/519
2018-05-26 12:39:30,020:INFO: Experiment Progress: 2.3% -- 12/519
2018-05-26 12:39:30,607:INFO: Experiment Progress: 2.5% -- 13/519
2018-05-26 12:39:31,157:INFO: Experiment Progress: 2.7% -- 14/519
2018-05-26 12:39:31,576:INFO: Experiment Progress: 2.9% -- 15/519
2018-05-26 12:39:32,070:INFO: Experiment Progress: 3.1% -- 16/519
2018-05-26 12:39:32,501:INFO: Experiment Progress: 3.3% -- 17/519
2018-05-26 12:39:33,874:INFO: Experiment Progress: 3.5% -- 18/519
2018-05-26 12:39:34,339:INFO: Experiment Progress: 3.7% -- 19/519
2018-05-26 12:39:35,699:INFO: Experiment Progress: 3.9% -- 20/519
2018-05-26 12:39:37,348:INFO: Experiment Progress: 4.0% -- 21/519
2018-05-26 12:39:37,990:INFO: Experiment Progress: 4.2% -- 22/519
2018-05-26 12:39:38,433:INFO: Experiment Progress: 4.4% -- 23/519
2018-05-26 12:39:38,765:INFO: Experiment Progress: 4.6% -- 24/519
2018-05-26 12:39:39,223:INFO: Experiment Progress: 4.8% -- 25/519
2018-05-26 12:39:39,747:INFO: Experiment Progress: 5.0% -- 26/519
2018-05-26 12:39:40,185:INFO: Experiment Progress: 5.2% -- 27/519
2018-05-26 12:39:40,830:INFO: Experiment Progress: 5.4% -- 28/519
2018-05-26 12:39:41,612:INFO: Experiment Progress: 5.6% -- 29/519
2018-05-26 12:39:42,162:INFO: Experiment Progress: 5.8% -- 30/519
2018-05-26 12:39:42,676:INFO: Experiment Progress: 6.0% -- 31/519
2018-05-26 12:39:43,389:INFO: Experiment Progress: 6.2% -- 32/519
2018-05-26 12:39:44,082:INFO: Experiment Progress: 6.4% -- 33/519
2018-05-26 12:39:44,507:INFO: Experiment Progress: 6.6% -- 34/519
2018-05-26 12:39:44,944:INFO: Experiment Progress: 6.7% -- 35/519
2018-05-26 12:39:45,151:INFO: Experiment Progress: 6.9% -- 36/519
2018-05-26 12:39:45,595:INFO: Experiment Progress: 7.1% -- 37/519
2018-05-26 12:39:45,992:INFO: Experiment Progress: 7.3% -- 38/519
2018-05-26 12:39:46,543:INFO: Experiment Progress: 7.5% -- 39/519
2018-05-26 12:39:47,090:INFO: Experiment Progress: 7.7% -- 40/519
2018-05-26 12:39:47,628:INFO: Experiment Progress: 7.9% -- 41/519
2018-05-26 12:39:48,093:INFO: Experiment Progress: 8.1% -- 42/519
2018-05-26 12:39:48,951:INFO: Experiment Progress: 8.3% -- 43/519
2018-05-26 12:39:49,444:INFO: Experiment Progress: 8.5% -- 44/519
2018-05-26 12:39:49,901:INFO: Experiment Progress: 8.7% -- 45/519
2018-05-26 12:39:50,621:INFO: Experiment Progress: 8.9% -- 46/519
2018-05-26 12:39:51,102:INFO: Experiment Progress: 9.1% -- 47/519
2018-05-26 12:39:51,753:INFO: Experiment Progress: 9.2% -- 48/519
2018-05-26 12:39:52,268:INFO: Experiment Progress: 9.4% -- 49/519
2018-05-26 12:39:52,775:INFO: Experiment Progress: 9.6% -- 50/519
2018-05-26 12:39:53,358:INFO: Experiment Progress: 9.8% -- 51/519
2018-05-26 12:39:54,055:INFO: Experiment Progress: 10.0% -- 52/519
2018-05-26 12:39:54,565:INFO: Experiment Progress: 10.2% -- 53/519
2018-05-26 12:39:55,110:INFO: Experiment Progress: 10.4% -- 54/519
2018-05-26 12:39:55,475:INFO: Experiment Progress: 10.6% -- 55/519
2018-05-26 12:39:56,034:INFO: Experiment Progress: 10.8% -- 56/519
2018-05-26 12:39:56,512:INFO: Experiment Progress: 11.0% -- 57/519
2018-05-26 12:39:57,238:INFO: Experiment Progress: 11.2% -- 58/519
2018-05-26 12:39:57,599:INFO: Experiment Progress: 11.4% -- 59/519
2018-05-26 12:39:58,170:INFO: Experiment Progress: 11.6% -- 60/519
2018-05-26 12:39:58,841:INFO: Experiment Progress: 11.8% -- 61/519
2018-05-26 12:39:59,297:INFO: Experiment Progress: 11.9% -- 62/519
2018-05-26 12:39:59,740:INFO: Experiment Progress: 12.1% -- 63/519
2018-05-26 12:40:00,328:INFO: Experiment Progress: 12.3% -- 64/519
2018-05-26 12:40:00,745:INFO: Experiment Progress: 12.5% -- 65/519
2018-05-26 12:40:01,142:INFO: Experiment Progress: 12.7% -- 66/519
2018-05-26 12:40:02,151:INFO: Experiment Progress: 12.9% -- 67/519
2018-05-26 12:40:02,780:INFO: Experiment Progress: 13.1% -- 68/519
2018-05-26 12:40:03,874:INFO: Experiment Progress: 13.3% -- 69/519
2018-05-26 12:40:05,112:INFO: Experiment Progress: 13.5% -- 70/519
2018-05-26 12:40:05,637:INFO: Experiment Progress: 13.7% -- 71/519
2018-05-26 12:40:06,074:INFO: Experiment Progress: 13.9% -- 72/519
2018-05-26 12:40:06,510:INFO: Experiment Progress: 14.1% -- 73/519
2018-05-26 12:40:06,971:INFO: Experiment Progress: 14.3% -- 74/519
2018-05-26 12:40:07,406:INFO: Experiment Progress: 14.5% -- 75/519
2018-05-26 12:40:07,903:INFO: Experiment Progress: 14.6% -- 76/519
2018-05-26 12:40:08,371:INFO: Experiment Progress: 14.8% -- 77/519
2018-05-26 12:40:09,771:INFO: Experiment Progress: 15.0% -- 78/519
2018-05-26 12:40:10,409:INFO: Experiment Progress: 15.2% -- 79/519
2018-05-26 12:40:11,454:INFO: Experiment Progress: 15.4% -- 80/519
2018-05-26 12:40:12,319:INFO: Experiment Progress: 15.6% -- 81/519
2018-05-26 12:40:12,859:INFO: Experiment Progress: 15.8% -- 82/519
2018-05-26 12:40:13,497:INFO: Experiment Progress: 16.0% -- 83/519
2018-05-26 12:40:14,192:INFO: Experiment Progress: 16.2% -- 84/519
2018-05-26 12:40:14,715:INFO: Experiment Progress: 16.4% -- 85/519
2018-05-26 12:40:15,185:INFO: Experiment Progress: 16.6% -- 86/519
2018-05-26 12:40:15,641:INFO: Experiment Progress: 16.8% -- 87/519
2018-05-26 12:40:16,225:INFO: Experiment Progress: 17.0% -- 88/519
2018-05-26 12:40:16,589:INFO: Experiment Progress: 17.1% -- 89/519
2018-05-26 12:40:17,001:INFO: Experiment Progress: 17.3% -- 90/519
2018-05-26 12:40:17,300:INFO: Experiment Progress: 17.5% -- 91/519
2018-05-26 12:40:20,345:INFO: Experiment Progress: 17.7% -- 92/519
2018-05-26 12:40:20,765:INFO: Experiment Progress: 17.9% -- 93/519
2018-05-26 12:40:21,172:INFO: Experiment Progress: 18.1% -- 94/519
2018-05-26 12:40:21,945:INFO: Experiment Progress: 18.3% -- 95/519
2018-05-26 12:40:22,386:INFO: Experiment Progress: 18.5% -- 96/519
2018-05-26 12:40:24,133:INFO: Experiment Progress: 18.7% -- 97/519
2018-05-26 12:40:24,603:INFO: Experiment Progress: 18.9% -- 98/519
2018-05-26 12:40:25,448:INFO: Experiment Progress: 19.1% -- 99/519
2018-05-26 12:40:25,949:INFO: Experiment Progress: 19.3% -- 100/519
2018-05-26 12:40:26,379:INFO: Experiment Progress: 19.5% -- 101/519
2018-05-26 12:40:26,826:INFO: Experiment Progress: 19.7% -- 102/519
2018-05-26 12:40:27,173:INFO: Experiment Progress: 19.8% -- 103/519
2018-05-26 12:40:29,126:INFO: Experiment Progress: 20.0% -- 104/519
2018-05-26 12:40:29,676:INFO: Experiment Progress: 20.2% -- 105/519
2018-05-26 12:40:30,388:INFO: Experiment Progress: 20.4% -- 106/519
2018-05-26 12:40:30,876:INFO: Experiment Progress: 20.6% -- 107/519
2018-05-26 12:40:31,300:INFO: Experiment Progress: 20.8% -- 108/519
2018-05-26 12:40:31,704:INFO: Experiment Progress: 21.0% -- 109/519
2018-05-26 12:40:32,129:INFO: Experiment Progress: 21.2% -- 110/519
2018-05-26 12:40:33,388:INFO: Experiment Progress: 21.4% -- 111/519
2018-05-26 12:40:33,820:INFO: Experiment Progress: 21.6% -- 112/519
2018-05-26 12:40:34,961:INFO: Experiment Progress: 21.8% -- 113/519
2018-05-26 12:40:35,370:INFO: Experiment Progress: 22.0% -- 114/519
2018-05-26 12:40:36,275:INFO: Experiment Progress: 22.2% -- 115/519
2018-05-26 12:40:36,736:INFO: Experiment Progress: 22.4% -- 116/519
2018-05-26 12:40:37,207:INFO: Experiment Progress: 22.5% -- 117/519
2018-05-26 12:40:37,629:INFO: Experiment Progress: 22.7% -- 118/519
2018-05-26 12:40:38,115:INFO: Experiment Progress: 22.9% -- 119/519
2018-05-26 12:40:46,961:INFO: Experiment Progress: 23.1% -- 120/519
2018-05-26 12:40:47,465:INFO: Experiment Progress: 23.3% -- 121/519
2018-05-26 12:40:47,910:INFO: Experiment Progress: 23.5% -- 122/519
2018-05-26 12:40:48,615:INFO: Experiment Progress: 23.7% -- 123/519
2018-05-26 12:40:49,432:INFO: Experiment Progress: 23.9% -- 124/519
2018-05-26 12:40:49,873:INFO: Experiment Progress: 24.1% -- 125/519
2018-05-26 12:40:50,375:INFO: Experiment Progress: 24.3% -- 126/519
2018-05-26 12:40:50,973:INFO: Experiment Progress: 24.5% -- 127/519
2018-05-26 12:40:52,004:INFO: Experiment Progress: 24.7% -- 128/519
2018-05-26 12:40:52,492:INFO: Experiment Progress: 24.9% -- 129/519
2018-05-26 12:40:52,970:INFO: Experiment Progress: 25.0% -- 130/519
2018-05-26 12:40:53,394:INFO: Experiment Progress: 25.2% -- 131/519
2018-05-26 12:40:56,909:INFO: Experiment Progress: 25.4% -- 132/519
2018-05-26 12:40:57,811:INFO: Experiment Progress: 25.6% -- 133/519
2018-05-26 12:40:58,340:INFO: Experiment Progress: 25.8% -- 134/519
2018-05-26 12:40:58,810:INFO: Experiment Progress: 26.0% -- 135/519
2018-05-26 12:40:59,303:INFO: Experiment Progress: 26.2% -- 136/519
2018-05-26 12:41:00,723:INFO: Experiment Progress: 26.4% -- 137/519
2018-05-26 12:41:01,241:INFO: Experiment Progress: 26.6% -- 138/519
2018-05-26 12:41:01,805:INFO: Experiment Progress: 26.8% -- 139/519
2018-05-26 12:41:04,376:INFO: Experiment Progress: 27.0% -- 140/519
2018-05-26 12:41:04,896:INFO: Experiment Progress: 27.2% -- 141/519
2018-05-26 12:41:05,392:INFO: Experiment Progress: 27.4% -- 142/519
2018-05-26 12:41:06,722:INFO: Experiment Progress: 27.6% -- 143/519
2018-05-26 12:41:07,288:INFO: Experiment Progress: 27.7% -- 144/519
2018-05-26 12:41:07,829:INFO: Experiment Progress: 27.9% -- 145/519
2018-05-26 12:41:08,283:INFO: Experiment Progress: 28.1% -- 146/519
2018-05-26 12:41:09,398:INFO: Experiment Progress: 28.3% -- 147/519
2018-05-26 12:41:09,975:INFO: Experiment Progress: 28.5% -- 148/519
2018-05-26 12:41:10,416:INFO: Experiment Progress: 28.7% -- 149/519
2018-05-26 12:41:11,172:INFO: Experiment Progress: 28.9% -- 150/519
2018-05-26 12:41:11,593:INFO: Experiment Progress: 29.1% -- 151/519
2018-05-26 12:41:11,979:INFO: Experiment Progress: 29.3% -- 152/519
2018-05-26 12:41:13,157:INFO: Experiment Progress: 29.5% -- 153/519
2018-05-26 12:41:13,642:INFO: Experiment Progress: 29.7% -- 154/519
2018-05-26 12:41:14,182:INFO: Experiment Progress: 29.9% -- 155/519
2018-05-26 12:41:17,143:INFO: Experiment Progress: 30.1% -- 156/519
2018-05-26 12:41:17,622:INFO: Experiment Progress: 30.3% -- 157/519
2018-05-26 12:41:18,265:INFO: Experiment Progress: 30.4% -- 158/519
2018-05-26 12:41:18,903:INFO: Experiment Progress: 30.6% -- 159/519
2018-05-26 12:41:19,362:INFO: Experiment Progress: 30.8% -- 160/519
2018-05-26 12:41:19,834:INFO: Experiment Progress: 31.0% -- 161/519
2018-05-26 12:41:23,512:INFO: Experiment Progress: 31.2% -- 162/519
2018-05-26 12:41:23,934:INFO: Experiment Progress: 31.4% -- 163/519
2018-05-26 12:41:24,420:INFO: Experiment Progress: 31.6% -- 164/519
2018-05-26 12:41:24,894:INFO: Experiment Progress: 31.8% -- 165/519
2018-05-26 12:41:25,372:INFO: Experiment Progress: 32.0% -- 166/519
2018-05-26 12:41:25,836:INFO: Experiment Progress: 32.2% -- 167/519
2018-05-26 12:41:26,284:INFO: Experiment Progress: 32.4% -- 168/519
2018-05-26 12:41:26,750:INFO: Experiment Progress: 32.6% -- 169/519
2018-05-26 12:41:27,793:INFO: Experiment Progress: 32.8% -- 170/519
2018-05-26 12:41:28,941:INFO: Experiment Progress: 32.9% -- 171/519
2018-05-26 12:41:29,587:INFO: Experiment Progress: 33.1% -- 172/519
2018-05-26 12:41:29,979:INFO: Experiment Progress: 33.3% -- 173/519
2018-05-26 12:41:32,113:INFO: Experiment Progress: 33.5% -- 174/519
2018-05-26 12:41:32,553:INFO: Experiment Progress: 33.7% -- 175/519
2018-05-26 12:41:32,901:INFO: Experiment Progress: 33.9% -- 176/519
2018-05-26 12:41:33,473:INFO: Experiment Progress: 34.1% -- 177/519
2018-05-26 12:41:34,034:INFO: Experiment Progress: 34.3% -- 178/519
2018-05-26 12:41:34,479:INFO: Experiment Progress: 34.5% -- 179/519
2018-05-26 12:41:34,920:INFO: Experiment Progress: 34.7% -- 180/519
2018-05-26 12:41:35,349:INFO: Experiment Progress: 34.9% -- 181/519
2018-05-26 12:41:35,813:INFO: Experiment Progress: 35.1% -- 182/519
2018-05-26 12:41:36,681:INFO: Experiment Progress: 35.3% -- 183/519
2018-05-26 12:41:37,459:INFO: Experiment Progress: 35.5% -- 184/519
2018-05-26 12:41:41,888:INFO: Experiment Progress: 35.6% -- 185/519
2018-05-26 12:41:43,147:INFO: Experiment Progress: 35.8% -- 186/519
2018-05-26 12:41:43,615:INFO: Experiment Progress: 36.0% -- 187/519
2018-05-26 12:41:44,016:INFO: Experiment Progress: 36.2% -- 188/519
2018-05-26 12:41:44,670:INFO: Experiment Progress: 36.4% -- 189/519
2018-05-26 12:41:45,129:INFO: Experiment Progress: 36.6% -- 190/519
2018-05-26 12:41:45,835:INFO: Experiment Progress: 36.8% -- 191/519
2018-05-26 12:41:46,287:INFO: Experiment Progress: 37.0% -- 192/519
2018-05-26 12:41:48,247:INFO: Experiment Progress: 37.2% -- 193/519
2018-05-26 12:41:48,747:INFO: Experiment Progress: 37.4% -- 194/519
2018-05-26 12:41:49,218:INFO: Experiment Progress: 37.6% -- 195/519
2018-05-26 12:41:49,714:INFO: Experiment Progress: 37.8% -- 196/519
2018-05-26 12:41:50,343:INFO: Experiment Progress: 38.0% -- 197/519
2018-05-26 12:41:51,063:INFO: Experiment Progress: 38.2% -- 198/519
2018-05-26 12:41:52,126:INFO: Experiment Progress: 38.3% -- 199/519
2018-05-26 12:41:52,725:INFO: Experiment Progress: 38.5% -- 200/519
2018-05-26 12:41:53,281:INFO: Experiment Progress: 38.7% -- 201/519
2018-05-26 12:41:53,871:INFO: Experiment Progress: 38.9% -- 202/519
2018-05-26 12:41:54,303:INFO: Experiment Progress: 39.1% -- 203/519
2018-05-26 12:41:54,960:INFO: Experiment Progress: 39.3% -- 204/519
2018-05-26 12:41:55,706:INFO: Experiment Progress: 39.5% -- 205/519
2018-05-26 12:41:56,313:INFO: Experiment Progress: 39.7% -- 206/519
2018-05-26 12:41:56,809:INFO: Experiment Progress: 39.9% -- 207/519
2018-05-26 12:41:57,219:INFO: Experiment Progress: 40.1% -- 208/519
2018-05-26 12:41:57,622:INFO: Experiment Progress: 40.3% -- 209/519
2018-05-26 12:41:58,027:INFO: Experiment Progress: 40.5% -- 210/519
2018-05-26 12:41:58,486:INFO: Experiment Progress: 40.7% -- 211/519
2018-05-26 12:41:58,948:INFO: Experiment Progress: 40.8% -- 212/519
2018-05-26 12:41:59,337:INFO: Experiment Progress: 41.0% -- 213/519
2018-05-26 12:41:59,746:INFO: Experiment Progress: 41.2% -- 214/519
2018-05-26 12:42:00,542:INFO: Experiment Progress: 41.4% -- 215/519
2018-05-26 12:42:01,084:INFO: Experiment Progress: 41.6% -- 216/519
2018-05-26 12:42:01,508:INFO: Experiment Progress: 41.8% -- 217/519
2018-05-26 12:42:02,275:INFO: Experiment Progress: 42.0% -- 218/519
2018-05-26 12:42:02,679:INFO: Experiment Progress: 42.2% -- 219/519
2018-05-26 12:42:02,977:INFO: Experiment Progress: 42.4% -- 220/519
2018-05-26 12:42:03,675:INFO: Experiment Progress: 42.6% -- 221/519
2018-05-26 12:42:04,093:INFO: Experiment Progress: 42.8% -- 222/519
2018-05-26 12:42:05,816:INFO: Experiment Progress: 43.0% -- 223/519
2018-05-26 12:42:06,372:INFO: Experiment Progress: 43.2% -- 224/519
2018-05-26 12:42:06,857:INFO: Experiment Progress: 43.4% -- 225/519
2018-05-26 12:42:07,444:INFO: Experiment Progress: 43.5% -- 226/519
2018-05-26 12:42:07,913:INFO: Experiment Progress: 43.7% -- 227/519
2018-05-26 12:42:08,380:INFO: Experiment Progress: 43.9% -- 228/519
2018-05-26 12:42:09,359:INFO: Experiment Progress: 44.1% -- 229/519
2018-05-26 12:42:09,769:INFO: Experiment Progress: 44.3% -- 230/519
2018-05-26 12:42:10,321:INFO: Experiment Progress: 44.5% -- 231/519
2018-05-26 12:42:11,291:INFO: Experiment Progress: 44.7% -- 232/519
2018-05-26 12:42:11,729:INFO: Experiment Progress: 44.9% -- 233/519
2018-05-26 12:42:13,151:INFO: Experiment Progress: 45.1% -- 234/519
2018-05-26 12:42:14,131:INFO: Experiment Progress: 45.3% -- 235/519
2018-05-26 12:42:14,605:INFO: Experiment Progress: 45.5% -- 236/519
2018-05-26 12:42:15,930:INFO: Experiment Progress: 45.7% -- 237/519
2018-05-26 12:42:16,352:INFO: Experiment Progress: 45.9% -- 238/519
2018-05-26 12:42:16,865:INFO: Experiment Progress: 46.1% -- 239/519
2018-05-26 12:42:17,287:INFO: Experiment Progress: 46.2% -- 240/519
2018-05-26 12:42:17,925:INFO: Experiment Progress: 46.4% -- 241/519
2018-05-26 12:42:19,566:INFO: Experiment Progress: 46.6% -- 242/519
2018-05-26 12:42:21,415:INFO: Experiment Progress: 46.8% -- 243/519
2018-05-26 12:42:21,954:INFO: Experiment Progress: 47.0% -- 244/519
2018-05-26 12:42:22,540:INFO: Experiment Progress: 47.2% -- 245/519
2018-05-26 12:42:23,722:INFO: Experiment Progress: 47.4% -- 246/519
2018-05-26 12:42:24,175:INFO: Experiment Progress: 47.6% -- 247/519
2018-05-26 12:42:26,175:INFO: Experiment Progress: 47.8% -- 248/519
2018-05-26 12:42:26,589:INFO: Experiment Progress: 48.0% -- 249/519
2018-05-26 12:42:27,477:INFO: Experiment Progress: 48.2% -- 250/519
2018-05-26 12:42:27,870:INFO: Experiment Progress: 48.4% -- 251/519
2018-05-26 12:42:28,367:INFO: Experiment Progress: 48.6% -- 252/519
2018-05-26 12:42:29,671:INFO: Experiment Progress: 48.7% -- 253/519
2018-05-26 12:42:29,979:INFO: Experiment Progress: 48.9% -- 254/519
2018-05-26 12:42:30,383:INFO: Experiment Progress: 49.1% -- 255/519
2018-05-26 12:42:30,787:INFO: Experiment Progress: 49.3% -- 256/519
2018-05-26 12:42:31,979:INFO: Experiment Progress: 49.5% -- 257/519
2018-05-26 12:42:32,371:INFO: Experiment Progress: 49.7% -- 258/519
2018-05-26 12:42:32,590:INFO: Experiment Progress: 49.9% -- 259/519
2018-05-26 12:42:33,607:INFO: Experiment Progress: 50.1% -- 260/519
2018-05-26 12:42:35,242:INFO: Experiment Progress: 50.3% -- 261/519
2018-05-26 12:42:35,783:INFO: Experiment Progress: 50.5% -- 262/519
2018-05-26 12:42:36,244:INFO: Experiment Progress: 50.7% -- 263/519
2018-05-26 12:42:36,607:INFO: Experiment Progress: 50.9% -- 264/519
2018-05-26 12:42:37,043:INFO: Experiment Progress: 51.1% -- 265/519
2018-05-26 12:42:37,396:INFO: Experiment Progress: 51.3% -- 266/519
2018-05-26 12:42:39,006:INFO: Experiment Progress: 51.4% -- 267/519
2018-05-26 12:42:39,684:INFO: Experiment Progress: 51.6% -- 268/519
2018-05-26 12:42:40,120:INFO: Experiment Progress: 51.8% -- 269/519
2018-05-26 12:42:40,497:INFO: Experiment Progress: 52.0% -- 270/519
2018-05-26 12:42:41,102:INFO: Experiment Progress: 52.2% -- 271/519
2018-05-26 12:42:41,512:INFO: Experiment Progress: 52.4% -- 272/519
2018-05-26 12:42:42,346:INFO: Experiment Progress: 52.6% -- 273/519
2018-05-26 12:42:42,917:INFO: Experiment Progress: 52.8% -- 274/519
2018-05-26 12:42:43,347:INFO: Experiment Progress: 53.0% -- 275/519
2018-05-26 12:42:43,741:INFO: Experiment Progress: 53.2% -- 276/519
2018-05-26 12:42:44,182:INFO: Experiment Progress: 53.4% -- 277/519
2018-05-26 12:42:46,436:INFO: Experiment Progress: 53.6% -- 278/519
2018-05-26 12:42:46,684:INFO: Experiment Progress: 53.8% -- 279/519
2018-05-26 12:42:47,644:INFO: Experiment Progress: 53.9% -- 280/519
2018-05-26 12:42:56,182:INFO: Experiment Progress: 54.1% -- 281/519
2018-05-26 12:42:56,607:INFO: Experiment Progress: 54.3% -- 282/519
2018-05-26 12:42:57,139:INFO: Experiment Progress: 54.5% -- 283/519
2018-05-26 12:42:57,818:INFO: Experiment Progress: 54.7% -- 284/519
2018-05-26 12:42:58,962:INFO: Experiment Progress: 54.9% -- 285/519
2018-05-26 12:42:59,478:INFO: Experiment Progress: 55.1% -- 286/519
2018-05-26 12:43:00,145:INFO: Experiment Progress: 55.3% -- 287/519
2018-05-26 12:43:00,683:INFO: Experiment Progress: 55.5% -- 288/519
2018-05-26 12:43:01,345:INFO: Experiment Progress: 55.7% -- 289/519
2018-05-26 12:43:02,534:INFO: Experiment Progress: 55.9% -- 290/519
2018-05-26 12:43:03,371:INFO: Experiment Progress: 56.1% -- 291/519
2018-05-26 12:43:04,336:INFO: Experiment Progress: 56.3% -- 292/519
2018-05-26 12:43:05,028:INFO: Experiment Progress: 56.5% -- 293/519
2018-05-26 12:43:05,475:INFO: Experiment Progress: 56.6% -- 294/519
2018-05-26 12:43:06,216:INFO: Experiment Progress: 56.8% -- 295/519
2018-05-26 12:43:06,873:INFO: Experiment Progress: 57.0% -- 296/519
2018-05-26 12:43:07,587:INFO: Experiment Progress: 57.2% -- 297/519
2018-05-26 12:43:10,655:INFO: Experiment Progress: 57.4% -- 298/519
2018-05-26 12:43:11,211:INFO: Experiment Progress: 57.6% -- 299/519
2018-05-26 12:43:11,972:INFO: Experiment Progress: 57.8% -- 300/519
2018-05-26 12:43:12,323:INFO: Experiment Progress: 58.0% -- 301/519
2018-05-26 12:43:12,826:INFO: Experiment Progress: 58.2% -- 302/519
2018-05-26 12:43:13,250:INFO: Experiment Progress: 58.4% -- 303/519
2018-05-26 12:43:13,693:INFO: Experiment Progress: 58.6% -- 304/519
2018-05-26 12:43:14,164:INFO: Experiment Progress: 58.8% -- 305/519
2018-05-26 12:43:14,680:INFO: Experiment Progress: 59.0% -- 306/519
2018-05-26 12:43:15,100:INFO: Experiment Progress: 59.2% -- 307/519
2018-05-26 12:43:15,616:INFO: Experiment Progress: 59.3% -- 308/519
2018-05-26 12:43:16,047:INFO: Experiment Progress: 59.5% -- 309/519
2018-05-26 12:43:16,488:INFO: Experiment Progress: 59.7% -- 310/519
2018-05-26 12:43:16,891:INFO: Experiment Progress: 59.9% -- 311/519
2018-05-26 12:43:17,286:INFO: Experiment Progress: 60.1% -- 312/519
2018-05-26 12:43:17,709:INFO: Experiment Progress: 60.3% -- 313/519
2018-05-26 12:43:18,353:INFO: Experiment Progress: 60.5% -- 314/519
2018-05-26 12:43:19,331:INFO: Experiment Progress: 60.7% -- 315/519
2018-05-26 12:43:20,953:INFO: Experiment Progress: 60.9% -- 316/519
2018-05-26 12:43:21,484:INFO: Experiment Progress: 61.1% -- 317/519
2018-05-26 12:43:22,427:INFO: Experiment Progress: 61.3% -- 318/519
2018-05-26 12:43:24,102:INFO: Experiment Progress: 61.5% -- 319/519
2018-05-26 12:43:26,633:INFO: Experiment Progress: 61.7% -- 320/519
2018-05-26 12:43:27,144:INFO: Experiment Progress: 61.8% -- 321/519
2018-05-26 12:43:28,278:INFO: Experiment Progress: 62.0% -- 322/519
2018-05-26 12:43:28,816:INFO: Experiment Progress: 62.2% -- 323/519
2018-05-26 12:43:29,255:INFO: Experiment Progress: 62.4% -- 324/519
2018-05-26 12:43:29,723:INFO: Experiment Progress: 62.6% -- 325/519
2018-05-26 12:43:30,246:INFO: Experiment Progress: 62.8% -- 326/519
2018-05-26 12:43:30,654:INFO: Experiment Progress: 63.0% -- 327/519
2018-05-26 12:43:31,669:INFO: Experiment Progress: 63.2% -- 328/519
2018-05-26 12:43:32,356:INFO: Experiment Progress: 63.4% -- 329/519
2018-05-26 12:43:33,223:INFO: Experiment Progress: 63.6% -- 330/519
2018-05-26 12:43:34,168:INFO: Experiment Progress: 63.8% -- 331/519
2018-05-26 12:43:35,085:INFO: Experiment Progress: 64.0% -- 332/519
2018-05-26 12:43:36,197:INFO: Experiment Progress: 64.2% -- 333/519
2018-05-26 12:43:36,733:INFO: Experiment Progress: 64.4% -- 334/519
2018-05-26 12:43:37,457:INFO: Experiment Progress: 64.5% -- 335/519
2018-05-26 12:43:38,557:INFO: Experiment Progress: 64.7% -- 336/519
2018-05-26 12:43:39,044:INFO: Experiment Progress: 64.9% -- 337/519
2018-05-26 12:43:40,650:INFO: Experiment Progress: 65.1% -- 338/519
2018-05-26 12:43:41,092:INFO: Experiment Progress: 65.3% -- 339/519
2018-05-26 12:43:41,840:INFO: Experiment Progress: 65.5% -- 340/519
2018-05-26 12:43:42,301:INFO: Experiment Progress: 65.7% -- 341/519
2018-05-26 12:43:42,875:INFO: Experiment Progress: 65.9% -- 342/519
2018-05-26 12:43:43,504:INFO: Experiment Progress: 66.1% -- 343/519
2018-05-26 12:43:44,674:INFO: Experiment Progress: 66.3% -- 344/519
2018-05-26 12:43:45,481:INFO: Experiment Progress: 66.5% -- 345/519
2018-05-26 12:43:45,868:INFO: Experiment Progress: 66.7% -- 346/519
2018-05-26 12:43:46,307:INFO: Experiment Progress: 66.9% -- 347/519
2018-05-26 12:43:46,719:INFO: Experiment Progress: 67.1% -- 348/519
2018-05-26 12:43:47,567:INFO: Experiment Progress: 67.2% -- 349/519
2018-05-26 12:43:48,376:INFO: Experiment Progress: 67.4% -- 350/519
2018-05-26 12:43:48,793:INFO: Experiment Progress: 67.6% -- 351/519
2018-05-26 12:43:49,772:INFO: Experiment Progress: 67.8% -- 352/519
2018-05-26 12:43:50,282:INFO: Experiment Progress: 68.0% -- 353/519
2018-05-26 12:43:50,690:INFO: Experiment Progress: 68.2% -- 354/519
2018-05-26 12:43:51,386:INFO: Experiment Progress: 68.4% -- 355/519
2018-05-26 12:43:51,988:INFO: Experiment Progress: 68.6% -- 356/519
2018-05-26 12:43:52,554:INFO: Experiment Progress: 68.8% -- 357/519
2018-05-26 12:43:53,006:INFO: Experiment Progress: 69.0% -- 358/519
2018-05-26 12:43:53,813:INFO: Experiment Progress: 69.2% -- 359/519
2018-05-26 12:43:54,403:INFO: Experiment Progress: 69.4% -- 360/519
2018-05-26 12:43:54,992:INFO: Experiment Progress: 69.6% -- 361/519
2018-05-26 12:43:55,461:INFO: Experiment Progress: 69.7% -- 362/519
2018-05-26 12:43:55,908:INFO: Experiment Progress: 69.9% -- 363/519
2018-05-26 12:43:56,492:INFO: Experiment Progress: 70.1% -- 364/519
2018-05-26 12:43:57,923:INFO: Experiment Progress: 70.3% -- 365/519
2018-05-26 12:43:58,274:INFO: Experiment Progress: 70.5% -- 366/519
2018-05-26 12:43:59,003:INFO: Experiment Progress: 70.7% -- 367/519
2018-05-26 12:43:59,169:INFO: Experiment Progress: 70.9% -- 368/519
2018-05-26 12:44:00,679:INFO: Experiment Progress: 71.1% -- 369/519
2018-05-26 12:44:01,652:INFO: Experiment Progress: 71.3% -- 370/519
2018-05-26 12:44:02,078:INFO: Experiment Progress: 71.5% -- 371/519
2018-05-26 12:44:02,408:INFO: Experiment Progress: 71.7% -- 372/519
2018-05-26 12:44:04,035:INFO: Experiment Progress: 71.9% -- 373/519
2018-05-26 12:44:05,193:INFO: Experiment Progress: 72.1% -- 374/519
2018-05-26 12:44:06,655:INFO: Experiment Progress: 72.3% -- 375/519
2018-05-26 12:44:07,079:INFO: Experiment Progress: 72.4% -- 376/519
2018-05-26 12:44:07,535:INFO: Experiment Progress: 72.6% -- 377/519
2018-05-26 12:44:08,220:INFO: Experiment Progress: 72.8% -- 378/519
2018-05-26 12:44:08,693:INFO: Experiment Progress: 73.0% -- 379/519
2018-05-26 12:44:09,147:INFO: Experiment Progress: 73.2% -- 380/519
2018-05-26 12:44:09,872:INFO: Experiment Progress: 73.4% -- 381/519
2018-05-26 12:44:10,599:INFO: Experiment Progress: 73.6% -- 382/519
2018-05-26 12:44:11,208:INFO: Experiment Progress: 73.8% -- 383/519
2018-05-26 12:44:11,661:INFO: Experiment Progress: 74.0% -- 384/519
2018-05-26 12:44:12,290:INFO: Experiment Progress: 74.2% -- 385/519
2018-05-26 12:44:12,721:INFO: Experiment Progress: 74.4% -- 386/519
2018-05-26 12:44:13,157:INFO: Experiment Progress: 74.6% -- 387/519
2018-05-26 12:44:13,608:INFO: Experiment Progress: 74.8% -- 388/519
2018-05-26 12:44:14,424:INFO: Experiment Progress: 75.0% -- 389/519
2018-05-26 12:44:14,912:INFO: Experiment Progress: 75.1% -- 390/519
2018-05-26 12:44:16,918:INFO: Experiment Progress: 75.3% -- 391/519
2018-05-26 12:44:17,438:INFO: Experiment Progress: 75.5% -- 392/519
2018-05-26 12:44:18,013:INFO: Experiment Progress: 75.7% -- 393/519
2018-05-26 12:44:18,428:INFO: Experiment Progress: 75.9% -- 394/519
2018-05-26 12:44:18,897:INFO: Experiment Progress: 76.1% -- 395/519
2018-05-26 12:44:19,570:INFO: Experiment Progress: 76.3% -- 396/519
2018-05-26 12:44:20,053:INFO: Experiment Progress: 76.5% -- 397/519
2018-05-26 12:44:20,687:INFO: Experiment Progress: 76.7% -- 398/519
2018-05-26 12:44:21,148:INFO: Experiment Progress: 76.9% -- 399/519
2018-05-26 12:44:21,722:INFO: Experiment Progress: 77.1% -- 400/519
2018-05-26 12:44:22,172:INFO: Experiment Progress: 77.3% -- 401/519
2018-05-26 12:44:22,687:INFO: Experiment Progress: 77.5% -- 402/519
2018-05-26 12:44:23,248:INFO: Experiment Progress: 77.6% -- 403/519
2018-05-26 12:44:23,725:INFO: Experiment Progress: 77.8% -- 404/519
2018-05-26 12:44:24,079:INFO: Experiment Progress: 78.0% -- 405/519
2018-05-26 12:44:25,023:INFO: Experiment Progress: 78.2% -- 406/519
2018-05-26 12:44:26,213:INFO: Experiment Progress: 78.4% -- 407/519
2018-05-26 12:44:26,648:INFO: Experiment Progress: 78.6% -- 408/519
2018-05-26 12:44:27,157:INFO: Experiment Progress: 78.8% -- 409/519
2018-05-26 12:44:27,801:INFO: Experiment Progress: 79.0% -- 410/519
2018-05-26 12:44:28,235:INFO: Experiment Progress: 79.2% -- 411/519
2018-05-26 12:44:28,999:INFO: Experiment Progress: 79.4% -- 412/519
2018-05-26 12:44:29,551:INFO: Experiment Progress: 79.6% -- 413/519
2018-05-26 12:44:30,260:INFO: Experiment Progress: 79.8% -- 414/519
2018-05-26 12:44:31,567:INFO: Experiment Progress: 80.0% -- 415/519
2018-05-26 12:44:32,123:INFO: Experiment Progress: 80.2% -- 416/519
2018-05-26 12:44:32,672:INFO: Experiment Progress: 80.3% -- 417/519
2018-05-26 12:44:33,108:INFO: Experiment Progress: 80.5% -- 418/519
2018-05-26 12:44:33,496:INFO: Experiment Progress: 80.7% -- 419/519
2018-05-26 12:44:33,925:INFO: Experiment Progress: 80.9% -- 420/519
2018-05-26 12:44:34,341:INFO: Experiment Progress: 81.1% -- 421/519
2018-05-26 12:44:34,752:INFO: Experiment Progress: 81.3% -- 422/519
2018-05-26 12:44:35,227:INFO: Experiment Progress: 81.5% -- 423/519
2018-05-26 12:44:35,732:INFO: Experiment Progress: 81.7% -- 424/519
2018-05-26 12:44:36,723:INFO: Experiment Progress: 81.9% -- 425/519
2018-05-26 12:44:37,244:INFO: Experiment Progress: 82.1% -- 426/519
2018-05-26 12:44:37,708:INFO: Experiment Progress: 82.3% -- 427/519
2018-05-26 12:44:39,545:INFO: Experiment Progress: 82.5% -- 428/519
2018-05-26 12:44:40,018:INFO: Experiment Progress: 82.7% -- 429/519
2018-05-26 12:44:40,632:INFO: Experiment Progress: 82.9% -- 430/519
2018-05-26 12:44:41,058:INFO: Experiment Progress: 83.0% -- 431/519
2018-05-26 12:44:41,650:INFO: Experiment Progress: 83.2% -- 432/519
2018-05-26 12:44:42,201:INFO: Experiment Progress: 83.4% -- 433/519
2018-05-26 12:44:42,736:INFO: Experiment Progress: 83.6% -- 434/519
2018-05-26 12:44:43,793:INFO: Experiment Progress: 83.8% -- 435/519
2018-05-26 12:44:45,177:INFO: Experiment Progress: 84.0% -- 436/519
2018-05-26 12:44:45,722:INFO: Experiment Progress: 84.2% -- 437/519
2018-05-26 12:44:46,538:INFO: Experiment Progress: 84.4% -- 438/519
2018-05-26 12:44:46,960:INFO: Experiment Progress: 84.6% -- 439/519
2018-05-26 12:44:47,435:INFO: Experiment Progress: 84.8% -- 440/519
2018-05-26 12:44:48,337:INFO: Experiment Progress: 85.0% -- 441/519
2018-05-26 12:44:48,964:INFO: Experiment Progress: 85.2% -- 442/519
2018-05-26 12:44:49,432:INFO: Experiment Progress: 85.4% -- 443/519
2018-05-26 12:44:49,831:INFO: Experiment Progress: 85.5% -- 444/519
2018-05-26 12:44:50,326:INFO: Experiment Progress: 85.7% -- 445/519
2018-05-26 12:44:50,799:INFO: Experiment Progress: 85.9% -- 446/519
2018-05-26 12:44:51,249:INFO: Experiment Progress: 86.1% -- 447/519
2018-05-26 12:44:51,801:INFO: Experiment Progress: 86.3% -- 448/519
2018-05-26 12:44:52,258:INFO: Experiment Progress: 86.5% -- 449/519
2018-05-26 12:44:52,665:INFO: Experiment Progress: 86.7% -- 450/519
2018-05-26 12:44:53,215:INFO: Experiment Progress: 86.9% -- 451/519
2018-05-26 12:44:53,727:INFO: Experiment Progress: 87.1% -- 452/519
2018-05-26 12:44:54,213:INFO: Experiment Progress: 87.3% -- 453/519
2018-05-26 12:44:54,836:INFO: Experiment Progress: 87.5% -- 454/519
2018-05-26 12:44:55,291:INFO: Experiment Progress: 87.7% -- 455/519
2018-05-26 12:44:56,132:INFO: Experiment Progress: 87.9% -- 456/519
2018-05-26 12:44:56,617:INFO: Experiment Progress: 88.1% -- 457/519
2018-05-26 12:44:57,236:INFO: Experiment Progress: 88.2% -- 458/519
2018-05-26 12:44:57,678:INFO: Experiment Progress: 88.4% -- 459/519
2018-05-26 12:44:58,393:INFO: Experiment Progress: 88.6% -- 460/519
2018-05-26 12:44:59,237:INFO: Experiment Progress: 88.8% -- 461/519
2018-05-26 12:45:03,051:INFO: Experiment Progress: 89.0% -- 462/519
2018-05-26 12:45:03,668:INFO: Experiment Progress: 89.2% -- 463/519
2018-05-26 12:45:04,425:INFO: Experiment Progress: 89.4% -- 464/519
2018-05-26 12:45:05,658:INFO: Experiment Progress: 89.6% -- 465/519
2018-05-26 12:45:06,049:INFO: Experiment Progress: 89.8% -- 466/519
2018-05-26 12:45:06,475:INFO: Experiment Progress: 90.0% -- 467/519
2018-05-26 12:45:06,961:INFO: Experiment Progress: 90.2% -- 468/519
2018-05-26 12:45:07,618:INFO: Experiment Progress: 90.4% -- 469/519
2018-05-26 12:45:08,290:INFO: Experiment Progress: 90.6% -- 470/519
2018-05-26 12:45:09,207:INFO: Experiment Progress: 90.8% -- 471/519
2018-05-26 12:45:09,782:INFO: Experiment Progress: 90.9% -- 472/519
2018-05-26 12:45:17,830:INFO: Experiment Progress: 91.1% -- 473/519
2018-05-26 12:45:18,275:INFO: Experiment Progress: 91.3% -- 474/519
2018-05-26 12:45:18,681:INFO: Experiment Progress: 91.5% -- 475/519
2018-05-26 12:45:19,197:INFO: Experiment Progress: 91.7% -- 476/519
2018-05-26 12:45:19,649:INFO: Experiment Progress: 91.9% -- 477/519
2018-05-26 12:45:20,107:INFO: Experiment Progress: 92.1% -- 478/519
2018-05-26 12:45:20,555:INFO: Experiment Progress: 92.3% -- 479/519
2018-05-26 12:45:24,804:INFO: Experiment Progress: 92.5% -- 480/519
2018-05-26 12:45:25,566:INFO: Experiment Progress: 92.7% -- 481/519
2018-05-26 12:45:26,219:INFO: Experiment Progress: 92.9% -- 482/519
2018-05-26 12:45:26,710:INFO: Experiment Progress: 93.1% -- 483/519
2018-05-26 12:45:27,864:INFO: Experiment Progress: 93.3% -- 484/519
2018-05-26 12:45:29,425:INFO: Experiment Progress: 93.4% -- 485/519
2018-05-26 12:45:29,837:INFO: Experiment Progress: 93.6% -- 486/519
2018-05-26 12:45:30,373:INFO: Experiment Progress: 93.8% -- 487/519
2018-05-26 12:45:30,795:INFO: Experiment Progress: 94.0% -- 488/519
2018-05-26 12:45:31,383:INFO: Experiment Progress: 94.2% -- 489/519
2018-05-26 12:45:31,793:INFO: Experiment Progress: 94.4% -- 490/519
2018-05-26 12:45:32,290:INFO: Experiment Progress: 94.6% -- 491/519
2018-05-26 12:45:32,708:INFO: Experiment Progress: 94.8% -- 492/519
2018-05-26 12:45:33,124:INFO: Experiment Progress: 95.0% -- 493/519
2018-05-26 12:45:33,515:INFO: Experiment Progress: 95.2% -- 494/519
2018-05-26 12:45:34,011:INFO: Experiment Progress: 95.4% -- 495/519
2018-05-26 12:45:35,343:INFO: Experiment Progress: 95.6% -- 496/519
2018-05-26 12:45:35,756:INFO: Experiment Progress: 95.8% -- 497/519
2018-05-26 12:45:36,249:INFO: Experiment Progress: 96.0% -- 498/519
2018-05-26 12:45:36,716:INFO: Experiment Progress: 96.1% -- 499/519
2018-05-26 12:45:37,156:INFO: Experiment Progress: 96.3% -- 500/519
2018-05-26 12:45:37,616:INFO: Experiment Progress: 96.5% -- 501/519
2018-05-26 12:45:38,586:INFO: Experiment Progress: 96.7% -- 502/519
2018-05-26 12:45:39,143:INFO: Experiment Progress: 96.9% -- 503/519
2018-05-26 12:45:39,739:INFO: Experiment Progress: 97.1% -- 504/519
2018-05-26 12:45:40,242:INFO: Experiment Progress: 97.3% -- 505/519
2018-05-26 12:45:40,928:INFO: Experiment Progress: 97.5% -- 506/519
2018-05-26 12:45:41,397:INFO: Experiment Progress: 97.7% -- 507/519
2018-05-26 12:45:41,892:INFO: Experiment Progress: 97.9% -- 508/519
2018-05-26 12:45:43,249:INFO: Experiment Progress: 98.1% -- 509/519
2018-05-26 12:45:44,079:INFO: Experiment Progress: 98.3% -- 510/519
2018-05-26 12:45:44,599:INFO: Experiment Progress: 98.5% -- 511/519
2018-05-26 12:45:46,727:INFO: Experiment Progress: 98.7% -- 512/519
2018-05-26 12:45:47,722:INFO: Experiment Progress: 98.8% -- 513/519
2018-05-26 12:45:48,191:INFO: Experiment Progress: 99.0% -- 514/519
2018-05-26 12:45:48,650:INFO: Experiment Progress: 99.2% -- 515/519
2018-05-26 12:45:49,161:INFO: Experiment Progress: 99.4% -- 516/519
2018-05-26 12:45:49,632:INFO: Experiment Progress: 99.6% -- 517/519
2018-05-26 12:45:50,558:INFO: Experiment Progress: 99.8% -- 518/519
2018-05-27 17:33:00,027:INFO: Disease Protein Prediction in the PPI Network
2018-05-27 17:33:00,027:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-27 17:33:00,027:INFO: ======================================
2018-05-27 17:33:00,028:INFO: Loading PPI Network...
2018-05-27 17:33:16,822:INFO: Loading Disease Associations...
2018-05-27 17:33:16,885:INFO: Loading PPI Matrix...
2018-05-27 17:33:54,273:INFO: Running Experiment...
2018-05-27 17:33:54,277:INFO: Experiment Progress: 0.0% -- 0/519
2018-05-27 17:33:54,994:INFO: Hydrops Fetalis, Non-Immune Recall-at-100: 0.00%
2018-05-27 17:33:54,994:INFO: Experiment Progress: 0.0% -- 1/519
2018-05-27 17:33:55,548:INFO: Psychoses, Substance-Induced Recall-at-100: 0.00%
2018-05-27 17:33:55,548:INFO: Experiment Progress: 0.0% -- 2/519
2018-05-27 17:33:56,039:INFO: Zellweger Syndrome Recall-at-100: 0.00%
2018-05-27 17:33:56,039:INFO: Experiment Progress: 0.0% -- 3/519
2018-05-27 17:33:57,224:INFO: Psoriasis Recall-at-100: 1.43%
2018-05-27 17:33:57,225:INFO: Experiment Progress: 0.0% -- 4/519
2018-05-27 17:33:57,807:INFO: Nephrotic Syndrome Recall-at-100: 0.00%
2018-05-27 17:33:57,807:INFO: Experiment Progress: 0.0% -- 5/519
2018-05-27 17:33:58,320:INFO: Nephrosis Recall-at-100: 0.00%
2018-05-27 17:33:58,320:INFO: Experiment Progress: 1.0% -- 6/519
2018-05-27 17:33:58,827:INFO: Mouth Diseases Recall-at-100: 0.00%
2018-05-27 17:33:58,827:INFO: Experiment Progress: 1.0% -- 7/519
2018-05-27 17:33:59,480:INFO: MITOCHONDRIAL COMPLEX I DEFICIENCY Recall-at-100: 3.33%
2018-05-27 17:33:59,480:INFO: Experiment Progress: 1.0% -- 8/519
2018-05-27 17:34:01,243:INFO: Substance-Related Disorders Recall-at-100: 0.00%
2018-05-27 17:34:01,243:INFO: Experiment Progress: 1.0% -- 9/519
2018-05-27 17:34:01,783:INFO: Anemia, Hemolytic Recall-at-100: 0.00%
2018-05-27 17:34:01,783:INFO: Experiment Progress: 1.0% -- 10/519
2018-05-27 17:34:05,878:INFO: Rheumatoid Arthritis Recall-at-100: 0.95%
2018-05-27 17:34:05,878:INFO: Experiment Progress: 2.0% -- 11/519
2018-05-27 17:34:06,449:INFO: Arthritis, Psoriatic Recall-at-100: 0.00%
2018-05-27 17:34:06,449:INFO: Experiment Progress: 2.0% -- 12/519
2018-05-27 17:34:07,149:INFO: Anemia Recall-at-100: 0.00%
2018-05-27 17:34:07,150:INFO: Experiment Progress: 2.0% -- 13/519
2018-05-27 17:34:07,802:INFO: Cholangiocarcinoma Recall-at-100: 0.00%
2018-05-27 17:34:07,802:INFO: Experiment Progress: 2.0% -- 14/519
2018-05-27 17:34:08,282:INFO: Neuroendocrine Tumors Recall-at-100: 0.00%
2018-05-27 17:34:08,282:INFO: Experiment Progress: 2.0% -- 15/519
2018-05-27 17:34:08,866:INFO: Malaria Recall-at-100: 0.00%
2018-05-27 17:34:08,866:INFO: Experiment Progress: 3.0% -- 16/519
2018-05-27 17:34:09,346:INFO: Hyperhomocysteinemia Recall-at-100: 0.00%
2018-05-27 17:34:09,346:INFO: Experiment Progress: 3.0% -- 17/519
2018-05-27 17:34:10,904:INFO: HIV Infections Recall-at-100: 0.00%
2018-05-27 17:34:10,904:INFO: Experiment Progress: 3.0% -- 18/519
2018-05-27 17:34:11,470:INFO: Ankylosing spondylitis Recall-at-100: 0.00%
2018-05-27 17:34:11,471:INFO: Experiment Progress: 3.0% -- 19/519
2018-05-27 17:34:13,384:INFO: Adenoid Cystic Carcinoma Recall-at-100: 0.00%
2018-05-27 17:34:13,385:INFO: Experiment Progress: 3.0% -- 20/519
2018-05-27 17:34:15,285:INFO: Juvenile arthritis Recall-at-100: 0.77%
2018-05-27 17:34:15,285:INFO: Experiment Progress: 4.0% -- 21/519
2018-05-27 17:34:16,031:INFO: Neoplasms, Experimental Recall-at-100: 0.00%
2018-05-27 17:34:16,031:INFO: Experiment Progress: 4.0% -- 22/519
2018-05-27 17:34:16,547:INFO: Neoplasms, Germ Cell and Embryonal Recall-at-100: 0.00%
2018-05-27 17:34:16,547:INFO: Experiment Progress: 4.0% -- 23/519
2018-05-27 17:34:16,942:INFO: Alopecia Areata Recall-at-100: 0.00%
2018-05-27 17:34:16,942:INFO: Experiment Progress: 4.0% -- 24/519
2018-05-27 17:34:17,472:INFO: Alopecia Recall-at-100: 0.00%
2018-05-27 17:34:17,473:INFO: Experiment Progress: 4.0% -- 25/519
2018-05-27 17:34:18,101:INFO: Bradycardia Recall-at-100: 0.00%
2018-05-27 17:34:18,101:INFO: Experiment Progress: 5.0% -- 26/519
2018-05-27 17:34:18,607:INFO: Common Variable Immunodeficiency Recall-at-100: 0.00%
2018-05-27 17:34:18,608:INFO: Experiment Progress: 5.0% -- 27/519
2018-05-27 17:34:19,276:INFO: Glomerulonephritis Recall-at-100: 0.00%
2018-05-27 17:34:19,276:INFO: Experiment Progress: 5.0% -- 28/519
2018-05-27 17:34:20,128:INFO: Alcoholic Intoxication, Chronic Recall-at-100: 0.00%
2018-05-27 17:34:20,128:INFO: Experiment Progress: 5.0% -- 29/519
2018-05-27 17:34:20,711:INFO: Lung Injury Recall-at-100: 0.00%
2018-05-27 17:34:20,711:INFO: Experiment Progress: 5.0% -- 30/519
2018-05-27 17:34:21,323:INFO: Hypercalcemia Recall-at-100: 0.00%
2018-05-27 17:34:21,323:INFO: Experiment Progress: 5.0% -- 31/519
2018-05-27 17:34:22,274:INFO: Cerebrovascular accident Recall-at-100: 2.50%
2018-05-27 17:34:22,275:INFO: Experiment Progress: 6.0% -- 32/519
2018-05-27 17:34:23,203:INFO: Diaphragmatic Hernia Recall-at-100: 0.00%
2018-05-27 17:34:23,204:INFO: Experiment Progress: 6.0% -- 33/519
2018-05-27 17:34:23,790:INFO: Prostatic Intraepithelial Neoplasias Recall-at-100: 0.00%
2018-05-27 17:34:23,791:INFO: Experiment Progress: 6.0% -- 34/519
2018-05-27 17:34:24,587:INFO: Migraine Disorders Recall-at-100: 0.00%
2018-05-27 17:34:24,587:INFO: Experiment Progress: 6.0% -- 35/519
2018-05-27 17:34:24,893:INFO: Restless Legs Syndrome Recall-at-100: 0.00%
2018-05-27 17:34:24,893:INFO: Experiment Progress: 6.0% -- 36/519
2018-05-27 17:34:25,426:INFO: Brugada Syndrome (disorder) Recall-at-100: 0.00%
2018-05-27 17:34:25,427:INFO: Experiment Progress: 7.0% -- 37/519
2018-05-27 17:34:25,972:INFO: Pathological accumulation of air in tissues Recall-at-100: 0.00%
2018-05-27 17:34:25,973:INFO: Experiment Progress: 7.0% -- 38/519
2018-05-27 17:34:26,603:INFO: Craniosynostosis Recall-at-100: 10.00%
2018-05-27 17:34:26,603:INFO: Experiment Progress: 7.0% -- 39/519
2018-05-27 17:34:27,226:INFO: Head and Neck Neoplasms Recall-at-100: 0.00%
2018-05-27 17:34:27,226:INFO: Experiment Progress: 7.0% -- 40/519
2018-05-27 17:34:27,857:INFO: Brain Neoplasms Recall-at-100: 0.00%
2018-05-27 17:34:27,857:INFO: Experiment Progress: 7.0% -- 41/519
2018-05-27 17:34:28,460:INFO: Hearing Loss, Partial Recall-at-100: 10.00%
2018-05-27 17:34:28,460:INFO: Experiment Progress: 8.0% -- 42/519
2018-05-27 17:34:28,990:INFO: Chromosome Aberrations Recall-at-100: 0.00%
2018-05-27 17:34:28,991:INFO: Experiment Progress: 8.0% -- 43/519
2018-05-27 17:34:29,935:INFO: Chronic Lymphocytic Leukemia Recall-at-100: 0.00%
2018-05-27 17:34:29,935:INFO: Experiment Progress: 8.0% -- 44/519
2018-05-27 17:34:30,528:INFO: Refractive Errors Recall-at-100: 0.00%
2018-05-27 17:34:30,528:INFO: Experiment Progress: 8.0% -- 45/519
2018-05-27 17:34:31,044:INFO: Hepatitis C Recall-at-100: 0.00%
2018-05-27 17:34:31,044:INFO: Experiment Progress: 8.0% -- 46/519
2018-05-27 17:34:31,939:INFO: Mesothelioma Recall-at-100: 0.00%
2018-05-27 17:34:31,939:INFO: Experiment Progress: 9.0% -- 47/519
2018-05-27 17:34:32,155:INFO: Noise-induced hearing loss Recall-at-100: 0.00%
2018-05-27 17:34:32,155:INFO: Experiment Progress: 9.0% -- 48/519
2018-05-27 17:34:33,176:INFO: Inflammatory dermatosis Recall-at-100: 0.00%
2018-05-27 17:34:33,176:INFO: Experiment Progress: 9.0% -- 49/519
2018-05-27 17:34:33,840:INFO: Kallmann Syndrome Recall-at-100: 0.00%
2018-05-27 17:34:33,840:INFO: Experiment Progress: 9.0% -- 50/519
2018-05-27 17:34:34,474:INFO: Lipoidosis Recall-at-100: 0.00%
2018-05-27 17:34:34,474:INFO: Experiment Progress: 9.0% -- 51/519
2018-05-27 17:34:35,418:INFO: Diabetes Mellitus Recall-at-100: 0.00%
2018-05-27 17:34:35,418:INFO: Experiment Progress: 10.0% -- 52/519
2018-05-27 17:34:42,173:INFO: Disease Protein Prediction in the PPI Network
2018-05-27 17:34:42,173:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-27 17:34:42,173:INFO: ======================================
2018-05-27 17:34:42,173:INFO: Loading PPI Network...
2018-05-27 17:34:54,080:INFO: Loading Disease Associations...
2018-05-27 17:34:54,115:INFO: Loading PPI Matrix...
2018-05-27 17:35:19,541:INFO: Running Experiment...
2018-05-27 17:35:19,543:INFO: Experiment Progress: 0.0% -- 0/519
2018-05-27 17:35:20,123:INFO: Hydrops Fetalis, Non-Immune Recall-at-100: 0.00%
2018-05-27 17:35:20,123:INFO: Experiment Progress: 0.0% -- 1/519
2018-05-27 17:35:20,721:INFO: Psychoses, Substance-Induced Recall-at-100: 0.00%
2018-05-27 17:35:20,721:INFO: Experiment Progress: 0.0% -- 2/519
2018-05-27 17:35:21,258:INFO: Zellweger Syndrome Recall-at-100: 0.00%
2018-05-27 17:35:21,259:INFO: Experiment Progress: 0.0% -- 3/519
2018-05-27 17:35:22,380:INFO: Psoriasis Recall-at-100: 1.43%
2018-05-27 17:35:22,380:INFO: Experiment Progress: 0.0% -- 4/519
2018-05-27 17:35:23,006:INFO: Nephrotic Syndrome Recall-at-100: 0.00%
2018-05-27 17:35:23,006:INFO: Experiment Progress: 0.0% -- 5/519
2018-05-27 17:35:23,577:INFO: Nephrosis Recall-at-100: 0.00%
2018-05-27 17:35:23,578:INFO: Experiment Progress: 1.0% -- 6/519
2018-05-27 17:35:24,089:INFO: Mouth Diseases Recall-at-100: 0.00%
2018-05-27 17:35:24,089:INFO: Experiment Progress: 1.0% -- 7/519
2018-05-27 17:35:24,770:INFO: MITOCHONDRIAL COMPLEX I DEFICIENCY Recall-at-100: 3.33%
2018-05-27 17:35:24,770:INFO: Experiment Progress: 1.0% -- 8/519
2018-05-27 17:35:26,434:INFO: Substance-Related Disorders Recall-at-100: 0.00%
2018-05-27 17:35:26,434:INFO: Experiment Progress: 1.0% -- 9/519
2018-05-27 17:35:27,008:INFO: Anemia, Hemolytic Recall-at-100: 0.00%
2018-05-27 17:35:27,008:INFO: Experiment Progress: 1.0% -- 10/519
2018-05-27 17:35:30,739:INFO: Rheumatoid Arthritis Recall-at-100: 0.95%
2018-05-27 17:35:30,739:INFO: Experiment Progress: 2.0% -- 11/519
2018-05-27 17:35:31,288:INFO: Arthritis, Psoriatic Recall-at-100: 0.00%
2018-05-27 17:35:31,288:INFO: Experiment Progress: 2.0% -- 12/519
2018-05-27 17:35:32,046:INFO: Anemia Recall-at-100: 0.00%
2018-05-27 17:35:32,046:INFO: Experiment Progress: 2.0% -- 13/519
2018-05-27 17:35:32,842:INFO: Cholangiocarcinoma Recall-at-100: 0.00%
2018-05-27 17:35:32,843:INFO: Experiment Progress: 2.0% -- 14/519
2018-05-27 17:35:33,415:INFO: Neuroendocrine Tumors Recall-at-100: 0.00%
2018-05-27 17:35:33,415:INFO: Experiment Progress: 2.0% -- 15/519
2018-05-27 17:35:34,165:INFO: Malaria Recall-at-100: 0.00%
2018-05-27 17:35:34,166:INFO: Experiment Progress: 3.0% -- 16/519
2018-05-27 17:35:34,712:INFO: Hyperhomocysteinemia Recall-at-100: 0.00%
2018-05-27 17:35:34,712:INFO: Experiment Progress: 3.0% -- 17/519
2018-05-27 17:35:36,525:INFO: HIV Infections Recall-at-100: 0.00%
2018-05-27 17:35:36,526:INFO: Experiment Progress: 3.0% -- 18/519
2018-05-27 17:35:37,244:INFO: Ankylosing spondylitis Recall-at-100: 0.00%
2018-05-27 17:35:37,244:INFO: Experiment Progress: 3.0% -- 19/519
2018-05-27 17:35:39,179:INFO: Adenoid Cystic Carcinoma Recall-at-100: 0.00%
2018-05-27 17:35:39,179:INFO: Experiment Progress: 3.0% -- 20/519
2018-05-27 17:35:41,460:INFO: Juvenile arthritis Recall-at-100: 0.77%
2018-05-27 17:35:41,461:INFO: Experiment Progress: 4.0% -- 21/519
2018-05-27 17:35:42,377:INFO: Neoplasms, Experimental Recall-at-100: 0.00%
2018-05-27 17:35:42,377:INFO: Experiment Progress: 4.0% -- 22/519
2018-05-27 17:35:43,027:INFO: Neoplasms, Germ Cell and Embryonal Recall-at-100: 0.00%
2018-05-27 17:35:43,027:INFO: Experiment Progress: 4.0% -- 23/519
2018-05-27 17:35:43,510:INFO: Alopecia Areata Recall-at-100: 0.00%
2018-05-27 17:35:43,510:INFO: Experiment Progress: 4.0% -- 24/519
2018-05-27 17:35:44,209:INFO: Alopecia Recall-at-100: 0.00%
2018-05-27 17:35:44,209:INFO: Experiment Progress: 4.0% -- 25/519
2018-05-27 17:35:44,923:INFO: Bradycardia Recall-at-100: 0.00%
2018-05-27 17:35:44,923:INFO: Experiment Progress: 5.0% -- 26/519
2018-05-27 17:35:45,431:INFO: Common Variable Immunodeficiency Recall-at-100: 0.00%
2018-05-27 17:35:45,431:INFO: Experiment Progress: 5.0% -- 27/519
2018-05-27 17:35:46,124:INFO: Glomerulonephritis Recall-at-100: 0.00%
2018-05-27 17:35:46,124:INFO: Experiment Progress: 5.0% -- 28/519
2018-05-27 17:35:46,956:INFO: Alcoholic Intoxication, Chronic Recall-at-100: 0.00%
2018-05-27 17:35:46,956:INFO: Experiment Progress: 5.0% -- 29/519
2018-05-27 17:35:47,619:INFO: Lung Injury Recall-at-100: 0.00%
2018-05-27 17:35:47,619:INFO: Experiment Progress: 5.0% -- 30/519
2018-05-27 17:35:48,108:INFO: Hypercalcemia Recall-at-100: 0.00%
2018-05-27 17:35:48,108:INFO: Experiment Progress: 5.0% -- 31/519
2018-05-27 17:35:48,884:INFO: Cerebrovascular accident Recall-at-100: 2.50%
2018-05-27 17:35:48,884:INFO: Experiment Progress: 6.0% -- 32/519
2018-05-27 17:35:49,694:INFO: Diaphragmatic Hernia Recall-at-100: 0.00%
2018-05-27 17:35:49,695:INFO: Experiment Progress: 6.0% -- 33/519
2018-05-27 17:35:50,183:INFO: Prostatic Intraepithelial Neoplasias Recall-at-100: 0.00%
2018-05-27 17:35:50,183:INFO: Experiment Progress: 6.0% -- 34/519
2018-05-27 17:35:50,862:INFO: Migraine Disorders Recall-at-100: 0.00%
2018-05-27 17:35:50,863:INFO: Experiment Progress: 6.0% -- 35/519
2018-05-27 17:35:51,116:INFO: Restless Legs Syndrome Recall-at-100: 0.00%
2018-05-27 17:35:51,117:INFO: Experiment Progress: 6.0% -- 36/519
2018-05-27 17:35:51,651:INFO: Brugada Syndrome (disorder) Recall-at-100: 0.00%
2018-05-27 17:35:51,652:INFO: Experiment Progress: 7.0% -- 37/519
2018-05-27 17:35:52,132:INFO: Pathological accumulation of air in tissues Recall-at-100: 0.00%
2018-05-27 17:35:52,132:INFO: Experiment Progress: 7.0% -- 38/519
2018-05-27 17:35:52,619:INFO: Craniosynostosis Recall-at-100: 10.00%
2018-05-27 17:35:52,620:INFO: Experiment Progress: 7.0% -- 39/519
2018-05-27 17:35:53,232:INFO: Head and Neck Neoplasms Recall-at-100: 0.00%
2018-05-27 17:35:53,232:INFO: Experiment Progress: 7.0% -- 40/519
2018-05-27 17:35:53,889:INFO: Brain Neoplasms Recall-at-100: 0.00%
2018-05-27 17:35:53,889:INFO: Experiment Progress: 7.0% -- 41/519
2018-05-27 17:35:54,537:INFO: Hearing Loss, Partial Recall-at-100: 10.00%
2018-05-27 17:35:54,537:INFO: Experiment Progress: 8.0% -- 42/519
2018-05-27 17:35:55,189:INFO: Chromosome Aberrations Recall-at-100: 0.00%
2018-05-27 17:35:55,190:INFO: Experiment Progress: 8.0% -- 43/519
2018-05-27 17:35:56,103:INFO: Chronic Lymphocytic Leukemia Recall-at-100: 0.00%
2018-05-27 17:35:56,103:INFO: Experiment Progress: 8.0% -- 44/519
2018-05-27 17:35:56,676:INFO: Refractive Errors Recall-at-100: 0.00%
2018-05-27 17:35:56,677:INFO: Experiment Progress: 8.0% -- 45/519
2018-05-27 17:42:00,248:INFO: Disease Protein Prediction in the PPI Network
2018-05-27 17:42:00,248:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-27 17:42:00,248:INFO: ======================================
2018-05-27 17:42:00,249:INFO: Loading PPI Network...
2018-05-27 17:42:12,739:INFO: Loading Disease Associations...
2018-05-27 17:42:12,775:INFO: Loading PPI Matrix...
2018-05-27 17:42:38,401:INFO: Running Experiment...
2018-05-27 17:42:38,403:INFO: Experiment Progress: 0.0% -- 0/519
2018-05-27 17:42:56,199:INFO: Disease Protein Prediction in the PPI Network
2018-05-27 17:42:56,200:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-27 17:42:56,200:INFO: ======================================
2018-05-27 17:42:56,200:INFO: Loading PPI Network...
2018-05-27 17:43:08,254:INFO: Loading Disease Associations...
2018-05-27 17:43:08,297:INFO: Loading PPI Matrix...
2018-05-27 17:43:33,229:INFO: Running Experiment...
2018-05-27 17:43:33,233:INFO: Experiment Progress: 0.0% -- 0/519
2018-05-27 17:43:52,850:INFO: Disease Protein Prediction in the PPI Network
2018-05-27 17:43:52,850:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-27 17:43:52,850:INFO: ======================================
2018-05-27 17:43:52,850:INFO: Loading PPI Network...
2018-05-27 17:44:05,341:INFO: Loading Disease Associations...
2018-05-27 17:44:05,374:INFO: Loading PPI Matrix...
2018-05-27 17:44:37,351:INFO: Running Experiment...
2018-05-27 17:44:37,353:INFO: Experiment Progress: 0.0% -- 0/519
2018-05-27 17:45:04,929:INFO: Disease Protein Prediction in the PPI Network
2018-05-27 17:45:04,929:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-27 17:45:04,929:INFO: ======================================
2018-05-27 17:45:04,929:INFO: Loading PPI Network...
2018-05-27 17:45:16,594:INFO: Loading Disease Associations...
2018-05-27 17:45:16,630:INFO: Loading PPI Matrix...
2018-05-27 17:45:39,721:INFO: Running Experiment...
2018-05-27 17:45:39,722:INFO: Experiment Progress: 0.0% -- 0/519
2018-05-27 17:52:50,913:INFO: Disease Protein Prediction in the PPI Network
2018-05-27 17:52:50,913:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-27 17:52:50,914:INFO: ======================================
2018-05-27 17:52:50,914:INFO: Loading PPI Network...
2018-05-27 17:53:03,791:INFO: Loading Disease Associations...
2018-05-27 17:53:03,829:INFO: Loading PPI Matrix...
2018-05-27 17:53:44,361:INFO: Running Experiment...
2018-05-27 17:53:44,365:INFO: Experiment Progress: 0.0% -- 0/519
2018-05-27 17:53:45,232:INFO: Hydrops Fetalis, Non-Immune Recall-at-100: 0.00%
2018-05-27 17:53:45,232:INFO: Experiment Progress: 0.0% -- 1/519
2018-05-27 17:53:46,078:INFO: Psychoses, Substance-Induced Recall-at-100: 0.00%
2018-05-27 17:53:46,078:INFO: Experiment Progress: 0.0% -- 2/519
2018-05-27 17:53:46,812:INFO: Zellweger Syndrome Recall-at-100: 0.00%
2018-05-27 17:53:46,812:INFO: Experiment Progress: 0.0% -- 3/519
2018-05-27 17:53:48,697:INFO: Psoriasis Recall-at-100: 1.43%
2018-05-27 17:53:48,697:INFO: Experiment Progress: 0.0% -- 4/519
2018-05-27 17:53:49,564:INFO: Nephrotic Syndrome Recall-at-100: 0.00%
2018-05-27 17:53:49,564:INFO: Experiment Progress: 0.0% -- 5/519
2018-05-27 17:53:50,306:INFO: Nephrosis Recall-at-100: 0.00%
2018-05-27 17:53:50,306:INFO: Experiment Progress: 1.0% -- 6/519
2018-05-27 17:53:50,978:INFO: Mouth Diseases Recall-at-100: 0.00%
2018-05-27 17:53:50,978:INFO: Experiment Progress: 1.0% -- 7/519
2018-05-27 17:53:51,974:INFO: MITOCHONDRIAL COMPLEX I DEFICIENCY Recall-at-100: 3.33%
2018-05-27 17:53:51,974:INFO: Experiment Progress: 1.0% -- 8/519
2018-05-27 17:53:55,053:INFO: Substance-Related Disorders Recall-at-100: 0.00%
2018-05-27 17:53:55,053:INFO: Experiment Progress: 1.0% -- 9/519
2018-05-27 17:53:55,747:INFO: Anemia, Hemolytic Recall-at-100: 0.00%
2018-05-27 17:53:55,747:INFO: Experiment Progress: 1.0% -- 10/519
2018-05-27 17:54:01,480:INFO: Rheumatoid Arthritis Recall-at-100: 0.48%
2018-05-27 17:54:01,480:INFO: Experiment Progress: 2.0% -- 11/519
2018-05-27 17:54:02,371:INFO: Arthritis, Psoriatic Recall-at-100: 0.00%
2018-05-27 17:54:02,371:INFO: Experiment Progress: 2.0% -- 12/519
2018-05-27 17:54:03,608:INFO: Anemia Recall-at-100: 0.00%
2018-05-27 17:54:03,608:INFO: Experiment Progress: 2.0% -- 13/519
2018-05-27 17:54:04,580:INFO: Cholangiocarcinoma Recall-at-100: 0.00%
2018-05-27 17:54:04,580:INFO: Experiment Progress: 2.0% -- 14/519
2018-05-27 17:54:05,198:INFO: Neuroendocrine Tumors Recall-at-100: 0.00%
2018-05-27 17:54:05,198:INFO: Experiment Progress: 2.0% -- 15/519
2018-05-27 17:54:06,142:INFO: Malaria Recall-at-100: 0.00%
2018-05-27 17:54:06,142:INFO: Experiment Progress: 3.0% -- 16/519
2018-05-27 17:54:06,807:INFO: Hyperhomocysteinemia Recall-at-100: 0.00%
2018-05-27 17:54:06,807:INFO: Experiment Progress: 3.0% -- 17/519
2018-05-27 17:54:09,333:INFO: HIV Infections Recall-at-100: 0.00%
2018-05-27 17:54:09,333:INFO: Experiment Progress: 3.0% -- 18/519
2018-05-27 17:54:10,072:INFO: Ankylosing spondylitis Recall-at-100: 0.00%
2018-05-27 17:54:10,072:INFO: Experiment Progress: 3.0% -- 19/519
2018-05-27 17:54:12,663:INFO: Adenoid Cystic Carcinoma Recall-at-100: 0.00%
2018-05-27 17:54:12,663:INFO: Experiment Progress: 3.0% -- 20/519
2018-05-27 17:54:15,809:INFO: Juvenile arthritis Recall-at-100: 0.77%
2018-05-27 17:54:15,809:INFO: Experiment Progress: 4.0% -- 21/519
2018-05-27 17:54:16,935:INFO: Neoplasms, Experimental Recall-at-100: 0.00%
2018-05-27 17:54:16,935:INFO: Experiment Progress: 4.0% -- 22/519
2018-05-27 17:54:17,651:INFO: Neoplasms, Germ Cell and Embryonal Recall-at-100: 0.00%
2018-05-27 17:54:17,651:INFO: Experiment Progress: 4.0% -- 23/519
2018-05-27 17:54:18,167:INFO: Alopecia Areata Recall-at-100: 0.00%
2018-05-27 17:54:18,167:INFO: Experiment Progress: 4.0% -- 24/519
2018-05-27 17:54:18,893:INFO: Alopecia Recall-at-100: 0.00%
2018-05-27 17:54:18,893:INFO: Experiment Progress: 4.0% -- 25/519
2018-05-27 17:54:19,890:INFO: Bradycardia Recall-at-100: 0.00%
2018-05-27 17:54:19,890:INFO: Experiment Progress: 5.0% -- 26/519
2018-05-27 17:54:20,582:INFO: Common Variable Immunodeficiency Recall-at-100: 0.00%
2018-05-27 17:54:20,582:INFO: Experiment Progress: 5.0% -- 27/519
2018-05-27 17:54:21,848:INFO: Glomerulonephritis Recall-at-100: 0.00%
2018-05-27 17:54:21,848:INFO: Experiment Progress: 5.0% -- 28/519
2018-05-27 17:54:23,520:INFO: Alcoholic Intoxication, Chronic Recall-at-100: 0.00%
2018-05-27 17:54:23,520:INFO: Experiment Progress: 5.0% -- 29/519
2018-05-27 17:54:24,847:INFO: Lung Injury Recall-at-100: 0.00%
2018-05-27 17:54:24,847:INFO: Experiment Progress: 5.0% -- 30/519
2018-05-27 17:54:25,630:INFO: Hypercalcemia Recall-at-100: 0.00%
2018-05-27 17:54:25,630:INFO: Experiment Progress: 5.0% -- 31/519
2018-05-27 17:54:26,941:INFO: Cerebrovascular accident Recall-at-100: 2.50%
2018-05-27 17:54:26,941:INFO: Experiment Progress: 6.0% -- 32/519
2018-05-27 17:54:28,471:INFO: Diaphragmatic Hernia Recall-at-100: 0.00%
2018-05-27 17:54:28,471:INFO: Experiment Progress: 6.0% -- 33/519
2018-05-27 17:54:29,142:INFO: Prostatic Intraepithelial Neoplasias Recall-at-100: 0.00%
2018-05-27 17:54:29,142:INFO: Experiment Progress: 6.0% -- 34/519
2018-05-27 17:54:30,146:INFO: Migraine Disorders Recall-at-100: 0.00%
2018-05-27 17:54:30,146:INFO: Experiment Progress: 6.0% -- 35/519
2018-05-27 17:54:30,472:INFO: Restless Legs Syndrome Recall-at-100: 0.00%
2018-05-27 17:54:30,472:INFO: Experiment Progress: 6.0% -- 36/519
2018-05-27 17:54:31,262:INFO: Brugada Syndrome (disorder) Recall-at-100: 0.00%
2018-05-27 17:54:31,264:INFO: Experiment Progress: 7.0% -- 37/519
2018-05-27 17:54:31,973:INFO: Pathological accumulation of air in tissues Recall-at-100: 0.00%
2018-05-27 17:54:31,973:INFO: Experiment Progress: 7.0% -- 38/519
2018-05-27 17:54:32,681:INFO: Craniosynostosis Recall-at-100: 10.00%
2018-05-27 17:54:32,681:INFO: Experiment Progress: 7.0% -- 39/519
2018-05-27 17:54:33,706:INFO: Head and Neck Neoplasms Recall-at-100: 0.00%
2018-05-27 17:54:33,707:INFO: Experiment Progress: 7.0% -- 40/519
2018-05-27 17:56:47,328:INFO: Disease Protein Prediction in the PPI Network
2018-05-27 17:56:47,328:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-27 17:56:47,329:INFO: ======================================
2018-05-27 17:56:47,331:INFO: Loading PPI Network...
2018-05-27 17:56:59,133:INFO: Loading Disease Associations...
2018-05-27 17:56:59,165:INFO: Loading PPI Matrix...
2018-05-27 17:57:26,349:INFO: Running Experiment...
2018-05-27 17:57:26,357:INFO: Experiment Progress: 0.0% -- 0/519
2018-05-27 17:57:27,124:INFO: Hydrops Fetalis, Non-Immune Recall-at-100: 0.00%
2018-05-27 17:57:27,124:INFO: Experiment Progress: 0.0% -- 1/519
2018-05-27 17:57:27,827:INFO: Psychoses, Substance-Induced Recall-at-100: 0.00%
2018-05-27 17:57:27,827:INFO: Experiment Progress: 0.0% -- 2/519
2018-05-27 17:57:28,486:INFO: Zellweger Syndrome Recall-at-100: 0.00%
2018-05-27 17:57:28,488:INFO: Experiment Progress: 0.0% -- 3/519
2018-05-27 17:57:30,312:INFO: Psoriasis Recall-at-100: 1.43%
2018-05-27 17:57:30,313:INFO: Experiment Progress: 0.0% -- 4/519
2018-05-27 17:57:31,123:INFO: Nephrotic Syndrome Recall-at-100: 0.00%
2018-05-27 17:57:31,123:INFO: Experiment Progress: 0.0% -- 5/519
2018-05-27 17:57:31,783:INFO: Nephrosis Recall-at-100: 0.00%
2018-05-27 17:57:31,783:INFO: Experiment Progress: 1.0% -- 6/519
2018-05-27 17:57:32,363:INFO: Mouth Diseases Recall-at-100: 0.00%
2018-05-27 17:57:32,363:INFO: Experiment Progress: 1.0% -- 7/519
2018-05-27 17:57:33,256:INFO: MITOCHONDRIAL COMPLEX I DEFICIENCY Recall-at-100: 3.33%
2018-05-27 17:57:33,258:INFO: Experiment Progress: 1.0% -- 8/519
2018-05-27 17:57:35,897:INFO: Substance-Related Disorders Recall-at-100: 0.00%
2018-05-27 17:57:35,898:INFO: Experiment Progress: 1.0% -- 9/519
2018-05-27 17:57:36,437:INFO: Anemia, Hemolytic Recall-at-100: 0.00%
2018-05-27 17:57:36,437:INFO: Experiment Progress: 1.0% -- 10/519
2018-05-27 17:57:43,091:INFO: Rheumatoid Arthritis Recall-at-100: 0.48%
2018-05-27 17:57:43,091:INFO: Experiment Progress: 2.0% -- 11/519
2018-05-27 17:57:43,778:INFO: Arthritis, Psoriatic Recall-at-100: 0.00%
2018-05-27 17:57:43,778:INFO: Experiment Progress: 2.0% -- 12/519
2018-05-27 17:57:44,765:INFO: Anemia Recall-at-100: 0.00%
2018-05-27 17:57:44,765:INFO: Experiment Progress: 2.0% -- 13/519
2018-05-27 17:57:45,601:INFO: Cholangiocarcinoma Recall-at-100: 0.00%
2018-05-27 17:57:45,601:INFO: Experiment Progress: 2.0% -- 14/519
2018-05-27 17:57:46,160:INFO: Neuroendocrine Tumors Recall-at-100: 0.00%
2018-05-27 17:57:46,160:INFO: Experiment Progress: 2.0% -- 15/519
2018-05-27 17:57:46,912:INFO: Malaria Recall-at-100: 0.00%
2018-05-27 17:57:46,913:INFO: Experiment Progress: 3.0% -- 16/519
2018-05-27 17:57:47,577:INFO: Hyperhomocysteinemia Recall-at-100: 0.00%
2018-05-27 17:57:47,577:INFO: Experiment Progress: 3.0% -- 17/519
2018-05-27 17:57:49,993:INFO: HIV Infections Recall-at-100: 0.00%
2018-05-27 17:57:49,993:INFO: Experiment Progress: 3.0% -- 18/519
2018-05-27 17:57:50,734:INFO: Ankylosing spondylitis Recall-at-100: 0.00%
2018-05-27 17:57:50,734:INFO: Experiment Progress: 3.0% -- 19/519
2018-05-27 17:57:53,629:INFO: Adenoid Cystic Carcinoma Recall-at-100: 0.00%
2018-05-27 17:57:53,629:INFO: Experiment Progress: 3.0% -- 20/519
2018-05-27 17:57:56,897:INFO: Juvenile arthritis Recall-at-100: 0.77%
2018-05-27 17:57:56,897:INFO: Experiment Progress: 4.0% -- 21/519
2018-05-27 17:57:57,998:INFO: Neoplasms, Experimental Recall-at-100: 0.00%
2018-05-27 17:57:57,998:INFO: Experiment Progress: 4.0% -- 22/519
2018-05-27 17:57:58,621:INFO: Neoplasms, Germ Cell and Embryonal Recall-at-100: 0.00%
2018-05-27 17:57:58,621:INFO: Experiment Progress: 4.0% -- 23/519
2018-05-27 17:57:59,138:INFO: Alopecia Areata Recall-at-100: 0.00%
2018-05-27 17:57:59,138:INFO: Experiment Progress: 4.0% -- 24/519
2018-05-27 17:57:59,812:INFO: Alopecia Recall-at-100: 0.00%
2018-05-27 17:57:59,812:INFO: Experiment Progress: 4.0% -- 25/519
2018-05-27 17:58:00,863:INFO: Bradycardia Recall-at-100: 0.00%
2018-05-27 17:58:00,863:INFO: Experiment Progress: 5.0% -- 26/519
2018-05-27 17:58:01,681:INFO: Common Variable Immunodeficiency Recall-at-100: 0.00%
2018-05-27 17:58:01,681:INFO: Experiment Progress: 5.0% -- 27/519
2018-05-27 17:58:03,012:INFO: Glomerulonephritis Recall-at-100: 0.00%
2018-05-27 17:58:03,013:INFO: Experiment Progress: 5.0% -- 28/519
2018-05-27 17:58:04,534:INFO: Alcoholic Intoxication, Chronic Recall-at-100: 0.00%
2018-05-27 17:58:04,534:INFO: Experiment Progress: 5.0% -- 29/519
2018-05-27 17:58:05,492:INFO: Lung Injury Recall-at-100: 0.00%
2018-05-27 17:58:05,492:INFO: Experiment Progress: 5.0% -- 30/519
2018-05-27 17:58:06,061:INFO: Hypercalcemia Recall-at-100: 0.00%
2018-05-27 17:58:06,061:INFO: Experiment Progress: 5.0% -- 31/519
2018-05-27 17:58:07,572:INFO: Cerebrovascular accident Recall-at-100: 2.50%
2018-05-27 17:58:07,572:INFO: Experiment Progress: 6.0% -- 32/519
2018-05-27 17:58:09,110:INFO: Diaphragmatic Hernia Recall-at-100: 0.00%
2018-05-27 17:58:09,111:INFO: Experiment Progress: 6.0% -- 33/519
2018-05-27 17:58:09,843:INFO: Prostatic Intraepithelial Neoplasias Recall-at-100: 0.00%
2018-05-27 17:58:09,844:INFO: Experiment Progress: 6.0% -- 34/519
2018-05-27 17:58:10,798:INFO: Migraine Disorders Recall-at-100: 0.00%
2018-05-27 17:58:10,798:INFO: Experiment Progress: 6.0% -- 35/519
2018-05-27 17:58:11,131:INFO: Restless Legs Syndrome Recall-at-100: 0.00%
2018-05-27 17:58:11,131:INFO: Experiment Progress: 6.0% -- 36/519
2018-05-27 17:58:11,826:INFO: Brugada Syndrome (disorder) Recall-at-100: 0.00%
2018-05-27 17:58:11,826:INFO: Experiment Progress: 7.0% -- 37/519
2018-05-27 17:58:12,439:INFO: Pathological accumulation of air in tissues Recall-at-100: 0.00%
2018-05-27 17:58:12,439:INFO: Experiment Progress: 7.0% -- 38/519
2018-05-27 17:58:13,072:INFO: Craniosynostosis Recall-at-100: 10.00%
2018-05-27 17:58:13,072:INFO: Experiment Progress: 7.0% -- 39/519
2018-05-27 17:58:13,915:INFO: Head and Neck Neoplasms Recall-at-100: 0.00%
2018-05-27 17:58:13,915:INFO: Experiment Progress: 7.0% -- 40/519
2018-05-27 17:58:14,793:INFO: Brain Neoplasms Recall-at-100: 0.00%
2018-05-27 17:58:14,794:INFO: Experiment Progress: 7.0% -- 41/519
2018-05-27 17:58:15,644:INFO: Hearing Loss, Partial Recall-at-100: 10.00%
2018-05-27 17:58:15,644:INFO: Experiment Progress: 8.0% -- 42/519
2018-05-27 17:58:16,403:INFO: Chromosome Aberrations Recall-at-100: 0.00%
2018-05-27 17:58:16,403:INFO: Experiment Progress: 8.0% -- 43/519
2018-05-27 17:58:17,937:INFO: Chronic Lymphocytic Leukemia Recall-at-100: 0.00%
2018-05-27 17:58:17,937:INFO: Experiment Progress: 8.0% -- 44/519
2018-05-27 17:58:18,679:INFO: Refractive Errors Recall-at-100: 0.00%
2018-05-27 17:58:18,680:INFO: Experiment Progress: 8.0% -- 45/519
2018-05-27 17:58:19,465:INFO: Hepatitis C Recall-at-100: 0.00%
2018-05-27 17:58:19,466:INFO: Experiment Progress: 8.0% -- 46/519
2018-05-27 17:58:21,180:INFO: Mesothelioma Recall-at-100: 0.00%
2018-05-27 17:58:21,181:INFO: Experiment Progress: 9.0% -- 47/519
2018-05-27 17:58:21,378:INFO: Noise-induced hearing loss Recall-at-100: 0.00%
2018-05-27 17:58:21,379:INFO: Experiment Progress: 9.0% -- 48/519
2018-05-27 17:58:22,376:INFO: Inflammatory dermatosis Recall-at-100: 0.00%
2018-05-27 17:58:22,376:INFO: Experiment Progress: 9.0% -- 49/519
2018-05-27 17:58:23,111:INFO: Kallmann Syndrome Recall-at-100: 0.00%
2018-05-27 17:58:23,112:INFO: Experiment Progress: 9.0% -- 50/519
2018-05-27 17:58:23,814:INFO: Lipoidosis Recall-at-100: 0.00%
2018-05-27 17:58:23,814:INFO: Experiment Progress: 9.0% -- 51/519
2018-05-27 17:58:24,663:INFO: Diabetes Mellitus Recall-at-100: 0.00%
2018-05-27 17:58:24,663:INFO: Experiment Progress: 10.0% -- 52/519
2018-05-27 17:58:25,761:INFO: Fibrosis Recall-at-100: 0.00%
2018-05-27 17:58:25,761:INFO: Experiment Progress: 10.0% -- 53/519
2018-05-27 17:58:26,804:INFO: Hypercholesterolemia Recall-at-100: 0.00%
2018-05-27 17:58:26,804:INFO: Experiment Progress: 10.0% -- 54/519
2018-05-27 17:58:27,736:INFO: Microcephaly Recall-at-100: 0.00%
2018-05-27 17:58:27,736:INFO: Experiment Progress: 10.0% -- 55/519
2018-05-27 17:58:47,226:INFO: Disease Protein Prediction in the PPI Network
2018-05-27 17:58:47,226:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-27 17:58:47,226:INFO: ======================================
2018-05-27 17:58:47,226:INFO: Loading PPI Network...
2018-05-27 17:59:00,621:INFO: Loading Disease Associations...
2018-05-27 17:59:00,659:INFO: Loading PPI Matrix...
2018-05-27 17:59:26,836:INFO: Running Experiment...
2018-05-27 17:59:26,841:INFO: Experiment Progress: 0.0% -- 0/519
2018-05-27 17:59:28,766:INFO: Hydrops Fetalis, Non-Immune Recall-at-100: 0.00%
2018-05-27 17:59:28,767:INFO: Experiment Progress: 0.0% -- 1/519
2018-05-27 17:59:30,723:INFO: Psychoses, Substance-Induced Recall-at-100: 0.00%
2018-05-27 17:59:30,724:INFO: Experiment Progress: 0.0% -- 2/519
2018-05-27 17:59:32,128:INFO: Zellweger Syndrome Recall-at-100: 0.00%
2018-05-27 17:59:32,129:INFO: Experiment Progress: 0.0% -- 3/519
2018-05-27 17:59:34,512:INFO: Psoriasis Recall-at-100: 0.00%
2018-05-27 17:59:34,512:INFO: Experiment Progress: 0.0% -- 4/519
2018-05-27 17:59:35,937:INFO: Nephrotic Syndrome Recall-at-100: 0.00%
2018-05-27 17:59:35,937:INFO: Experiment Progress: 0.0% -- 5/519
2018-05-27 17:59:36,843:INFO: Nephrosis Recall-at-100: 0.00%
2018-05-27 17:59:36,843:INFO: Experiment Progress: 1.0% -- 6/519
2018-05-27 17:59:37,624:INFO: Mouth Diseases Recall-at-100: 10.00%
2018-05-27 17:59:37,624:INFO: Experiment Progress: 1.0% -- 7/519
2018-05-27 17:59:38,895:INFO: MITOCHONDRIAL COMPLEX I DEFICIENCY Recall-at-100: 6.67%
2018-05-27 17:59:38,895:INFO: Experiment Progress: 1.0% -- 8/519
2018-05-27 17:59:42,122:INFO: Substance-Related Disorders Recall-at-100: 0.00%
2018-05-27 17:59:42,122:INFO: Experiment Progress: 1.0% -- 9/519
2018-05-27 17:59:42,752:INFO: Anemia, Hemolytic Recall-at-100: 0.00%
2018-05-27 17:59:42,752:INFO: Experiment Progress: 1.0% -- 10/519
2018-05-27 17:59:50,619:INFO: Rheumatoid Arthritis Recall-at-100: 0.00%
2018-05-27 17:59:50,619:INFO: Experiment Progress: 2.0% -- 11/519
2018-05-27 17:59:51,407:INFO: Arthritis, Psoriatic Recall-at-100: 0.00%
2018-05-27 17:59:51,407:INFO: Experiment Progress: 2.0% -- 12/519
2018-05-27 17:59:52,358:INFO: Anemia Recall-at-100: 0.00%
2018-05-27 17:59:52,358:INFO: Experiment Progress: 2.0% -- 13/519
2018-05-27 17:59:53,271:INFO: Cholangiocarcinoma Recall-at-100: 0.00%
2018-05-27 17:59:53,272:INFO: Experiment Progress: 2.0% -- 14/519
2018-05-27 17:59:53,850:INFO: Neuroendocrine Tumors Recall-at-100: 0.00%
2018-05-27 17:59:53,850:INFO: Experiment Progress: 2.0% -- 15/519
2018-05-27 17:59:54,617:INFO: Malaria Recall-at-100: 0.00%
2018-05-27 17:59:54,618:INFO: Experiment Progress: 3.0% -- 16/519
2018-05-27 17:59:55,204:INFO: Hyperhomocysteinemia Recall-at-100: 0.00%
2018-05-27 17:59:55,204:INFO: Experiment Progress: 3.0% -- 17/519
2018-05-27 17:59:57,852:INFO: HIV Infections Recall-at-100: 0.00%
2018-05-27 17:59:57,852:INFO: Experiment Progress: 3.0% -- 18/519
2018-05-27 17:59:58,493:INFO: Ankylosing spondylitis Recall-at-100: 0.00%
2018-05-27 17:59:58,493:INFO: Experiment Progress: 3.0% -- 19/519
2018-05-27 18:00:01,153:INFO: Adenoid Cystic Carcinoma Recall-at-100: 1.00%
2018-05-27 18:00:01,153:INFO: Experiment Progress: 3.0% -- 20/519
2018-05-27 18:00:04,459:INFO: Juvenile arthritis Recall-at-100: 1.60%
2018-05-27 18:00:04,459:INFO: Experiment Progress: 4.0% -- 21/519
2018-05-27 18:00:05,539:INFO: Neoplasms, Experimental Recall-at-100: 0.00%
2018-05-27 18:00:05,539:INFO: Experiment Progress: 4.0% -- 22/519
2018-05-27 18:00:06,193:INFO: Neoplasms, Germ Cell and Embryonal Recall-at-100: 0.00%
2018-05-27 18:00:06,193:INFO: Experiment Progress: 4.0% -- 23/519
2018-05-27 18:00:06,658:INFO: Alopecia Areata Recall-at-100: 0.00%
2018-05-27 18:00:06,658:INFO: Experiment Progress: 4.0% -- 24/519
2018-05-27 18:00:07,332:INFO: Alopecia Recall-at-100: 0.00%
2018-05-27 18:00:07,333:INFO: Experiment Progress: 4.0% -- 25/519
2018-05-27 18:00:08,181:INFO: Bradycardia Recall-at-100: 0.00%
2018-05-27 18:00:08,182:INFO: Experiment Progress: 5.0% -- 26/519
2018-05-27 18:00:08,782:INFO: Common Variable Immunodeficiency Recall-at-100: 5.00%
2018-05-27 18:00:08,782:INFO: Experiment Progress: 5.0% -- 27/519
2018-05-27 18:00:09,698:INFO: Glomerulonephritis Recall-at-100: 0.00%
2018-05-27 18:00:09,698:INFO: Experiment Progress: 5.0% -- 28/519
2018-05-27 18:00:10,861:INFO: Alcoholic Intoxication, Chronic Recall-at-100: 2.50%
2018-05-27 18:00:10,861:INFO: Experiment Progress: 5.0% -- 29/519
2018-05-27 18:00:11,617:INFO: Lung Injury Recall-at-100: 0.00%
2018-05-27 18:00:11,617:INFO: Experiment Progress: 5.0% -- 30/519
2018-05-27 18:00:12,179:INFO: Hypercalcemia Recall-at-100: 0.00%
2018-05-27 18:00:12,180:INFO: Experiment Progress: 5.0% -- 31/519
2018-05-27 18:00:13,281:INFO: Cerebrovascular accident Recall-at-100: 0.00%
2018-05-27 18:00:13,281:INFO: Experiment Progress: 6.0% -- 32/519
2018-05-27 18:00:14,467:INFO: Diaphragmatic Hernia Recall-at-100: 0.00%
2018-05-27 18:00:14,467:INFO: Experiment Progress: 6.0% -- 33/519
2018-05-27 18:00:15,043:INFO: Prostatic Intraepithelial Neoplasias Recall-at-100: 0.00%
2018-05-27 18:00:15,043:INFO: Experiment Progress: 6.0% -- 34/519
2018-05-27 18:00:15,967:INFO: Migraine Disorders Recall-at-100: 0.00%
2018-05-27 18:00:15,968:INFO: Experiment Progress: 6.0% -- 35/519
2018-05-27 18:00:16,259:INFO: Restless Legs Syndrome Recall-at-100: 0.00%
2018-05-27 18:00:16,259:INFO: Experiment Progress: 6.0% -- 36/519
2018-05-27 18:00:16,941:INFO: Brugada Syndrome (disorder) Recall-at-100: 5.00%
2018-05-27 18:00:16,941:INFO: Experiment Progress: 7.0% -- 37/519
2018-05-27 18:00:17,532:INFO: Pathological accumulation of air in tissues Recall-at-100: 10.00%
2018-05-27 18:00:17,532:INFO: Experiment Progress: 7.0% -- 38/519
2018-05-27 18:00:18,116:INFO: Craniosynostosis Recall-at-100: 10.00%
2018-05-27 18:00:18,117:INFO: Experiment Progress: 7.0% -- 39/519
2018-05-27 18:00:18,959:INFO: Head and Neck Neoplasms Recall-at-100: 0.00%
2018-05-27 18:00:18,959:INFO: Experiment Progress: 7.0% -- 40/519
2018-05-27 18:00:19,776:INFO: Brain Neoplasms Recall-at-100: 0.00%
2018-05-27 18:00:19,776:INFO: Experiment Progress: 7.0% -- 41/519
2018-05-27 18:00:20,584:INFO: Hearing Loss, Partial Recall-at-100: 5.00%
2018-05-27 18:00:20,585:INFO: Experiment Progress: 8.0% -- 42/519
2018-05-27 18:00:21,286:INFO: Chromosome Aberrations Recall-at-100: 0.00%
2018-05-27 18:00:21,287:INFO: Experiment Progress: 8.0% -- 43/519
2018-05-27 18:00:22,721:INFO: Chronic Lymphocytic Leukemia Recall-at-100: 0.00%
2018-05-27 18:00:22,721:INFO: Experiment Progress: 8.0% -- 44/519
2018-05-27 18:00:23,463:INFO: Refractive Errors Recall-at-100: 0.00%
2018-05-27 18:00:23,464:INFO: Experiment Progress: 8.0% -- 45/519
2018-05-27 18:00:24,102:INFO: Hepatitis C Recall-at-100: 0.00%
2018-05-27 18:00:24,102:INFO: Experiment Progress: 8.0% -- 46/519
2018-05-27 18:00:25,328:INFO: Mesothelioma Recall-at-100: 0.00%
2018-05-27 18:00:25,328:INFO: Experiment Progress: 9.0% -- 47/519
2018-05-27 18:00:25,549:INFO: Noise-induced hearing loss Recall-at-100: 0.00%
2018-05-27 18:00:25,549:INFO: Experiment Progress: 9.0% -- 48/519
2018-05-27 18:00:26,622:INFO: Inflammatory dermatosis Recall-at-100: 3.33%
2018-05-27 18:00:26,622:INFO: Experiment Progress: 9.0% -- 49/519
2018-05-27 18:00:27,433:INFO: Kallmann Syndrome Recall-at-100: 0.00%
2018-05-27 18:00:27,433:INFO: Experiment Progress: 9.0% -- 50/519
2018-05-27 18:00:28,183:INFO: Lipoidosis Recall-at-100: 0.00%
2018-05-27 18:00:28,183:INFO: Experiment Progress: 9.0% -- 51/519
2018-05-27 18:00:29,108:INFO: Diabetes Mellitus Recall-at-100: 0.00%
2018-05-27 18:00:29,108:INFO: Experiment Progress: 10.0% -- 52/519
2018-05-27 18:00:30,289:INFO: Fibrosis Recall-at-100: 0.00%
2018-05-27 18:00:30,289:INFO: Experiment Progress: 10.0% -- 53/519
2018-05-27 18:00:31,394:INFO: Hypercholesterolemia Recall-at-100: 0.00%
2018-05-27 18:00:31,395:INFO: Experiment Progress: 10.0% -- 54/519
2018-05-27 18:00:32,263:INFO: Microcephaly Recall-at-100: 0.00%
2018-05-27 18:00:32,263:INFO: Experiment Progress: 10.0% -- 55/519
2018-05-27 18:00:32,757:INFO: Tongue Neoplasms Recall-at-100: 0.00%
2018-05-27 18:00:32,757:INFO: Experiment Progress: 10.0% -- 56/519
2018-05-27 18:00:33,355:INFO: Common Migraine Recall-at-100: 0.00%
2018-05-27 18:00:33,355:INFO: Experiment Progress: 10.0% -- 57/519
2018-05-27 18:00:33,930:INFO: Carotid Artery Diseases Recall-at-100: 0.00%
2018-05-27 18:00:33,931:INFO: Experiment Progress: 11.0% -- 58/519
2018-05-27 18:00:34,982:INFO: Growth Disorders Recall-at-100: 0.00%
2018-05-27 18:00:34,982:INFO: Experiment Progress: 11.0% -- 59/519
2018-05-27 18:00:35,468:INFO: Absence Epilepsy Recall-at-100: 0.00%
2018-05-27 18:00:35,469:INFO: Experiment Progress: 11.0% -- 60/519
2018-05-27 18:00:36,305:INFO: Epilepsy, Temporal Lobe Recall-at-100: 3.33%
2018-05-27 18:00:36,305:INFO: Experiment Progress: 11.0% -- 61/519
2018-05-27 18:00:37,461:INFO: Memory Disorders Recall-at-100: 0.00%
2018-05-27 18:00:37,461:INFO: Experiment Progress: 11.0% -- 62/519
2018-05-27 18:00:38,152:INFO: Catalepsy Recall-at-100: 0.00%
2018-05-27 18:00:38,153:INFO: Experiment Progress: 12.0% -- 63/519
2018-05-27 18:00:38,794:INFO: Hereditary Nonpolyposis Colorectal Cancer Recall-at-100: 0.00%
2018-05-27 18:00:38,794:INFO: Experiment Progress: 12.0% -- 64/519
2018-05-27 18:00:39,777:INFO: Acute Promyelocytic Leukemia Recall-at-100: 0.00%
2018-05-27 18:00:39,777:INFO: Experiment Progress: 12.0% -- 65/519
2018-05-27 18:00:40,368:INFO: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma Recall-at-100: 0.00%
2018-05-27 18:00:40,368:INFO: Experiment Progress: 12.0% -- 66/519
2018-05-27 18:00:40,937:INFO: Gout Recall-at-100: 0.00%
2018-05-27 18:00:40,937:INFO: Experiment Progress: 12.0% -- 67/519
2018-05-27 18:00:42,716:INFO: Coronary Artery Disease Recall-at-100: 0.00%
2018-05-27 18:00:42,716:INFO: Experiment Progress: 13.0% -- 68/519
2018-05-27 18:00:43,760:INFO: Venous Thromboembolism Recall-at-100: 0.00%
2018-05-27 18:00:43,760:INFO: Experiment Progress: 13.0% -- 69/519
2018-05-27 18:00:45,680:INFO: Precancerous Conditions Recall-at-100: 0.00%
2018-05-27 18:00:45,681:INFO: Experiment Progress: 13.0% -- 70/519
2018-05-27 18:00:48,431:INFO: Crohn Disease Recall-at-100: 0.00%
2018-05-27 18:00:48,431:INFO: Experiment Progress: 13.0% -- 71/519
2018-05-27 18:00:49,245:INFO: Uterine Cervical Neoplasm Recall-at-100: 0.00%
2018-05-27 18:00:49,245:INFO: Experiment Progress: 13.0% -- 72/519
2018-05-27 18:00:49,924:INFO: Dyskinesia, Drug-Induced Recall-at-100: 10.00%
2018-05-27 18:00:49,924:INFO: Experiment Progress: 14.0% -- 73/519
2018-05-27 18:00:50,593:INFO: Ataxia, Spinocerebellar Recall-at-100: 0.00%
2018-05-27 18:00:50,593:INFO: Experiment Progress: 14.0% -- 74/519
2018-05-27 18:00:51,231:INFO: Optic Atrophy, Hereditary, Leber Recall-at-100: 35.00%
2018-05-27 18:00:51,231:INFO: Experiment Progress: 14.0% -- 75/519
2018-05-27 18:00:52,000:INFO: Liver Cirrhosis, Alcoholic Recall-at-100: 0.00%
2018-05-27 18:00:52,000:INFO: Experiment Progress: 14.0% -- 76/519
2018-05-27 18:00:52,963:INFO: Acute Lung Injury Recall-at-100: 0.00%
2018-05-27 18:00:52,963:INFO: Experiment Progress: 14.0% -- 77/519
2018-05-27 18:00:56,653:INFO: Liver Cirrhosis, Experimental Recall-at-100: 0.00%
2018-05-27 18:00:56,653:INFO: Experiment Progress: 15.0% -- 78/519
2018-05-27 18:00:57,917:INFO: Chloracne Recall-at-100: 3.33%
2018-05-27 18:00:57,917:INFO: Experiment Progress: 15.0% -- 79/519
2018-05-27 18:01:04,666:INFO: Disease Protein Prediction in the PPI Network
2018-05-27 18:01:04,667:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-27 18:01:04,667:INFO: ======================================
2018-05-27 18:01:04,667:INFO: Loading PPI Network...
2018-05-27 18:01:19,097:INFO: Loading Disease Associations...
2018-05-27 18:01:19,136:INFO: Loading PPI Matrix...
2018-05-27 18:01:47,799:INFO: Running Experiment...
2018-05-27 18:01:47,801:INFO: Experiment Progress: 0.0% -- 0/519
2018-05-27 18:01:48,488:INFO: Hydrops Fetalis, Non-Immune Recall-at-100: 0.00%
2018-05-27 18:01:48,488:INFO: Experiment Progress: 0.0% -- 1/519
2018-05-27 18:01:49,278:INFO: Psychoses, Substance-Induced Recall-at-100: 0.00%
2018-05-27 18:01:49,279:INFO: Experiment Progress: 0.0% -- 2/519
2018-05-27 18:01:49,968:INFO: Zellweger Syndrome Recall-at-100: 0.00%
2018-05-27 18:01:49,968:INFO: Experiment Progress: 0.0% -- 3/519
2018-05-27 18:01:51,901:INFO: Psoriasis Recall-at-100: 0.00%
2018-05-27 18:01:51,901:INFO: Experiment Progress: 0.0% -- 4/519
2018-05-27 18:01:52,700:INFO: Nephrotic Syndrome Recall-at-100: 0.00%
2018-05-27 18:01:52,700:INFO: Experiment Progress: 0.0% -- 5/519
2018-05-27 18:01:53,440:INFO: Nephrosis Recall-at-100: 0.00%
2018-05-27 18:01:53,441:INFO: Experiment Progress: 1.0% -- 6/519
2018-05-27 18:01:54,436:INFO: Mouth Diseases Recall-at-100: 10.00%
2018-05-27 18:01:54,436:INFO: Experiment Progress: 1.0% -- 7/519
2018-05-27 18:01:55,966:INFO: MITOCHONDRIAL COMPLEX I DEFICIENCY Recall-at-100: 6.67%
2018-05-27 18:01:55,966:INFO: Experiment Progress: 1.0% -- 8/519
2018-05-27 18:01:59,359:INFO: Substance-Related Disorders Recall-at-100: 0.00%
2018-05-27 18:01:59,359:INFO: Experiment Progress: 1.0% -- 9/519
2018-05-27 18:02:00,001:INFO: Anemia, Hemolytic Recall-at-100: 0.00%
2018-05-27 18:02:00,002:INFO: Experiment Progress: 1.0% -- 10/519
2018-05-27 18:02:09,239:INFO: Rheumatoid Arthritis Recall-at-100: 0.00%
2018-05-27 18:02:09,239:INFO: Experiment Progress: 2.0% -- 11/519
2018-05-27 18:02:09,970:INFO: Arthritis, Psoriatic Recall-at-100: 0.00%
2018-05-27 18:02:09,971:INFO: Experiment Progress: 2.0% -- 12/519
2018-05-27 18:02:10,910:INFO: Anemia Recall-at-100: 0.00%
2018-05-27 18:02:10,910:INFO: Experiment Progress: 2.0% -- 13/519
2018-05-27 18:02:11,809:INFO: Cholangiocarcinoma Recall-at-100: 0.00%
2018-05-27 18:02:11,809:INFO: Experiment Progress: 2.0% -- 14/519
2018-05-27 18:02:12,333:INFO: Neuroendocrine Tumors Recall-at-100: 0.00%
2018-05-27 18:02:12,333:INFO: Experiment Progress: 2.0% -- 15/519
2018-05-27 18:02:13,195:INFO: Malaria Recall-at-100: 0.00%
2018-05-27 18:02:13,195:INFO: Experiment Progress: 3.0% -- 16/519
2018-05-27 18:02:14,047:INFO: Hyperhomocysteinemia Recall-at-100: 0.00%
2018-05-27 18:02:14,047:INFO: Experiment Progress: 3.0% -- 17/519
2018-05-27 18:02:17,240:INFO: HIV Infections Recall-at-100: 0.00%
2018-05-27 18:02:17,240:INFO: Experiment Progress: 3.0% -- 18/519
2018-05-27 18:02:17,975:INFO: Ankylosing spondylitis Recall-at-100: 0.00%
2018-05-27 18:02:17,975:INFO: Experiment Progress: 3.0% -- 19/519
2018-05-27 18:02:21,116:INFO: Adenoid Cystic Carcinoma Recall-at-100: 1.00%
2018-05-27 18:02:21,117:INFO: Experiment Progress: 3.0% -- 20/519
2018-05-27 18:02:24,864:INFO: Juvenile arthritis Recall-at-100: 1.60%
2018-05-27 18:02:24,865:INFO: Experiment Progress: 4.0% -- 21/519
2018-05-27 18:02:25,921:INFO: Neoplasms, Experimental Recall-at-100: 0.00%
2018-05-27 18:02:25,921:INFO: Experiment Progress: 4.0% -- 22/519
2018-05-27 18:02:26,568:INFO: Neoplasms, Germ Cell and Embryonal Recall-at-100: 0.00%
2018-05-27 18:02:26,568:INFO: Experiment Progress: 4.0% -- 23/519
2018-05-27 18:02:27,072:INFO: Alopecia Areata Recall-at-100: 0.00%
2018-05-27 18:02:27,072:INFO: Experiment Progress: 4.0% -- 24/519
2018-05-27 18:02:27,711:INFO: Alopecia Recall-at-100: 0.00%
2018-05-27 18:02:27,711:INFO: Experiment Progress: 4.0% -- 25/519
2018-05-27 18:02:28,584:INFO: Bradycardia Recall-at-100: 0.00%
2018-05-27 18:02:28,584:INFO: Experiment Progress: 5.0% -- 26/519
2018-05-27 18:02:29,256:INFO: Common Variable Immunodeficiency Recall-at-100: 5.00%
2018-05-27 18:02:29,256:INFO: Experiment Progress: 5.0% -- 27/519
2018-05-27 18:02:30,180:INFO: Glomerulonephritis Recall-at-100: 0.00%
2018-05-27 18:02:30,180:INFO: Experiment Progress: 5.0% -- 28/519
2018-05-27 18:02:31,432:INFO: Alcoholic Intoxication, Chronic Recall-at-100: 2.50%
2018-05-27 18:02:31,432:INFO: Experiment Progress: 5.0% -- 29/519
2018-05-27 18:02:32,195:INFO: Lung Injury Recall-at-100: 0.00%
2018-05-27 18:02:32,195:INFO: Experiment Progress: 5.0% -- 30/519
2018-05-27 18:02:32,741:INFO: Hypercalcemia Recall-at-100: 0.00%
2018-05-27 18:02:32,741:INFO: Experiment Progress: 5.0% -- 31/519
2018-05-27 18:02:33,821:INFO: Cerebrovascular accident Recall-at-100: 0.00%
2018-05-27 18:02:33,821:INFO: Experiment Progress: 6.0% -- 32/519
2018-05-27 18:02:35,005:INFO: Diaphragmatic Hernia Recall-at-100: 0.00%
2018-05-27 18:02:35,005:INFO: Experiment Progress: 6.0% -- 33/519
2018-05-27 18:02:35,557:INFO: Prostatic Intraepithelial Neoplasias Recall-at-100: 0.00%
2018-05-27 18:02:35,557:INFO: Experiment Progress: 6.0% -- 34/519
2018-05-27 18:02:36,427:INFO: Migraine Disorders Recall-at-100: 0.00%
2018-05-27 18:02:36,427:INFO: Experiment Progress: 6.0% -- 35/519
2018-05-27 18:02:36,698:INFO: Restless Legs Syndrome Recall-at-100: 0.00%
2018-05-27 18:02:36,698:INFO: Experiment Progress: 6.0% -- 36/519
2018-05-27 18:02:37,433:INFO: Brugada Syndrome (disorder) Recall-at-100: 5.00%
2018-05-27 18:02:37,434:INFO: Experiment Progress: 7.0% -- 37/519
2018-05-27 18:02:37,947:INFO: Pathological accumulation of air in tissues Recall-at-100: 10.00%
2018-05-27 18:02:37,949:INFO: Experiment Progress: 7.0% -- 38/519
2018-05-27 18:02:38,502:INFO: Craniosynostosis Recall-at-100: 10.00%
2018-05-27 18:02:38,502:INFO: Experiment Progress: 7.0% -- 39/519
2018-05-27 18:02:39,281:INFO: Head and Neck Neoplasms Recall-at-100: 0.00%
2018-05-27 18:02:39,282:INFO: Experiment Progress: 7.0% -- 40/519
2018-05-27 18:02:40,084:INFO: Brain Neoplasms Recall-at-100: 0.00%
2018-05-27 18:02:40,084:INFO: Experiment Progress: 7.0% -- 41/519
2018-05-27 18:02:40,845:INFO: Hearing Loss, Partial Recall-at-100: 5.00%
2018-05-27 18:02:40,845:INFO: Experiment Progress: 8.0% -- 42/519
2018-05-27 18:02:41,486:INFO: Chromosome Aberrations Recall-at-100: 0.00%
2018-05-27 18:02:41,486:INFO: Experiment Progress: 8.0% -- 43/519
2018-05-27 18:02:42,924:INFO: Chronic Lymphocytic Leukemia Recall-at-100: 0.00%
2018-05-27 18:02:42,925:INFO: Experiment Progress: 8.0% -- 44/519
2018-05-27 18:02:43,667:INFO: Refractive Errors Recall-at-100: 0.00%
2018-05-27 18:02:43,667:INFO: Experiment Progress: 8.0% -- 45/519
2018-05-27 18:02:44,284:INFO: Hepatitis C Recall-at-100: 0.00%
2018-05-27 18:02:44,284:INFO: Experiment Progress: 8.0% -- 46/519
2018-05-27 18:02:45,508:INFO: Mesothelioma Recall-at-100: 0.00%
2018-05-27 18:02:45,508:INFO: Experiment Progress: 9.0% -- 47/519
2018-05-27 18:02:45,708:INFO: Noise-induced hearing loss Recall-at-100: 0.00%
2018-05-27 18:02:45,708:INFO: Experiment Progress: 9.0% -- 48/519
2018-05-27 18:02:46,758:INFO: Inflammatory dermatosis Recall-at-100: 3.33%
2018-05-27 18:02:46,758:INFO: Experiment Progress: 9.0% -- 49/519
2018-05-27 18:02:47,535:INFO: Kallmann Syndrome Recall-at-100: 0.00%
2018-05-27 18:02:47,535:INFO: Experiment Progress: 9.0% -- 50/519
2018-05-27 18:02:48,299:INFO: Lipoidosis Recall-at-100: 0.00%
2018-05-27 18:02:48,299:INFO: Experiment Progress: 9.0% -- 51/519
2018-05-27 18:02:49,238:INFO: Diabetes Mellitus Recall-at-100: 0.00%
2018-05-27 18:02:49,238:INFO: Experiment Progress: 10.0% -- 52/519
2018-05-27 18:02:50,462:INFO: Fibrosis Recall-at-100: 0.00%
2018-05-27 18:02:50,462:INFO: Experiment Progress: 10.0% -- 53/519
2018-05-27 18:02:51,256:INFO: Hypercholesterolemia Recall-at-100: 0.00%
2018-05-27 18:02:51,256:INFO: Experiment Progress: 10.0% -- 54/519
2018-05-27 18:02:52,095:INFO: Microcephaly Recall-at-100: 0.00%
2018-05-27 18:02:52,095:INFO: Experiment Progress: 10.0% -- 55/519
2018-05-27 18:02:52,549:INFO: Tongue Neoplasms Recall-at-100: 0.00%
2018-05-27 18:02:52,550:INFO: Experiment Progress: 10.0% -- 56/519
2018-05-27 18:02:53,131:INFO: Common Migraine Recall-at-100: 0.00%
2018-05-27 18:02:53,131:INFO: Experiment Progress: 10.0% -- 57/519
2018-05-27 18:02:53,686:INFO: Carotid Artery Diseases Recall-at-100: 0.00%
2018-05-27 18:02:53,686:INFO: Experiment Progress: 11.0% -- 58/519
2018-05-27 18:02:55,283:INFO: Growth Disorders Recall-at-100: 0.00%
2018-05-27 18:02:55,284:INFO: Experiment Progress: 11.0% -- 59/519
2018-05-27 18:02:55,847:INFO: Absence Epilepsy Recall-at-100: 0.00%
2018-05-27 18:02:55,847:INFO: Experiment Progress: 11.0% -- 60/519
2018-05-27 18:02:56,780:INFO: Epilepsy, Temporal Lobe Recall-at-100: 3.33%
2018-05-27 18:02:56,782:INFO: Experiment Progress: 11.0% -- 61/519
2018-05-27 18:02:58,071:INFO: Memory Disorders Recall-at-100: 0.00%
2018-05-27 18:02:58,071:INFO: Experiment Progress: 11.0% -- 62/519
2018-05-27 18:02:58,964:INFO: Catalepsy Recall-at-100: 0.00%
2018-05-27 18:02:58,965:INFO: Experiment Progress: 12.0% -- 63/519
2018-05-27 18:02:59,879:INFO: Hereditary Nonpolyposis Colorectal Cancer Recall-at-100: 0.00%
2018-05-27 18:02:59,879:INFO: Experiment Progress: 12.0% -- 64/519
2018-05-27 18:03:01,302:INFO: Acute Promyelocytic Leukemia Recall-at-100: 0.00%
2018-05-27 18:03:01,302:INFO: Experiment Progress: 12.0% -- 65/519
2018-05-27 18:03:01,978:INFO: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma Recall-at-100: 0.00%
2018-05-27 18:03:01,978:INFO: Experiment Progress: 12.0% -- 66/519
2018-05-27 18:03:02,507:INFO: Gout Recall-at-100: 0.00%
2018-05-27 18:03:02,507:INFO: Experiment Progress: 12.0% -- 67/519
2018-05-27 18:03:04,266:INFO: Coronary Artery Disease Recall-at-100: 0.00%
2018-05-27 18:03:04,266:INFO: Experiment Progress: 13.0% -- 68/519
2018-05-27 18:03:05,397:INFO: Venous Thromboembolism Recall-at-100: 0.00%
2018-05-27 18:03:05,397:INFO: Experiment Progress: 13.0% -- 69/519
2018-05-27 18:03:07,680:INFO: Precancerous Conditions Recall-at-100: 0.00%
2018-05-27 18:03:07,680:INFO: Experiment Progress: 13.0% -- 70/519
2018-05-27 18:03:10,541:INFO: Crohn Disease Recall-at-100: 0.00%
2018-05-27 18:03:10,542:INFO: Experiment Progress: 13.0% -- 71/519
2018-05-27 18:03:11,368:INFO: Uterine Cervical Neoplasm Recall-at-100: 0.00%
2018-05-27 18:03:11,368:INFO: Experiment Progress: 13.0% -- 72/519
2018-05-27 18:03:12,016:INFO: Dyskinesia, Drug-Induced Recall-at-100: 10.00%
2018-05-27 18:03:12,016:INFO: Experiment Progress: 14.0% -- 73/519
2018-05-27 18:03:12,687:INFO: Ataxia, Spinocerebellar Recall-at-100: 0.00%
2018-05-27 18:03:12,687:INFO: Experiment Progress: 14.0% -- 74/519
2018-05-27 18:03:13,578:INFO: Optic Atrophy, Hereditary, Leber Recall-at-100: 35.00%
2018-05-27 18:03:13,578:INFO: Experiment Progress: 14.0% -- 75/519
2018-05-27 18:03:14,370:INFO: Liver Cirrhosis, Alcoholic Recall-at-100: 0.00%
2018-05-27 18:03:14,370:INFO: Experiment Progress: 14.0% -- 76/519
2018-05-27 18:03:15,008:INFO: Acute Lung Injury Recall-at-100: 0.00%
2018-05-27 18:03:15,008:INFO: Experiment Progress: 14.0% -- 77/519
2018-05-27 18:03:17,900:INFO: Liver Cirrhosis, Experimental Recall-at-100: 0.00%
2018-05-27 18:03:17,900:INFO: Experiment Progress: 15.0% -- 78/519
2018-05-27 18:03:18,942:INFO: Chloracne Recall-at-100: 3.33%
2018-05-27 18:03:18,942:INFO: Experiment Progress: 15.0% -- 79/519
2018-05-27 18:03:20,734:INFO: Liver diseases Recall-at-100: 0.00%
2018-05-27 18:03:20,734:INFO: Experiment Progress: 15.0% -- 80/519
2018-05-27 18:03:22,008:INFO: Kidney Failure, Chronic Recall-at-100: 0.00%
2018-05-27 18:03:22,008:INFO: Experiment Progress: 15.0% -- 81/519
2018-05-27 18:03:22,722:INFO: Weight decreased Recall-at-100: 0.00%
2018-05-27 18:03:22,722:INFO: Experiment Progress: 15.0% -- 82/519
2018-05-27 18:03:23,952:INFO: Leigh Disease Recall-at-100: 0.00%
2018-05-27 18:03:23,953:INFO: Experiment Progress: 15.0% -- 83/519
2018-05-27 18:03:25,401:INFO: Celiac Disease Recall-at-100: 2.50%
2018-05-27 18:03:25,402:INFO: Experiment Progress: 16.0% -- 84/519
2018-05-27 18:03:26,143:INFO: Glaucoma Recall-at-100: 0.00%
2018-05-27 18:03:26,143:INFO: Experiment Progress: 16.0% -- 85/519
2018-05-27 18:03:26,793:INFO: Tachycardia Recall-at-100: 0.00%
2018-05-27 18:03:26,794:INFO: Experiment Progress: 16.0% -- 86/519
2018-05-27 18:03:27,330:INFO: Breast Cancer, Familial Recall-at-100: 20.00%
2018-05-27 18:03:27,330:INFO: Experiment Progress: 16.0% -- 87/519
2018-05-27 18:03:28,347:INFO: Ischemia Recall-at-100: 0.00%
2018-05-27 18:03:28,347:INFO: Experiment Progress: 16.0% -- 88/519
2018-05-27 18:03:28,785:INFO: Adenomatous Polyposis Coli Recall-at-100: 0.00%
2018-05-27 18:03:28,785:INFO: Experiment Progress: 17.0% -- 89/519
2018-05-27 18:03:29,346:INFO: Thyroid Diseases Recall-at-100: 0.00%
2018-05-27 18:03:29,346:INFO: Experiment Progress: 17.0% -- 90/519
2018-05-27 18:03:29,729:INFO: Panic Disorder Recall-at-100: 0.00%
2018-05-27 18:03:29,730:INFO: Experiment Progress: 17.0% -- 91/519
2018-05-27 18:03:38,799:INFO: Colorectal Neoplasms Recall-at-100: 0.45%
2018-05-27 18:03:38,799:INFO: Experiment Progress: 17.0% -- 92/519
2018-05-27 18:03:39,304:INFO: Adrenal Gland Neoplasms Recall-at-100: 0.00%
2018-05-27 18:03:39,304:INFO: Experiment Progress: 17.0% -- 93/519
2018-05-27 18:03:39,841:INFO: Sudden infant death syndrome Recall-at-100: 0.00%
2018-05-27 18:03:39,841:INFO: Experiment Progress: 18.0% -- 94/519
2018-05-27 18:03:41,081:INFO: Neuroblastoma Recall-at-100: 0.00%
2018-05-27 18:03:41,081:INFO: Experiment Progress: 18.0% -- 95/519
2018-05-27 18:03:41,648:INFO: Prostate cancer, familial Recall-at-100: 0.00%
2018-05-27 18:03:41,648:INFO: Experiment Progress: 18.0% -- 96/519
2018-05-27 18:03:45,478:INFO: Animal Mammary Neoplasms Recall-at-100: 0.71%
2018-05-27 18:03:45,478:INFO: Experiment Progress: 18.0% -- 97/519
2018-05-27 18:03:46,112:INFO: Osteochondrodysplasias Recall-at-100: 0.00%
2018-05-27 18:03:46,112:INFO: Experiment Progress: 18.0% -- 98/519
2018-05-27 18:03:46,903:INFO: Hepatolenticular Degeneration Recall-at-100: 0.00%
2018-05-27 18:03:46,903:INFO: Experiment Progress: 19.0% -- 99/519
2018-05-27 18:03:47,728:INFO: Fanconi Anemia Recall-at-100: 0.00%
2018-05-27 18:03:47,729:INFO: Experiment Progress: 19.0% -- 100/519
2018-05-27 18:03:48,333:INFO: Eye Abnormalities Recall-at-100: 0.00%
2018-05-27 18:03:48,333:INFO: Experiment Progress: 19.0% -- 101/519
2018-05-27 18:03:48,936:INFO: Limb Deformities, Congenital Recall-at-100: 0.00%
2018-05-27 18:03:48,936:INFO: Experiment Progress: 19.0% -- 102/519
2018-05-27 18:03:49,377:INFO: Electrocardiogram: P-R interval Recall-at-100: 0.00%
2018-05-27 18:03:49,377:INFO: Experiment Progress: 19.0% -- 103/519
2018-05-27 18:03:54,244:INFO: Mammary Neoplasms, Experimental Recall-at-100: 0.67%
2018-05-27 18:03:54,244:INFO: Experiment Progress: 20.0% -- 104/519
2018-05-27 18:03:55,037:INFO: Heart valve disease Recall-at-100: 0.00%
2018-05-27 18:03:55,037:INFO: Experiment Progress: 20.0% -- 105/519
2018-05-27 18:03:56,085:INFO: Diffuse Large B-Cell Lymphoma Recall-at-100: 0.00%
2018-05-27 18:03:56,085:INFO: Experiment Progress: 20.0% -- 106/519
2018-05-27 18:03:56,732:INFO: Hepatitis Recall-at-100: 0.00%
2018-05-27 18:03:56,732:INFO: Experiment Progress: 20.0% -- 107/519
2018-05-27 18:03:57,255:INFO: Impaired glucose tolerance Recall-at-100: 0.00%
2018-05-27 18:03:57,255:INFO: Experiment Progress: 20.0% -- 108/519
2018-05-27 18:03:57,773:INFO: Mitochondrial Encephalomyopathies Recall-at-100: 0.00%
2018-05-27 18:03:57,774:INFO: Experiment Progress: 21.0% -- 109/519
2018-05-27 18:03:58,567:INFO: Colon Carcinoma Recall-at-100: 0.00%
2018-05-27 18:03:58,567:INFO: Experiment Progress: 21.0% -- 110/519
2018-05-27 18:03:59,122:INFO: Hepatic Encephalopathy Recall-at-100: 0.00%
2018-05-27 18:03:59,122:INFO: Experiment Progress: 21.0% -- 111/519
2018-05-27 18:04:01,615:INFO: Multiple Sclerosis Recall-at-100: 0.00%
2018-05-27 18:04:01,615:INFO: Experiment Progress: 21.0% -- 112/519
2018-05-27 18:04:02,180:INFO: Neurogenic Inflammation Recall-at-100: 10.00%
2018-05-27 18:04:02,180:INFO: Experiment Progress: 21.0% -- 113/519
2018-05-27 18:04:04,161:INFO: Lupus Erythematosus, Systemic Recall-at-100: 1.43%
2018-05-27 18:04:04,161:INFO: Experiment Progress: 21.0% -- 114/519
2018-05-27 18:04:04,694:INFO: Ceroid lipofuscinosis, neuronal 1, infantile Recall-at-100: 0.00%
2018-05-27 18:04:04,694:INFO: Experiment Progress: 22.0% -- 115/519
2018-05-27 18:04:06,010:INFO: Adenocarcinoma of lung (disorder) Recall-at-100: 0.00%
2018-05-27 18:04:06,010:INFO: Experiment Progress: 22.0% -- 116/519
2018-05-27 18:04:06,921:INFO: Charcot-Marie-Tooth Disease Recall-at-100: 0.00%
2018-05-27 18:04:06,921:INFO: Experiment Progress: 22.0% -- 117/519
2018-05-27 18:04:07,494:INFO: Osteogenesis imperfecta type III (disorder) Recall-at-100: 0.00%
2018-05-27 18:04:07,495:INFO: Experiment Progress: 22.0% -- 118/519
2018-05-27 18:04:08,021:INFO: Osteogenesis imperfecta type IV (disorder) Recall-at-100: 0.00%
2018-05-27 18:04:08,021:INFO: Experiment Progress: 22.0% -- 119/519
2018-05-27 18:04:08,811:INFO: Hepatitis, Autoimmune Recall-at-100: 0.00%
2018-05-27 18:04:08,811:INFO: Experiment Progress: 23.0% -- 120/519
2018-05-27 18:04:40,154:INFO: Prostatic Neoplasms Recall-at-100: 0.00%
2018-05-27 18:04:40,155:INFO: Experiment Progress: 23.0% -- 121/519
2018-05-27 18:04:40,882:INFO: NADH:Q(1) Oxidoreductase deficiency Recall-at-100: 0.00%
2018-05-27 18:04:40,882:INFO: Experiment Progress: 23.0% -- 122/519
2018-05-27 18:04:41,459:INFO: Hypospadias Recall-at-100: 0.00%
2018-05-27 18:04:41,459:INFO: Experiment Progress: 23.0% -- 123/519
2018-05-27 18:04:42,575:INFO: Multiple Myeloma Recall-at-100: 2.50%
2018-05-27 18:04:42,575:INFO: Experiment Progress: 23.0% -- 124/519
2018-05-27 18:04:43,951:INFO: Fatty Liver Recall-at-100: 0.00%
2018-05-27 18:04:43,951:INFO: Experiment Progress: 24.0% -- 125/519
2018-05-27 18:04:44,517:INFO: Leishmaniasis, Visceral Recall-at-100: 0.00%
2018-05-27 18:04:44,517:INFO: Experiment Progress: 24.0% -- 126/519
2018-05-27 18:04:45,197:INFO: Early infantile epileptic encephalopathy with suppression bursts Recall-at-100: 0.00%
2018-05-27 18:04:45,197:INFO: Experiment Progress: 24.0% -- 127/519
2018-05-27 18:04:46,036:INFO: Kartagener Syndrome Recall-at-100: 0.00%
2018-05-27 18:04:46,036:INFO: Experiment Progress: 24.0% -- 128/519
2018-05-27 18:04:46,597:INFO: Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse Recall-at-100: 0.00%
2018-05-27 18:04:46,597:INFO: Experiment Progress: 24.0% -- 129/519
2018-05-27 18:04:48,296:INFO: Bipolar Disorder Recall-at-100: 0.00%
2018-05-27 18:04:48,297:INFO: Experiment Progress: 25.0% -- 130/519
2018-05-27 18:04:48,802:INFO: Erectile dysfunction Recall-at-100: 0.00%
2018-05-27 18:04:48,803:INFO: Experiment Progress: 25.0% -- 131/519
2018-05-27 18:04:49,376:INFO: Meckel-Gruber syndrome Recall-at-100: 0.00%
2018-05-27 18:04:49,377:INFO: Experiment Progress: 25.0% -- 132/519
2018-05-27 18:04:52,731:INFO: Colonic Neoplasms Recall-at-100: 0.77%
2018-05-27 18:04:52,731:INFO: Experiment Progress: 25.0% -- 133/519
2018-05-27 18:05:00,953:INFO: Autistic Disorder Recall-at-100: 0.85%
2018-05-27 18:05:00,953:INFO: Experiment Progress: 25.0% -- 134/519
2018-05-27 18:05:02,415:INFO: Liver Neoplasms, Experimental Recall-at-100: 0.00%
2018-05-27 18:05:02,415:INFO: Experiment Progress: 26.0% -- 135/519
2018-05-27 18:05:03,097:INFO: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Recall-at-100: 0.00%
2018-05-27 18:05:03,097:INFO: Experiment Progress: 26.0% -- 136/519
2018-05-27 18:05:03,753:INFO: Narcolepsy Recall-at-100: 0.00%
2018-05-27 18:05:03,753:INFO: Experiment Progress: 26.0% -- 137/519
2018-05-27 18:05:04,464:INFO: Fever Recall-at-100: 0.00%
2018-05-27 18:05:04,464:INFO: Experiment Progress: 26.0% -- 138/519
2018-05-27 18:05:07,266:INFO: Adenocarcinoma Recall-at-100: 3.64%
2018-05-27 18:05:07,266:INFO: Experiment Progress: 26.0% -- 139/519
2018-05-27 18:05:07,801:INFO: Aortic Valve Insufficiency Recall-at-100: 0.00%
2018-05-27 18:05:07,802:INFO: Experiment Progress: 26.0% -- 140/519
2018-05-27 18:05:08,492:INFO: Carcinoma, Pancreatic Ductal Recall-at-100: 0.00%
2018-05-27 18:05:08,493:INFO: Experiment Progress: 27.0% -- 141/519
2018-05-27 18:05:09,335:INFO: Infarction, Middle Cerebral Artery Recall-at-100: 0.00%
2018-05-27 18:05:09,335:INFO: Experiment Progress: 27.0% -- 142/519
2018-05-27 18:05:15,705:INFO: Hypertensive disease Recall-at-100: 1.61%
2018-05-27 18:05:15,706:INFO: Experiment Progress: 27.0% -- 143/519
2018-05-27 18:05:16,411:INFO: Juvenile Myelomonocytic Leukemia Recall-at-100: 0.00%
2018-05-27 18:05:16,411:INFO: Experiment Progress: 27.0% -- 144/519
2018-05-27 18:05:17,082:INFO: Leprosy Recall-at-100: 0.00%
2018-05-27 18:05:17,082:INFO: Experiment Progress: 27.0% -- 145/519
2018-05-27 18:05:19,292:INFO: Myocardial Infarction Recall-at-100: 0.00%
2018-05-27 18:05:19,292:INFO: Experiment Progress: 28.0% -- 146/519
2018-05-27 18:05:19,923:INFO: Urticaria Recall-at-100: 0.00%
2018-05-27 18:05:19,923:INFO: Experiment Progress: 28.0% -- 147/519
2018-05-27 18:05:20,600:INFO: Cardiac Arrhythmia Recall-at-100: 0.00%
2018-05-27 18:05:20,600:INFO: Experiment Progress: 28.0% -- 148/519
2018-05-27 18:05:21,148:INFO: Hemochromatosis Recall-at-100: 0.00%
2018-05-27 18:05:21,149:INFO: Experiment Progress: 28.0% -- 149/519
2018-05-27 18:05:23,238:INFO: Pancreatic Neoplasm Recall-at-100: 0.00%
2018-05-27 18:05:23,239:INFO: Experiment Progress: 28.0% -- 150/519
2018-05-27 18:05:24,502:INFO: Cardiomyopathy, Dilated Recall-at-100: 0.00%
2018-05-27 18:05:24,502:INFO: Experiment Progress: 29.0% -- 151/519
2018-05-27 18:05:25,027:INFO: Papilloma Recall-at-100: 0.00%
2018-05-27 18:05:25,027:INFO: Experiment Progress: 29.0% -- 152/519
2018-05-27 18:05:26,243:INFO: Pain Recall-at-100: 0.00%
2018-05-27 18:05:26,243:INFO: Experiment Progress: 29.0% -- 153/519
2018-05-27 18:05:26,760:INFO: Congenital Abnormality Recall-at-100: 10.00%
2018-05-27 18:05:26,760:INFO: Experiment Progress: 29.0% -- 154/519
2018-05-27 18:05:27,264:INFO: MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO (finding) Recall-at-100: 0.00%
2018-05-27 18:05:27,264:INFO: Experiment Progress: 29.0% -- 155/519
2018-05-27 18:05:29,364:INFO: Kidney Diseases Recall-at-100: 0.00%
2018-05-27 18:05:29,364:INFO: Experiment Progress: 30.0% -- 156/519
2018-05-27 18:05:29,997:INFO: Lung Diseases, Interstitial Recall-at-100: 0.00%
2018-05-27 18:05:29,997:INFO: Experiment Progress: 30.0% -- 157/519
2018-05-27 18:05:30,767:INFO: Basal cell carcinoma Recall-at-100: 0.00%
2018-05-27 18:05:30,768:INFO: Experiment Progress: 30.0% -- 158/519
2018-05-27 18:05:38,756:INFO: Liver carcinoma Recall-at-100: 0.00%
2018-05-27 18:05:38,756:INFO: Experiment Progress: 30.0% -- 159/519
2018-05-27 18:05:39,356:INFO: gliosarcoma Recall-at-100: 0.00%
2018-05-27 18:05:39,356:INFO: Experiment Progress: 30.0% -- 160/519
2018-05-27 18:05:40,308:INFO: Acute Coronary Syndrome Recall-at-100: 0.00%
2018-05-27 18:05:40,308:INFO: Experiment Progress: 31.0% -- 161/519
2018-05-27 18:05:41,259:INFO: Ovarian Cysts Recall-at-100: 3.33%
2018-05-27 18:05:41,259:INFO: Experiment Progress: 31.0% -- 162/519
2018-05-27 18:05:41,866:INFO: Schizophrenia, Childhood Recall-at-100: 0.00%
2018-05-27 18:05:41,866:INFO: Experiment Progress: 31.0% -- 163/519
2018-05-27 18:05:42,508:INFO: Adrenocortical carcinoma Recall-at-100: 0.00%
2018-05-27 18:05:42,508:INFO: Experiment Progress: 31.0% -- 164/519
2018-05-27 18:05:50,548:INFO: Schizophrenia Recall-at-100: 0.42%
2018-05-27 18:05:50,549:INFO: Experiment Progress: 31.0% -- 165/519
2018-05-27 18:05:51,032:INFO: Atrophic Recall-at-100: 0.00%
2018-05-27 18:05:51,032:INFO: Experiment Progress: 31.0% -- 166/519
2018-05-27 18:05:51,679:INFO: Idiopathic Pulmonary Fibrosis Recall-at-100: 5.00%
2018-05-27 18:05:51,679:INFO: Experiment Progress: 32.0% -- 167/519
2018-05-27 18:05:52,291:INFO: Lobar Holoprosencephaly Recall-at-100: 0.00%
2018-05-27 18:05:52,291:INFO: Experiment Progress: 32.0% -- 168/519
2018-05-27 18:05:53,231:INFO: Alobar Holoprosencephaly Recall-at-100: 0.00%
2018-05-27 18:05:53,232:INFO: Experiment Progress: 32.0% -- 169/519
2018-05-27 18:05:54,486:INFO: Immunologic Deficiency Syndromes Recall-at-100: 0.00%
2018-05-27 18:05:54,486:INFO: Experiment Progress: 32.0% -- 170/519
2018-05-27 18:05:55,203:INFO: Ataxia Recall-at-100: 0.00%
2018-05-27 18:05:55,203:INFO: Experiment Progress: 32.0% -- 171/519
2018-05-27 18:05:55,771:INFO: Adenocarcinoma Of Esophagus Recall-at-100: 0.00%
2018-05-27 18:05:55,772:INFO: Experiment Progress: 33.0% -- 172/519
2018-05-27 18:05:57,585:INFO: Retinitis Pigmentosa Recall-at-100: 1.43%
2018-05-27 18:05:57,585:INFO: Experiment Progress: 33.0% -- 173/519
2018-05-27 18:05:59,694:INFO: Squamous cell carcinoma of esophagus Recall-at-100: 0.00%
2018-05-27 18:05:59,694:INFO: Experiment Progress: 33.0% -- 174/519
2018-05-27 18:06:00,688:INFO: Autoimmune Diseases Recall-at-100: 0.00%
2018-05-27 18:06:00,688:INFO: Experiment Progress: 33.0% -- 175/519
2018-05-27 18:06:01,170:INFO: Diarrhea Recall-at-100: 0.00%
2018-05-27 18:06:01,170:INFO: Experiment Progress: 33.0% -- 176/519
2018-05-27 18:06:06,216:INFO: Myocardial Ischemia Recall-at-100: 0.59%
2018-05-27 18:06:06,216:INFO: Experiment Progress: 34.0% -- 177/519
2018-05-27 18:06:06,807:INFO: Essential Hypertension Recall-at-100: 0.00%
2018-05-27 18:06:06,808:INFO: Experiment Progress: 34.0% -- 178/519
2018-05-27 18:06:07,265:INFO: Hepatomegaly Recall-at-100: 0.00%
2018-05-27 18:06:07,266:INFO: Experiment Progress: 34.0% -- 179/519
2018-05-27 18:06:08,101:INFO: Myopathy Recall-at-100: 0.00%
2018-05-27 18:06:08,101:INFO: Experiment Progress: 34.0% -- 180/519
2018-05-27 18:06:09,512:INFO: Adverse reaction to drug Recall-at-100: 0.00%
2018-05-27 18:06:09,513:INFO: Experiment Progress: 34.0% -- 181/519
2018-05-27 18:06:10,053:INFO: Myoclonic Epilepsies, Progressive Recall-at-100: 0.00%
2018-05-27 18:06:10,053:INFO: Experiment Progress: 35.0% -- 182/519
2018-05-27 18:06:10,616:INFO: Muscular Atrophy Recall-at-100: 0.00%
2018-05-27 18:06:10,616:INFO: Experiment Progress: 35.0% -- 183/519
2018-05-27 18:06:11,127:INFO: Basal Ganglia Diseases Recall-at-100: 0.00%
2018-05-27 18:06:11,127:INFO: Experiment Progress: 35.0% -- 184/519
2018-05-27 18:06:11,733:INFO: Hepatitis B Recall-at-100: 10.00%
2018-05-27 18:06:11,733:INFO: Experiment Progress: 35.0% -- 185/519
2018-05-27 18:06:12,970:INFO: Lung diseases Recall-at-100: 2.50%
2018-05-27 18:06:12,970:INFO: Experiment Progress: 35.0% -- 186/519
2018-05-27 18:06:14,212:INFO: Chronic Obstructive Airway Disease Recall-at-100: 2.00%
2018-05-27 18:06:14,212:INFO: Experiment Progress: 36.0% -- 187/519
2018-05-27 18:06:24,934:INFO: Peripheral Neuropathy Recall-at-100: 0.00%
2018-05-27 18:06:24,934:INFO: Experiment Progress: 36.0% -- 188/519
2018-05-27 18:06:27,232:INFO: Weight Gain Recall-at-100: 0.00%
2018-05-27 18:06:27,233:INFO: Experiment Progress: 36.0% -- 189/519
2018-05-27 18:06:27,845:INFO: Deafness Recall-at-100: 0.00%
2018-05-27 18:06:27,845:INFO: Experiment Progress: 36.0% -- 190/519
2018-05-27 18:06:28,350:INFO: Renal dysplasia and retinal aplasia (disorder) Recall-at-100: 0.00%
2018-05-27 18:06:28,350:INFO: Experiment Progress: 36.0% -- 191/519
2018-05-27 18:06:29,365:INFO: Attention deficit hyperactivity disorder Recall-at-100: 0.00%
2018-05-27 18:06:29,365:INFO: Experiment Progress: 36.0% -- 192/519
2018-05-27 18:06:29,964:INFO: Tetralogy of Fallot Recall-at-100: 0.00%
2018-05-27 18:06:29,964:INFO: Experiment Progress: 37.0% -- 193/519
2018-05-27 18:06:31,049:INFO: Neurodegenerative Disorders Recall-at-100: 2.50%
2018-05-27 18:06:31,049:INFO: Experiment Progress: 37.0% -- 194/519
2018-05-27 18:06:31,623:INFO: Barrett Esophagus Recall-at-100: 0.00%
2018-05-27 18:06:31,623:INFO: Experiment Progress: 37.0% -- 195/519
2018-05-27 18:06:35,668:INFO: Craniofacial Abnormalities Recall-at-100: 0.71%
2018-05-27 18:06:35,668:INFO: Experiment Progress: 37.0% -- 196/519
2018-05-27 18:06:36,314:INFO: Necrotizing Enterocolitis Recall-at-100: 0.00%
2018-05-27 18:06:36,314:INFO: Experiment Progress: 37.0% -- 197/519
2018-05-27 18:06:36,962:INFO: Hyperlipidemia Recall-at-100: 0.00%
2018-05-27 18:06:36,962:INFO: Experiment Progress: 38.0% -- 198/519
2018-05-27 18:06:37,635:INFO: MYELODYSPLASTIC SYNDROME Recall-at-100: 0.00%
2018-05-27 18:06:37,635:INFO: Experiment Progress: 38.0% -- 199/519
2018-05-27 18:06:38,586:INFO: Anoxia Recall-at-100: 0.00%
2018-05-27 18:06:38,586:INFO: Experiment Progress: 38.0% -- 200/519
2018-05-27 18:06:39,729:INFO: Small cell carcinoma of lung Recall-at-100: 2.50%
2018-05-27 18:06:39,729:INFO: Experiment Progress: 38.0% -- 201/519
2018-05-27 18:06:41,365:INFO: Epilepsy Recall-at-100: 0.00%
2018-05-27 18:06:41,366:INFO: Experiment Progress: 38.0% -- 202/519
2018-05-27 18:06:42,099:INFO: Liver Failure, Acute Recall-at-100: 0.00%
2018-05-27 18:06:42,099:INFO: Experiment Progress: 39.0% -- 203/519
2018-05-27 18:06:42,739:INFO: Micronuclei, Chromosome-Defective Recall-at-100: 15.00%
2018-05-27 18:06:42,739:INFO: Experiment Progress: 39.0% -- 204/519
2018-05-27 18:06:43,501:INFO: Cognition Disorders Recall-at-100: 8.33%
2018-05-27 18:06:43,501:INFO: Experiment Progress: 39.0% -- 205/519
2018-05-27 18:06:44,002:INFO: Tonic-Clonic Epilepsy Recall-at-100: 0.00%
2018-05-27 18:06:44,002:INFO: Experiment Progress: 39.0% -- 206/519
2018-05-27 18:06:45,177:INFO: Heart Diseases Recall-at-100: 0.00%
2018-05-27 18:06:45,177:INFO: Experiment Progress: 39.0% -- 207/519
2018-05-27 18:06:46,058:INFO: Adult T-Cell Lymphoma/Leukemia Recall-at-100: 0.00%
2018-05-27 18:06:46,058:INFO: Experiment Progress: 40.0% -- 208/519
2018-05-27 18:06:46,750:INFO: Primary biliary cirrhosis Recall-at-100: 0.00%
2018-05-27 18:06:46,750:INFO: Experiment Progress: 40.0% -- 209/519
2018-05-27 18:06:47,227:INFO: beta Thalassemia Recall-at-100: 10.00%
2018-05-27 18:06:47,227:INFO: Experiment Progress: 40.0% -- 210/519
2018-05-27 18:06:47,700:INFO: Marijuana Abuse Recall-at-100: 0.00%
2018-05-27 18:06:47,701:INFO: Experiment Progress: 40.0% -- 211/519
2018-05-27 18:06:48,316:INFO: Long QT Syndrome Recall-at-100: 0.00%
2018-05-27 18:06:48,316:INFO: Experiment Progress: 40.0% -- 212/519
2018-05-27 18:06:48,921:INFO: Burkitt Lymphoma Recall-at-100: 0.00%
2018-05-27 18:06:48,921:INFO: Experiment Progress: 41.0% -- 213/519
2018-05-27 18:06:49,395:INFO: TOBACCO ADDICTION, SUSCEPTIBILITY TO (finding) Recall-at-100: 0.00%
2018-05-27 18:06:49,396:INFO: Experiment Progress: 41.0% -- 214/519
2018-05-27 18:06:50,705:INFO: Insulin Resistance Recall-at-100: 6.00%
2018-05-27 18:06:50,705:INFO: Experiment Progress: 41.0% -- 215/519
2018-05-27 18:06:51,478:INFO: Left Ventricular Hypertrophy Recall-at-100: 0.00%
2018-05-27 18:06:51,478:INFO: Experiment Progress: 41.0% -- 216/519
2018-05-27 18:06:52,018:INFO: Bronchial Hyperreactivity Recall-at-100: 0.00%
2018-05-27 18:06:52,019:INFO: Experiment Progress: 41.0% -- 217/519
2018-05-27 18:06:53,299:INFO: AMYOTROPHIC LATERAL SCLEROSIS 1 Recall-at-100: 0.00%
2018-05-27 18:06:53,300:INFO: Experiment Progress: 42.0% -- 218/519
2018-05-27 18:06:53,812:INFO: Fetal Growth Retardation Recall-at-100: 0.00%
2018-05-27 18:06:53,812:INFO: Experiment Progress: 42.0% -- 219/519
2018-05-27 18:06:54,171:INFO: Holoprosencephaly Recall-at-100: 0.00%
2018-05-27 18:06:54,171:INFO: Experiment Progress: 42.0% -- 220/519
2018-05-27 18:06:55,228:INFO: Arthritis, Experimental Recall-at-100: 0.00%
2018-05-27 18:06:55,228:INFO: Experiment Progress: 42.0% -- 221/519
2018-05-27 18:06:56,217:INFO: Congenital Heart Defects Recall-at-100: 0.00%
2018-05-27 18:06:56,217:INFO: Experiment Progress: 42.0% -- 222/519
2018-05-27 18:06:56,635:INFO: Pseudohypoaldosteronism Recall-at-100: 0.00%
2018-05-27 18:06:56,635:INFO: Experiment Progress: 42.0% -- 223/519
2018-05-27 18:06:57,357:INFO: Cataract Recall-at-100: 0.00%
2018-05-27 18:06:57,357:INFO: Experiment Progress: 43.0% -- 224/519
2018-05-27 18:06:57,882:INFO: Giant Cell Glioblastoma Recall-at-100: 0.00%
2018-05-27 18:06:57,882:INFO: Experiment Progress: 43.0% -- 225/519
2018-05-27 18:06:58,561:INFO: Seizure Adverse Event Recall-at-100: 0.00%
2018-05-27 18:06:58,561:INFO: Experiment Progress: 43.0% -- 226/519
2018-05-27 18:06:59,142:INFO: Body Weight Recall-at-100: 5.00%
2018-05-27 18:06:59,142:INFO: Experiment Progress: 43.0% -- 227/519
2018-05-27 18:06:59,675:INFO: Huntington Disease Recall-at-100: 5.00%
2018-05-27 18:06:59,676:INFO: Experiment Progress: 43.0% -- 228/519
2018-05-27 18:07:01,258:INFO: Glioblastoma Recall-at-100: 0.00%
2018-05-27 18:07:01,258:INFO: Experiment Progress: 44.0% -- 229/519
2018-05-27 18:07:01,795:INFO: Congenital diaphragmatic hernia Recall-at-100: 10.00%
2018-05-27 18:07:01,796:INFO: Experiment Progress: 44.0% -- 230/519
2018-05-27 18:07:02,567:INFO: Systemic Scleroderma Recall-at-100: 0.00%
2018-05-27 18:07:02,567:INFO: Experiment Progress: 44.0% -- 231/519
2018-05-27 18:07:04,251:INFO: Acute kidney injury Recall-at-100: 1.43%
2018-05-27 18:07:04,251:INFO: Experiment Progress: 44.0% -- 232/519
2018-05-27 18:07:04,760:INFO: Copper-Overload Cirrhosis Recall-at-100: 0.00%
2018-05-27 18:07:04,760:INFO: Experiment Progress: 44.0% -- 233/519
2018-05-27 18:07:07,381:INFO: Spontaneous abortion Recall-at-100: 0.00%
2018-05-27 18:07:07,381:INFO: Experiment Progress: 45.0% -- 234/519
2018-05-27 18:07:09,095:INFO: Glioma Recall-at-100: 0.00%
2018-05-27 18:07:09,095:INFO: Experiment Progress: 45.0% -- 235/519
2018-05-27 18:07:09,696:INFO: Gliosis Recall-at-100: 0.00%
2018-05-27 18:07:09,696:INFO: Experiment Progress: 45.0% -- 236/519
2018-05-27 18:07:10,256:INFO: LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY Recall-at-100: 10.00%
2018-05-27 18:07:10,256:INFO: Experiment Progress: 45.0% -- 237/519
2018-05-27 18:07:10,744:INFO: Dementia Recall-at-100: 0.00%
2018-05-27 18:07:10,744:INFO: Experiment Progress: 45.0% -- 238/519
2018-05-27 18:07:11,434:INFO: Pancreatitis Recall-at-100: 0.00%
2018-05-27 18:07:11,434:INFO: Experiment Progress: 46.0% -- 239/519
2018-05-27 18:07:11,980:INFO: Amino Acid Metabolism, Inborn Errors Recall-at-100: 0.00%
2018-05-27 18:07:11,980:INFO: Experiment Progress: 46.0% -- 240/519
2018-05-27 18:07:12,926:INFO: Thyroid Neoplasm Recall-at-100: 0.00%
2018-05-27 18:07:12,926:INFO: Experiment Progress: 46.0% -- 241/519
2018-05-27 18:07:16,244:INFO: Neoplasm Invasiveness Recall-at-100: 0.00%
2018-05-27 18:07:16,244:INFO: Experiment Progress: 46.0% -- 242/519
2018-05-27 18:07:20,096:INFO: Neoplasm Metastasis Recall-at-100: 1.43%
2018-05-27 18:07:20,097:INFO: Experiment Progress: 46.0% -- 243/519
2018-05-27 18:07:20,769:INFO: Albuminuria Recall-at-100: 0.00%
2018-05-27 18:07:20,769:INFO: Experiment Progress: 47.0% -- 244/519
2018-05-27 18:07:21,422:INFO: Pre-Eclampsia Recall-at-100: 0.00%
2018-05-27 18:07:21,422:INFO: Experiment Progress: 47.0% -- 245/519
2018-05-27 18:07:23,305:INFO: Nerve Degeneration Recall-at-100: 0.00%
2018-05-27 18:07:23,305:INFO: Experiment Progress: 47.0% -- 246/519
2018-05-27 18:07:23,836:INFO: Thromboembolism Recall-at-100: 0.00%
2018-05-27 18:07:23,836:INFO: Experiment Progress: 47.0% -- 247/519
2018-05-27 18:07:28,125:INFO: Polycystic Ovary Syndrome Recall-at-100: 0.71%
2018-05-27 18:07:28,126:INFO: Experiment Progress: 47.0% -- 248/519
2018-05-27 18:07:28,613:INFO: Transient Ischemic Attack Recall-at-100: 0.00%
2018-05-27 18:07:28,613:INFO: Experiment Progress: 47.0% -- 249/519
2018-05-27 18:07:30,098:INFO: Brain Ischemia Recall-at-100: 0.00%
2018-05-27 18:07:30,099:INFO: Experiment Progress: 48.0% -- 250/519
2018-05-27 18:07:30,596:INFO: Cerebral Infarction Recall-at-100: 0.00%
2018-05-27 18:07:30,596:INFO: Experiment Progress: 48.0% -- 251/519
2018-05-27 18:07:31,270:INFO: Malignant neoplasm of esophagus Recall-at-100: 0.00%
2018-05-27 18:07:31,270:INFO: Experiment Progress: 48.0% -- 252/519
2018-05-27 18:07:33,632:INFO: Degenerative polyarthritis Recall-at-100: 1.00%
2018-05-27 18:07:33,633:INFO: Experiment Progress: 48.0% -- 253/519
2018-05-27 18:07:33,986:INFO: Osteitis Deformans Recall-at-100: 0.00%
2018-05-27 18:07:33,987:INFO: Experiment Progress: 48.0% -- 254/519
2018-05-27 18:07:34,485:INFO: Diabetic Cardiomyopathies Recall-at-100: 0.00%
2018-05-27 18:07:34,486:INFO: Experiment Progress: 49.0% -- 255/519
2018-05-27 18:07:35,011:INFO: Nuclear cataract Recall-at-100: 0.00%
2018-05-27 18:07:35,011:INFO: Experiment Progress: 49.0% -- 256/519
2018-05-27 18:07:35,593:INFO: Anorexia Recall-at-100: 0.00%
2018-05-27 18:07:35,593:INFO: Experiment Progress: 49.0% -- 257/519
2018-05-27 18:07:37,747:INFO: Cocaine-Related Disorders Recall-at-100: 0.00%
2018-05-27 18:07:37,747:INFO: Experiment Progress: 49.0% -- 258/519
2018-05-27 18:07:38,218:INFO: MELAS Syndrome Recall-at-100: 20.00%
2018-05-27 18:07:38,219:INFO: Experiment Progress: 49.0% -- 259/519
2018-05-27 18:07:38,469:INFO: Mitochondrial Myopathies Recall-at-100: 0.00%
2018-05-27 18:07:38,470:INFO: Experiment Progress: 50.0% -- 260/519
2018-05-27 18:07:40,359:INFO: Amphetamine-Related Disorders Recall-at-100: 0.00%
2018-05-27 18:07:40,359:INFO: Experiment Progress: 50.0% -- 261/519
2018-05-27 18:07:40,843:INFO: Birth Weight Recall-at-100: 0.00%
2018-05-27 18:07:40,843:INFO: Experiment Progress: 50.0% -- 262/519
2018-05-27 18:07:41,595:INFO: Brain Diseases Recall-at-100: 0.00%
2018-05-27 18:07:41,595:INFO: Experiment Progress: 50.0% -- 263/519
2018-05-27 18:07:42,201:INFO: Dyslipidemias Recall-at-100: 0.00%
2018-05-27 18:07:42,201:INFO: Experiment Progress: 50.0% -- 264/519
2018-05-27 18:07:42,619:INFO: Berylliosis Recall-at-100: 0.00%
2018-05-27 18:07:42,619:INFO: Experiment Progress: 51.0% -- 265/519
2018-05-27 18:07:43,270:INFO: Mental Retardation, X-Linked Recall-at-100: 0.00%
2018-05-27 18:07:43,270:INFO: Experiment Progress: 51.0% -- 266/519
2018-05-27 18:07:43,634:INFO: Sarcoidosis Recall-at-100: 0.00%
2018-05-27 18:07:43,634:INFO: Experiment Progress: 51.0% -- 267/519
2018-05-27 18:07:46,420:INFO: Liver neoplasms Recall-at-100: 0.00%
2018-05-27 18:07:46,420:INFO: Experiment Progress: 51.0% -- 268/519
2018-05-27 18:07:47,407:INFO: Myocardial Reperfusion Injury Recall-at-100: 0.00%
2018-05-27 18:07:47,407:INFO: Experiment Progress: 51.0% -- 269/519
2018-05-27 18:07:47,931:INFO: Microsatellite Instability Recall-at-100: 10.00%
2018-05-27 18:07:47,931:INFO: Experiment Progress: 52.0% -- 270/519
2018-05-27 18:07:48,437:INFO: Night blindness, congenital stationary Recall-at-100: 0.00%
2018-05-27 18:07:48,437:INFO: Experiment Progress: 52.0% -- 271/519
2018-05-27 18:07:49,320:INFO: Stevens-Johnson Syndrome Recall-at-100: 0.00%
2018-05-27 18:07:49,321:INFO: Experiment Progress: 52.0% -- 272/519
2018-05-27 18:07:49,840:INFO: Leukemia, Lymphocytic, Acute, L1 Recall-at-100: 0.00%
2018-05-27 18:07:49,841:INFO: Experiment Progress: 52.0% -- 273/519
2018-05-27 18:07:51,176:INFO: Systemic arterial pressure Recall-at-100: 2.00%
2018-05-27 18:07:51,176:INFO: Experiment Progress: 52.0% -- 274/519
2018-05-27 18:07:52,036:INFO: Learning Disorders Recall-at-100: 0.00%
2018-05-27 18:07:52,036:INFO: Experiment Progress: 52.0% -- 275/519
2018-05-27 18:07:52,594:INFO: Walker-Warburg congenital muscular dystrophy Recall-at-100: 0.00%
2018-05-27 18:07:52,594:INFO: Experiment Progress: 53.0% -- 276/519
2018-05-27 18:07:53,080:INFO: Marfan Syndrome Recall-at-100: 0.00%
2018-05-27 18:07:53,080:INFO: Experiment Progress: 53.0% -- 277/519
2018-05-27 18:07:53,595:INFO: Congenital ocular coloboma (disorder) Recall-at-100: 10.00%
2018-05-27 18:07:53,595:INFO: Experiment Progress: 53.0% -- 278/519
2018-05-27 18:07:58,609:INFO: Lung Neoplasms Recall-at-100: 0.00%
2018-05-27 18:07:58,609:INFO: Experiment Progress: 53.0% -- 279/519
2018-05-27 18:07:58,921:INFO: Myoclonic Epilepsy, Juvenile Recall-at-100: 0.00%
2018-05-27 18:07:58,921:INFO: Experiment Progress: 53.0% -- 280/519
2018-05-27 18:08:00,971:INFO: Inflammatory Bowel Diseases Recall-at-100: 0.00%
2018-05-27 18:08:00,971:INFO: Experiment Progress: 54.0% -- 281/519
2018-05-27 18:08:25,166:INFO: Mammary Neoplasms Recall-at-100: 0.74%
2018-05-27 18:08:25,167:INFO: Experiment Progress: 54.0% -- 282/519
2018-05-27 18:08:25,419:INFO: Idiopathic generalized epilepsy Recall-at-100: 0.00%
2018-05-27 18:08:25,419:INFO: Experiment Progress: 54.0% -- 283/519
2018-05-27 18:08:25,923:INFO: Neuralgia Recall-at-100: 0.00%
2018-05-27 18:08:25,923:INFO: Experiment Progress: 54.0% -- 284/519
2018-05-27 18:08:26,736:INFO: Neural Tube Defects Recall-at-100: 0.00%
2018-05-27 18:08:26,736:INFO: Experiment Progress: 54.0% -- 285/519
2018-05-27 18:08:28,435:INFO: Dermatitis, Allergic Contact Recall-at-100: 0.00%
2018-05-27 18:08:28,435:INFO: Experiment Progress: 55.0% -- 286/519
2018-05-27 18:08:29,050:INFO: Inborn Errors of Metabolism Recall-at-100: 0.00%
2018-05-27 18:08:29,050:INFO: Experiment Progress: 55.0% -- 287/519
2018-05-27 18:08:29,938:INFO: Platelet mean volume finding Recall-at-100: 0.00%
2018-05-27 18:08:29,938:INFO: Experiment Progress: 55.0% -- 288/519
2018-05-27 18:08:30,439:INFO: Intestinal Neoplasms Recall-at-100: 10.00%
2018-05-27 18:08:30,439:INFO: Experiment Progress: 55.0% -- 289/519
2018-05-27 18:08:30,955:INFO: Allergic rhinitis (disorder) Recall-at-100: 0.00%
2018-05-27 18:08:30,955:INFO: Experiment Progress: 55.0% -- 290/519
2018-05-27 18:08:32,297:INFO: Blood pressure finding Recall-at-100: 0.00%
2018-05-27 18:08:32,297:INFO: Experiment Progress: 56.0% -- 291/519
2018-05-27 18:08:33,316:INFO: Age related macular degeneration Recall-at-100: 0.00%
2018-05-27 18:08:33,316:INFO: Experiment Progress: 56.0% -- 292/519
2018-05-27 18:08:34,127:INFO: Hyperplasia Recall-at-100: 0.00%
2018-05-27 18:08:34,127:INFO: Experiment Progress: 56.0% -- 293/519
2018-05-27 18:08:35,020:INFO: Pulmonary function (finding) Recall-at-100: 0.00%
2018-05-27 18:08:35,021:INFO: Experiment Progress: 56.0% -- 294/519
2018-05-27 18:08:35,530:INFO: Spina Bifida Recall-at-100: 0.00%
2018-05-27 18:08:35,530:INFO: Experiment Progress: 56.0% -- 295/519
2018-05-27 18:08:36,226:INFO: Hypertrophic Cardiomyopathy Recall-at-100: 0.00%
2018-05-27 18:08:36,226:INFO: Experiment Progress: 57.0% -- 296/519
2018-05-27 18:08:36,926:INFO: Bardet-Biedl Syndrome Recall-at-100: 0.00%
2018-05-27 18:08:36,926:INFO: Experiment Progress: 57.0% -- 297/519
2018-05-27 18:08:37,899:INFO: Keloid Recall-at-100: 0.00%
2018-05-27 18:08:37,899:INFO: Experiment Progress: 57.0% -- 298/519
2018-05-27 18:08:43,964:INFO: melanoma Recall-at-100: 0.00%
2018-05-27 18:08:43,964:INFO: Experiment Progress: 57.0% -- 299/519
2018-05-27 18:08:44,657:INFO: LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 3 Recall-at-100: 5.00%
2018-05-27 18:08:44,658:INFO: Experiment Progress: 57.0% -- 300/519
2018-05-27 18:08:45,890:INFO: Pneumonia Recall-at-100: 0.00%
2018-05-27 18:08:45,890:INFO: Experiment Progress: 57.0% -- 301/519
2018-05-27 18:08:49,100:INFO: Disease Progression Recall-at-100: 0.00%
2018-05-27 18:08:49,100:INFO: Experiment Progress: 58.0% -- 302/519
2018-05-27 18:08:49,708:INFO: Nephroblastoma Recall-at-100: 0.00%
2018-05-27 18:08:49,708:INFO: Experiment Progress: 58.0% -- 303/519
2018-05-27 18:08:50,204:INFO: Severe Combined Immunodeficiency Recall-at-100: 0.00%
2018-05-27 18:08:50,204:INFO: Experiment Progress: 58.0% -- 304/519
2018-05-27 18:08:50,742:INFO: Malignant neoplasm of ovary Recall-at-100: 0.00%
2018-05-27 18:08:50,742:INFO: Experiment Progress: 58.0% -- 305/519
2018-05-27 18:08:51,343:INFO: Pheochromocytoma Recall-at-100: 0.00%
2018-05-27 18:08:51,343:INFO: Experiment Progress: 58.0% -- 306/519
2018-05-27 18:08:52,053:INFO: Testicular Germ Cell Tumor Recall-at-100: 5.00%
2018-05-27 18:08:52,053:INFO: Experiment Progress: 59.0% -- 307/519
2018-05-27 18:08:52,575:INFO: Hypogonadism Recall-at-100: 0.00%
2018-05-27 18:08:52,576:INFO: Experiment Progress: 59.0% -- 308/519
2018-05-27 18:08:53,277:INFO: Movement Disorders Recall-at-100: 0.00%
2018-05-27 18:08:53,277:INFO: Experiment Progress: 59.0% -- 309/519
2018-05-27 18:08:53,827:INFO: Sarcoma Recall-at-100: 0.00%
2018-05-27 18:08:53,827:INFO: Experiment Progress: 59.0% -- 310/519
2018-05-27 18:08:54,373:INFO: Lymphatic Metastasis Recall-at-100: 0.00%
2018-05-27 18:08:54,373:INFO: Experiment Progress: 59.0% -- 311/519
2018-05-27 18:08:54,872:INFO: Hypoglycemia Recall-at-100: 0.00%
2018-05-27 18:08:54,872:INFO: Experiment Progress: 60.0% -- 312/519
2018-05-27 18:08:55,362:INFO: Anemia, Sickle Cell Recall-at-100: 0.00%
2018-05-27 18:08:55,362:INFO: Experiment Progress: 60.0% -- 313/519
2018-05-27 18:08:55,884:INFO: Muscular Dystrophy, Facioscapulohumeral Recall-at-100: 0.00%
2018-05-27 18:08:55,884:INFO: Experiment Progress: 60.0% -- 314/519
2018-05-27 18:08:56,748:INFO: Colorectal Cancer Recall-at-100: 0.00%
2018-05-27 18:08:56,749:INFO: Experiment Progress: 60.0% -- 315/519
2018-05-27 18:08:58,166:INFO: Atherosclerosis Recall-at-100: 0.00%
2018-05-27 18:08:58,166:INFO: Experiment Progress: 60.0% -- 316/519
2018-05-27 18:09:00,837:INFO: Asthma Recall-at-100: 0.00%
2018-05-27 18:09:00,837:INFO: Experiment Progress: 61.0% -- 317/519
2018-05-27 18:09:01,566:INFO: Cardiomyopathy, Hypertrophic, Familial Recall-at-100: 0.00%
2018-05-27 18:09:01,566:INFO: Experiment Progress: 61.0% -- 318/519
2018-05-27 18:09:02,764:INFO: Skin Neoplasms Recall-at-100: 0.00%
2018-05-27 18:09:02,764:INFO: Experiment Progress: 61.0% -- 319/519
2018-05-27 18:09:05,117:INFO: Seizures Recall-at-100: 3.22%
2018-05-27 18:09:05,117:INFO: Experiment Progress: 61.0% -- 320/519
2018-05-27 18:09:09,094:INFO: Alzheimer's Disease Recall-at-100: 0.71%
2018-05-27 18:09:09,095:INFO: Experiment Progress: 61.0% -- 321/519
2018-05-27 18:09:09,747:INFO: Menopause present (finding) Recall-at-100: 0.00%
2018-05-27 18:09:09,747:INFO: Experiment Progress: 62.0% -- 322/519
2018-05-27 18:09:11,026:INFO: Neoplastic Syndromes, Hereditary Recall-at-100: 0.00%
2018-05-27 18:09:11,027:INFO: Experiment Progress: 62.0% -- 323/519
2018-05-27 18:09:11,544:INFO: Gastrointestinal Diseases Recall-at-100: 0.00%
2018-05-27 18:09:11,544:INFO: Experiment Progress: 62.0% -- 324/519
2018-05-27 18:09:12,097:INFO: Cytochrome-c Oxidase Deficiency Recall-at-100: 0.00%
2018-05-27 18:09:12,097:INFO: Experiment Progress: 62.0% -- 325/519
2018-05-27 18:09:12,702:INFO: Retinal Degeneration Recall-at-100: 0.00%
2018-05-27 18:09:12,702:INFO: Experiment Progress: 62.0% -- 326/519
2018-05-27 18:09:13,403:INFO: Retinal Diseases Recall-at-100: 0.00%
2018-05-27 18:09:13,403:INFO: Experiment Progress: 63.0% -- 327/519
2018-05-27 18:09:13,893:INFO: Methylmalonic acidemia Recall-at-100: 0.00%
2018-05-27 18:09:13,893:INFO: Experiment Progress: 63.0% -- 328/519
2018-05-27 18:09:15,721:INFO: Contact Dermatitis Recall-at-100: 2.86%
2018-05-27 18:09:15,721:INFO: Experiment Progress: 63.0% -- 329/519
2018-05-27 18:09:16,802:INFO: Dermatitis, Atopic Recall-at-100: 0.00%
2018-05-27 18:09:16,802:INFO: Experiment Progress: 63.0% -- 330/519
2018-05-27 18:09:18,263:INFO: Coronary heart disease Recall-at-100: 0.00%
2018-05-27 18:09:18,263:INFO: Experiment Progress: 63.0% -- 331/519
2018-05-27 18:09:19,848:INFO: Osteoporosis Recall-at-100: 0.00%
2018-05-27 18:09:19,848:INFO: Experiment Progress: 63.0% -- 332/519
2018-05-27 18:09:21,486:INFO: Cardiomegaly Recall-at-100: 0.00%
2018-05-27 18:09:21,487:INFO: Experiment Progress: 64.0% -- 333/519
2018-05-27 18:09:23,521:INFO: Heart failure Recall-at-100: 0.00%
2018-05-27 18:09:23,522:INFO: Experiment Progress: 64.0% -- 334/519
2018-05-27 18:09:24,105:INFO: Hereditary Breast and Ovarian Cancer Syndrome Recall-at-100: 25.00%
2018-05-27 18:09:24,105:INFO: Experiment Progress: 64.0% -- 335/519
2018-05-27 18:09:25,042:INFO: Major Depressive Disorder Recall-at-100: 0.00%
2018-05-27 18:09:25,042:INFO: Experiment Progress: 64.0% -- 336/519
2018-05-27 18:09:26,668:INFO: Dermatologic disorders Recall-at-100: 1.67%
2018-05-27 18:09:26,669:INFO: Experiment Progress: 64.0% -- 337/519
2018-05-27 18:09:29,463:INFO: Inflammation Recall-at-100: 0.00%
2018-05-27 18:09:29,463:INFO: Experiment Progress: 65.0% -- 338/519
2018-05-27 18:09:30,000:INFO: Diabetic Neuropathies Recall-at-100: 0.00%
2018-05-27 18:09:30,000:INFO: Experiment Progress: 65.0% -- 339/519
2018-05-27 18:09:31,181:INFO: Male infertility Recall-at-100: 0.00%
2018-05-27 18:09:31,181:INFO: Experiment Progress: 65.0% -- 340/519
2018-05-27 18:09:31,793:INFO: Vascular Diseases Recall-at-100: 0.00%
2018-05-27 18:09:31,793:INFO: Experiment Progress: 65.0% -- 341/519
2018-05-27 18:09:32,627:INFO: Female infertility Recall-at-100: 0.00%
2018-05-27 18:09:32,628:INFO: Experiment Progress: 65.0% -- 342/519
2018-05-27 18:09:33,568:INFO: leukemia Recall-at-100: 0.00%
2018-05-27 18:09:33,568:INFO: Experiment Progress: 66.0% -- 343/519
2018-05-27 18:09:35,624:INFO: Ulcerative Colitis Recall-at-100: 1.25%
2018-05-27 18:09:35,624:INFO: Experiment Progress: 66.0% -- 344/519
2018-05-27 18:09:36,949:INFO: Influenza Recall-at-100: 0.00%
2018-05-27 18:09:36,949:INFO: Experiment Progress: 66.0% -- 345/519
2018-05-27 18:09:37,431:INFO: Nephritis, Interstitial Recall-at-100: 0.00%
2018-05-27 18:09:37,431:INFO: Experiment Progress: 66.0% -- 346/519
2018-05-27 18:09:37,965:INFO: Sjogren's Syndrome Recall-at-100: 0.00%
2018-05-27 18:09:37,965:INFO: Experiment Progress: 66.0% -- 347/519
2018-05-27 18:09:38,484:INFO: Infant length Recall-at-100: 0.00%
2018-05-27 18:09:38,484:INFO: Experiment Progress: 67.0% -- 348/519
2018-05-27 18:09:39,860:INFO: Child Development Disorders, Pervasive Recall-at-100: 0.00%
2018-05-27 18:09:39,860:INFO: Experiment Progress: 67.0% -- 349/519
2018-05-27 18:09:41,160:INFO: Substance Withdrawal Syndrome Recall-at-100: 1.67%
2018-05-27 18:09:41,160:INFO: Experiment Progress: 67.0% -- 350/519
2018-05-27 18:09:41,658:INFO: Malformations of Cortical Development Recall-at-100: 0.00%
2018-05-27 18:09:41,659:INFO: Experiment Progress: 67.0% -- 351/519
2018-05-27 18:09:43,352:INFO: Amyotrophic Lateral Sclerosis Recall-at-100: 1.67%
2018-05-27 18:09:43,353:INFO: Experiment Progress: 67.0% -- 352/519
2018-05-27 18:09:44,031:INFO: Developmental Disabilities Recall-at-100: 0.00%
2018-05-27 18:09:44,032:INFO: Experiment Progress: 68.0% -- 353/519
2018-05-27 18:09:44,531:INFO: Febrile Convulsions Recall-at-100: 0.00%
2018-05-27 18:09:44,531:INFO: Experiment Progress: 68.0% -- 354/519
2018-05-27 18:09:45,654:INFO: Cholestasis Recall-at-100: 0.00%
2018-05-27 18:09:45,654:INFO: Experiment Progress: 68.0% -- 355/519
2018-05-27 18:09:46,541:INFO: Pulmonary Hypertension Recall-at-100: 6.67%
2018-05-27 18:09:46,542:INFO: Experiment Progress: 68.0% -- 356/519
2018-05-27 18:09:47,334:INFO: Papillary thyroid carcinoma Recall-at-100: 0.00%
2018-05-27 18:09:47,334:INFO: Experiment Progress: 68.0% -- 357/519
2018-05-27 18:09:48,544:INFO: Salivary Gland Neoplasms Recall-at-100: 0.00%
2018-05-27 18:09:48,544:INFO: Experiment Progress: 68.0% -- 358/519
2018-05-27 18:09:49,612:INFO: Non-alcoholic Fatty Liver Disease Recall-at-100: 0.00%
2018-05-27 18:09:49,612:INFO: Experiment Progress: 69.0% -- 359/519
2018-05-27 18:09:50,109:INFO: Hay fever Recall-at-100: 0.00%
2018-05-27 18:09:50,109:INFO: Experiment Progress: 69.0% -- 360/519
2018-05-27 18:09:50,730:INFO: Hypercholesterolemia, Familial Recall-at-100: 0.00%
2018-05-27 18:09:50,730:INFO: Experiment Progress: 69.0% -- 361/519
2018-05-27 18:09:53,196:INFO: Down Syndrome Recall-at-100: 1.00%
2018-05-27 18:09:53,196:INFO: Experiment Progress: 69.0% -- 362/519
2018-05-27 18:09:53,701:INFO: Arrhythmogenic Right Ventricular Dysplasia Recall-at-100: 0.00%
2018-05-27 18:09:53,701:INFO: Experiment Progress: 69.0% -- 363/519
2018-05-27 18:09:54,285:INFO: Semilobar Holoprosencephaly Recall-at-100: 0.00%
2018-05-27 18:09:54,285:INFO: Experiment Progress: 70.0% -- 364/519
2018-05-27 18:09:54,856:INFO: Hypertriglyceridemia Recall-at-100: 0.00%
2018-05-27 18:09:54,856:INFO: Experiment Progress: 70.0% -- 365/519
2018-05-27 18:09:55,281:INFO: Sensorineural Hearing Loss (disorder) Recall-at-100: 0.00%
2018-05-27 18:09:55,281:INFO: Experiment Progress: 70.0% -- 366/519
2018-05-27 18:09:56,421:INFO: Metabolic Syndrome X Recall-at-100: 0.00%
2018-05-27 18:09:56,421:INFO: Experiment Progress: 70.0% -- 367/519
2018-05-27 18:09:57,052:INFO: Malignant neoplasm of lung Recall-at-100: 0.00%
2018-05-27 18:09:57,053:INFO: Experiment Progress: 70.0% -- 368/519
2018-05-27 18:09:59,989:INFO: Leukemia, Myelocytic, Acute Recall-at-100: 0.91%
2018-05-27 18:09:59,989:INFO: Experiment Progress: 71.0% -- 369/519
2018-05-27 18:10:01,663:INFO: Malignant neoplasm of prostate Recall-at-100: 1.43%
2018-05-27 18:10:01,663:INFO: Experiment Progress: 71.0% -- 370/519
2018-05-27 18:10:02,147:INFO: Renal Insufficiency Recall-at-100: 0.00%
2018-05-27 18:10:02,147:INFO: Experiment Progress: 71.0% -- 371/519
2018-05-27 18:10:02,559:INFO: Jeune thoracic dystrophy Recall-at-100: 0.00%
2018-05-27 18:10:02,559:INFO: Experiment Progress: 71.0% -- 372/519
2018-05-27 18:10:05,766:INFO: Renal Cell Carcinoma Recall-at-100: 0.00%
2018-05-27 18:10:05,766:INFO: Experiment Progress: 71.0% -- 373/519
2018-05-27 18:10:08,092:INFO: Squamous cell carcinoma Recall-at-100: 1.25%
2018-05-27 18:10:08,092:INFO: Experiment Progress: 72.0% -- 374/519
2018-05-27 18:10:11,489:INFO: Non-Small Cell Lung Carcinoma Recall-at-100: 0.91%
2018-05-27 18:10:11,489:INFO: Experiment Progress: 72.0% -- 375/519
2018-05-27 18:10:12,041:INFO: Manganese Poisoning Recall-at-100: 0.00%
2018-05-27 18:10:12,042:INFO: Experiment Progress: 72.0% -- 376/519
2018-05-27 18:10:12,640:INFO: Ventricular Dysfunction, Left Recall-at-100: 0.00%
2018-05-27 18:10:12,640:INFO: Experiment Progress: 72.0% -- 377/519
2018-05-27 18:10:13,566:INFO: Carcinoma, Transitional Cell Recall-at-100: 3.33%
2018-05-27 18:10:13,566:INFO: Experiment Progress: 72.0% -- 378/519
2018-05-27 18:10:14,089:INFO: Mucocutaneous Lymph Node Syndrome Recall-at-100: 0.00%
2018-05-27 18:10:14,089:INFO: Experiment Progress: 73.0% -- 379/519
2018-05-27 18:10:14,603:INFO: Tobacco Use Disorder Recall-at-100: 0.00%
2018-05-27 18:10:14,603:INFO: Experiment Progress: 73.0% -- 380/519
2018-05-27 18:10:15,776:INFO: Proteinuria Recall-at-100: 2.50%
2018-05-27 18:10:15,776:INFO: Experiment Progress: 73.0% -- 381/519
2018-05-27 18:10:17,169:INFO: Diabetic Nephropathy Recall-at-100: 0.00%
2018-05-27 18:10:17,169:INFO: Experiment Progress: 73.0% -- 382/519
2018-05-27 18:10:18,160:INFO: Williams Syndrome Recall-at-100: 0.00%
2018-05-27 18:10:18,161:INFO: Experiment Progress: 73.0% -- 383/519
2018-05-27 18:10:19,150:INFO: Oral Submucous Fibrosis Recall-at-100: 0.00%
2018-05-27 18:10:19,150:INFO: Experiment Progress: 73.0% -- 384/519
2018-05-27 18:10:20,415:INFO: Adenoma Recall-at-100: 0.00%
2018-05-27 18:10:20,415:INFO: Experiment Progress: 74.0% -- 385/519
2018-05-27 18:10:21,062:INFO: Neutropenia Recall-at-100: 0.00%
2018-05-27 18:10:21,062:INFO: Experiment Progress: 74.0% -- 386/519
2018-05-27 18:10:21,767:INFO: Poor school performance Recall-at-100: 0.00%
2018-05-27 18:10:21,767:INFO: Experiment Progress: 74.0% -- 387/519
2018-05-27 18:10:22,572:INFO: Pneumoconiosis Recall-at-100: 0.00%
2018-05-27 18:10:22,573:INFO: Experiment Progress: 74.0% -- 388/519
2018-05-27 18:10:24,143:INFO: Cardiovascular Diseases Recall-at-100: 0.00%
2018-05-27 18:10:24,143:INFO: Experiment Progress: 74.0% -- 389/519
2018-05-27 18:10:24,889:INFO: Fibrinogen Adverse Event Recall-at-100: 0.00%
2018-05-27 18:10:24,889:INFO: Experiment Progress: 75.0% -- 390/519
2018-05-27 18:10:30,259:INFO: Diabetes Mellitus, Non-Insulin-Dependent Recall-at-100: 0.67%
2018-05-27 18:10:30,259:INFO: Experiment Progress: 75.0% -- 391/519
2018-05-27 18:10:31,028:INFO: Thrombocytopenia Recall-at-100: 0.00%
2018-05-27 18:10:31,028:INFO: Experiment Progress: 75.0% -- 392/519
2018-05-27 18:10:32,016:INFO: Sezary Syndrome Recall-at-100: 0.00%
2018-05-27 18:10:32,016:INFO: Experiment Progress: 75.0% -- 393/519
2018-05-27 18:10:32,575:INFO: Nuclear non-senile cataract Recall-at-100: 0.00%
2018-05-27 18:10:32,575:INFO: Experiment Progress: 75.0% -- 394/519
2018-05-27 18:10:33,214:INFO: Diabetic Retinopathy Recall-at-100: 0.00%
2018-05-27 18:10:33,214:INFO: Experiment Progress: 76.0% -- 395/519
2018-05-27 18:10:34,276:INFO: hearing impairment Recall-at-100: 0.00%
2018-05-27 18:10:34,276:INFO: Experiment Progress: 76.0% -- 396/519
2018-05-27 18:10:34,936:INFO: Psychotic Disorders Recall-at-100: 0.00%
2018-05-27 18:10:34,937:INFO: Experiment Progress: 76.0% -- 397/519
2018-05-27 18:10:35,916:INFO: Anxiety Disorders Recall-at-100: 5.83%
2018-05-27 18:10:35,916:INFO: Experiment Progress: 76.0% -- 398/519
2018-05-27 18:10:36,554:INFO: Finding of Mean Corpuscular Hemoglobin Recall-at-100: 0.00%
2018-05-27 18:10:36,554:INFO: Experiment Progress: 76.0% -- 399/519
2018-05-27 18:10:37,164:INFO: Motion Sickness Recall-at-100: 0.00%
2018-05-27 18:10:37,165:INFO: Experiment Progress: 77.0% -- 400/519
2018-05-27 18:10:37,939:INFO: Lymphoma, Non-Hodgkin Recall-at-100: 0.00%
2018-05-27 18:10:37,939:INFO: Experiment Progress: 77.0% -- 401/519
2018-05-27 18:10:38,735:INFO: Lymphoma, Follicular Recall-at-100: 0.00%
2018-05-27 18:10:38,735:INFO: Experiment Progress: 77.0% -- 402/519
2018-05-27 18:10:39,523:INFO: Thrombocythemia, Essential Recall-at-100: 0.00%
2018-05-27 18:10:39,524:INFO: Experiment Progress: 77.0% -- 403/519
2018-05-27 18:10:40,031:INFO: Arthritis Recall-at-100: 0.00%
2018-05-27 18:10:40,031:INFO: Experiment Progress: 77.0% -- 404/519
2018-05-27 18:10:41,497:INFO: Hypotension Recall-at-100: 0.00%
2018-05-27 18:10:41,497:INFO: Experiment Progress: 78.0% -- 405/519
2018-05-27 18:10:43,623:INFO: Reperfusion Injury Recall-at-100: 0.00%
2018-05-27 18:10:43,623:INFO: Experiment Progress: 78.0% -- 406/519
2018-05-27 18:10:44,144:INFO: Heat Stroke Recall-at-100: 0.00%
2018-05-27 18:10:44,145:INFO: Experiment Progress: 78.0% -- 407/519
2018-05-27 18:10:44,787:INFO: Hemangiosarcoma Recall-at-100: 0.00%
2018-05-27 18:10:44,787:INFO: Experiment Progress: 78.0% -- 408/519
2018-05-27 18:10:45,872:INFO: Drug Allergy Recall-at-100: 0.00%
2018-05-27 18:10:45,872:INFO: Experiment Progress: 78.0% -- 409/519
2018-05-27 18:10:46,654:INFO: SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR Recall-at-100: 0.00%
2018-05-27 18:10:46,654:INFO: Experiment Progress: 78.0% -- 410/519
2018-05-27 18:10:48,017:INFO: Medulloblastoma Recall-at-100: 0.00%
2018-05-27 18:10:48,017:INFO: Experiment Progress: 79.0% -- 411/519
2018-05-27 18:10:48,993:INFO: Cleft Lip Recall-at-100: 0.00%
2018-05-27 18:10:48,994:INFO: Experiment Progress: 79.0% -- 412/519
2018-05-27 18:10:50,602:INFO: Cleft Palate Recall-at-100: 0.00%
2018-05-27 18:10:50,602:INFO: Experiment Progress: 79.0% -- 413/519
2018-05-27 18:10:53,009:INFO: Muscle Weakness Recall-at-100: 1.11%
2018-05-27 18:10:53,009:INFO: Experiment Progress: 79.0% -- 414/519
2018-05-27 18:10:53,549:INFO: Mental disorders Recall-at-100: 0.00%
2018-05-27 18:10:53,549:INFO: Experiment Progress: 79.0% -- 415/519
2018-05-27 18:10:54,362:INFO: Astrocytoma Recall-at-100: 0.00%
2018-05-27 18:10:54,362:INFO: Experiment Progress: 80.0% -- 416/519
2018-05-27 18:10:54,920:INFO: Anemia, Diamond-Blackfan Recall-at-100: 0.00%
2018-05-27 18:10:54,920:INFO: Experiment Progress: 80.0% -- 417/519
2018-05-27 18:10:55,486:INFO: Asthma, Aspirin-Induced Recall-at-100: 0.00%
2018-05-27 18:10:55,486:INFO: Experiment Progress: 80.0% -- 418/519
2018-05-27 18:10:56,216:INFO: Leber Congenital Amaurosis Recall-at-100: 5.00%
2018-05-27 18:10:56,216:INFO: Experiment Progress: 80.0% -- 419/519
2018-05-27 18:12:03,141:INFO: Disease Protein Prediction in the PPI Network
2018-05-27 18:12:03,142:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-27 18:12:03,142:INFO: ======================================
2018-05-27 18:12:03,142:INFO: Loading PPI Network...
2018-05-27 18:12:14,652:INFO: Loading Disease Associations...
2018-05-27 18:12:14,686:INFO: Loading PPI Matrix...
2018-05-27 18:12:49,874:INFO: Running Experiment...
2018-05-27 18:12:49,899:INFO: Experiment Progress: 0.0% -- 0/519
2018-05-27 18:12:50,812:INFO: Hydrops Fetalis, Non-Immune Recall-at-100: 0.00%
2018-05-27 18:12:50,813:INFO: Experiment Progress: 0.0% -- 1/519
2018-05-27 18:12:51,535:INFO: Psychoses, Substance-Induced Recall-at-100: 0.00%
2018-05-27 18:12:51,535:INFO: Experiment Progress: 0.0% -- 2/519
2018-05-27 18:12:52,162:INFO: Zellweger Syndrome Recall-at-100: 0.00%
2018-05-27 18:12:52,162:INFO: Experiment Progress: 0.0% -- 3/519
2018-05-27 18:12:54,004:INFO: Psoriasis Recall-at-100: 0.00%
2018-05-27 18:12:54,006:INFO: Experiment Progress: 0.0% -- 4/519
2018-05-27 18:12:54,781:INFO: Nephrotic Syndrome Recall-at-100: 5.00%
2018-05-27 18:12:54,781:INFO: Experiment Progress: 0.0% -- 5/519
2018-05-27 18:12:55,451:INFO: Nephrosis Recall-at-100: 0.00%
2018-05-27 18:12:55,451:INFO: Experiment Progress: 1.0% -- 6/519
2018-05-27 18:12:56,103:INFO: Mouth Diseases Recall-at-100: 0.00%
2018-05-27 18:12:56,103:INFO: Experiment Progress: 1.0% -- 7/519
2018-05-27 18:12:57,017:INFO: MITOCHONDRIAL COMPLEX I DEFICIENCY Recall-at-100: 6.67%
2018-05-27 18:12:57,017:INFO: Experiment Progress: 1.0% -- 8/519
2018-05-27 18:13:00,057:INFO: Substance-Related Disorders Recall-at-100: 1.00%
2018-05-27 18:13:00,057:INFO: Experiment Progress: 1.0% -- 9/519
2018-05-27 18:13:00,649:INFO: Anemia, Hemolytic Recall-at-100: 0.00%
2018-05-27 18:13:00,649:INFO: Experiment Progress: 1.0% -- 10/519
2018-05-27 18:13:08,385:INFO: Rheumatoid Arthritis Recall-at-100: 0.45%
2018-05-27 18:13:08,386:INFO: Experiment Progress: 2.0% -- 11/519
2018-05-27 18:13:09,004:INFO: Arthritis, Psoriatic Recall-at-100: 0.00%
2018-05-27 18:13:09,005:INFO: Experiment Progress: 2.0% -- 12/519
2018-05-27 18:13:09,902:INFO: Anemia Recall-at-100: 0.00%
2018-05-27 18:13:09,902:INFO: Experiment Progress: 2.0% -- 13/519
2018-05-27 18:13:10,674:INFO: Cholangiocarcinoma Recall-at-100: 8.33%
2018-05-27 18:13:10,674:INFO: Experiment Progress: 2.0% -- 14/519
2018-05-27 18:13:11,175:INFO: Neuroendocrine Tumors Recall-at-100: 0.00%
2018-05-27 18:13:11,175:INFO: Experiment Progress: 2.0% -- 15/519
2018-05-27 18:13:11,858:INFO: Malaria Recall-at-100: 0.00%
2018-05-27 18:13:11,858:INFO: Experiment Progress: 3.0% -- 16/519
2018-05-27 18:13:12,369:INFO: Hyperhomocysteinemia Recall-at-100: 0.00%
2018-05-27 18:13:12,369:INFO: Experiment Progress: 3.0% -- 17/519
2018-05-27 18:13:14,728:INFO: HIV Infections Recall-at-100: 0.00%
2018-05-27 18:13:14,728:INFO: Experiment Progress: 3.0% -- 18/519
2018-05-27 18:13:15,348:INFO: Ankylosing spondylitis Recall-at-100: 0.00%
2018-05-27 18:13:15,348:INFO: Experiment Progress: 3.0% -- 19/519
2018-05-27 18:13:17,852:INFO: Adenoid Cystic Carcinoma Recall-at-100: 0.00%
2018-05-27 18:13:17,852:INFO: Experiment Progress: 3.0% -- 20/519
2018-05-27 18:13:20,949:INFO: Juvenile arthritis Recall-at-100: 1.67%
2018-05-27 18:13:20,949:INFO: Experiment Progress: 4.0% -- 21/519
2018-05-27 18:13:21,921:INFO: Neoplasms, Experimental Recall-at-100: 0.00%
2018-05-27 18:13:21,921:INFO: Experiment Progress: 4.0% -- 22/519
2018-05-27 18:13:22,497:INFO: Neoplasms, Germ Cell and Embryonal Recall-at-100: 0.00%
2018-05-27 18:13:22,497:INFO: Experiment Progress: 4.0% -- 23/519
2018-05-27 18:13:22,899:INFO: Alopecia Areata Recall-at-100: 0.00%
2018-05-27 18:13:22,899:INFO: Experiment Progress: 4.0% -- 24/519
2018-05-27 18:13:23,486:INFO: Alopecia Recall-at-100: 0.00%
2018-05-27 18:13:23,487:INFO: Experiment Progress: 4.0% -- 25/519
2018-05-27 18:13:24,261:INFO: Bradycardia Recall-at-100: 0.00%
2018-05-27 18:13:24,261:INFO: Experiment Progress: 5.0% -- 26/519
2018-05-27 18:13:24,808:INFO: Common Variable Immunodeficiency Recall-at-100: 5.00%
2018-05-27 18:13:24,808:INFO: Experiment Progress: 5.0% -- 27/519
2018-05-27 18:13:25,652:INFO: Glomerulonephritis Recall-at-100: 0.00%
2018-05-27 18:13:25,652:INFO: Experiment Progress: 5.0% -- 28/519
2018-05-27 18:13:26,726:INFO: Alcoholic Intoxication, Chronic Recall-at-100: 0.00%
2018-05-27 18:13:26,727:INFO: Experiment Progress: 5.0% -- 29/519
2018-05-27 18:13:27,434:INFO: Lung Injury Recall-at-100: 0.00%
2018-05-27 18:13:27,434:INFO: Experiment Progress: 5.0% -- 30/519
2018-05-27 18:13:27,932:INFO: Hypercalcemia Recall-at-100: 0.00%
2018-05-27 18:13:27,932:INFO: Experiment Progress: 5.0% -- 31/519
2018-05-27 18:13:29,024:INFO: Cerebrovascular accident Recall-at-100: 0.00%
2018-05-27 18:13:29,024:INFO: Experiment Progress: 6.0% -- 32/519
2018-05-27 18:13:30,540:INFO: Diaphragmatic Hernia Recall-at-100: 5.00%
2018-05-27 18:13:30,541:INFO: Experiment Progress: 6.0% -- 33/519
2018-05-27 18:13:31,319:INFO: Prostatic Intraepithelial Neoplasias Recall-at-100: 0.00%
2018-05-27 18:13:31,319:INFO: Experiment Progress: 6.0% -- 34/519
2018-05-27 18:13:37,734:INFO: Disease Protein Prediction in the PPI Network
2018-05-27 18:13:37,734:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-27 18:13:37,734:INFO: ======================================
2018-05-27 18:13:37,734:INFO: Loading PPI Network...
2018-05-27 18:13:51,390:INFO: Loading Disease Associations...
2018-05-27 18:13:51,424:INFO: Loading PPI Matrix...
2018-05-27 18:14:16,391:INFO: Running Experiment...
2018-05-27 18:14:16,394:INFO: Experiment Progress: 0.0% -- 0/519
2018-05-27 18:14:17,068:INFO: Hydrops Fetalis, Non-Immune Recall-at-100: 0.00%
2018-05-27 18:14:17,069:INFO: Experiment Progress: 0.0% -- 1/519
2018-05-27 18:14:17,758:INFO: Psychoses, Substance-Induced Recall-at-100: 0.00%
2018-05-27 18:14:17,758:INFO: Experiment Progress: 0.0% -- 2/519
2018-05-27 18:14:18,369:INFO: Zellweger Syndrome Recall-at-100: 0.00%
2018-05-27 18:14:18,370:INFO: Experiment Progress: 0.0% -- 3/519
2018-05-27 18:14:20,192:INFO: Psoriasis Recall-at-100: 3.10%
2018-05-27 18:14:20,192:INFO: Experiment Progress: 0.0% -- 4/519
2018-05-27 18:14:20,971:INFO: Nephrotic Syndrome Recall-at-100: 5.00%
2018-05-27 18:14:20,971:INFO: Experiment Progress: 0.0% -- 5/519
2018-05-27 18:14:21,608:INFO: Nephrosis Recall-at-100: 5.00%
2018-05-27 18:14:21,609:INFO: Experiment Progress: 1.0% -- 6/519
2018-05-27 18:14:22,164:INFO: Mouth Diseases Recall-at-100: 0.00%
2018-05-27 18:14:22,165:INFO: Experiment Progress: 1.0% -- 7/519
2018-05-27 18:14:23,023:INFO: MITOCHONDRIAL COMPLEX I DEFICIENCY Recall-at-100: 6.67%
2018-05-27 18:14:23,023:INFO: Experiment Progress: 1.0% -- 8/519
2018-05-27 18:14:25,808:INFO: Substance-Related Disorders Recall-at-100: 1.00%
2018-05-27 18:14:25,808:INFO: Experiment Progress: 1.0% -- 9/519
2018-05-27 18:14:26,323:INFO: Anemia, Hemolytic Recall-at-100: 0.00%
2018-05-27 18:14:26,323:INFO: Experiment Progress: 1.0% -- 10/519
2018-05-27 18:14:34,037:INFO: Rheumatoid Arthritis Recall-at-100: 0.93%
2018-05-27 18:14:34,037:INFO: Experiment Progress: 2.0% -- 11/519
2018-05-27 18:14:34,736:INFO: Arthritis, Psoriatic Recall-at-100: 0.00%
2018-05-27 18:14:34,737:INFO: Experiment Progress: 2.0% -- 12/519
2018-05-27 18:14:35,755:INFO: Anemia Recall-at-100: 0.00%
2018-05-27 18:14:35,755:INFO: Experiment Progress: 2.0% -- 13/519
2018-05-27 18:14:36,701:INFO: Cholangiocarcinoma Recall-at-100: 8.33%
2018-05-27 18:14:36,701:INFO: Experiment Progress: 2.0% -- 14/519
2018-05-27 18:14:37,231:INFO: Neuroendocrine Tumors Recall-at-100: 0.00%
2018-05-27 18:14:37,232:INFO: Experiment Progress: 2.0% -- 15/519
2018-05-27 18:14:37,937:INFO: Malaria Recall-at-100: 5.00%
2018-05-27 18:14:37,938:INFO: Experiment Progress: 3.0% -- 16/519
2018-05-27 18:14:38,468:INFO: Hyperhomocysteinemia Recall-at-100: 0.00%
2018-05-27 18:14:38,468:INFO: Experiment Progress: 3.0% -- 17/519
2018-05-27 18:14:41,044:INFO: HIV Infections Recall-at-100: 0.00%
2018-05-27 18:14:41,044:INFO: Experiment Progress: 3.0% -- 18/519
2018-05-27 18:14:41,640:INFO: Ankylosing spondylitis Recall-at-100: 0.00%
2018-05-27 18:14:41,640:INFO: Experiment Progress: 3.0% -- 19/519
2018-05-27 18:14:44,199:INFO: Adenoid Cystic Carcinoma Recall-at-100: 0.00%
2018-05-27 18:14:44,199:INFO: Experiment Progress: 3.0% -- 20/519
2018-05-27 18:14:47,522:INFO: Juvenile arthritis Recall-at-100: 1.67%
2018-05-27 18:14:47,522:INFO: Experiment Progress: 4.0% -- 21/519
2018-05-27 18:14:48,531:INFO: Neoplasms, Experimental Recall-at-100: 0.00%
2018-05-27 18:14:48,532:INFO: Experiment Progress: 4.0% -- 22/519
2018-05-27 18:14:49,113:INFO: Neoplasms, Germ Cell and Embryonal Recall-at-100: 0.00%
2018-05-27 18:14:49,113:INFO: Experiment Progress: 4.0% -- 23/519
2018-05-27 18:14:49,516:INFO: Alopecia Areata Recall-at-100: 0.00%
2018-05-27 18:14:49,517:INFO: Experiment Progress: 4.0% -- 24/519
2018-05-27 18:14:50,117:INFO: Alopecia Recall-at-100: 0.00%
2018-05-27 18:14:50,117:INFO: Experiment Progress: 4.0% -- 25/519
2018-05-27 18:14:50,925:INFO: Bradycardia Recall-at-100: 0.00%
2018-05-27 18:14:50,926:INFO: Experiment Progress: 5.0% -- 26/519
2018-05-27 18:14:51,495:INFO: Common Variable Immunodeficiency Recall-at-100: 15.00%
2018-05-27 18:14:51,495:INFO: Experiment Progress: 5.0% -- 27/519
2018-05-27 18:14:52,352:INFO: Glomerulonephritis Recall-at-100: 0.00%
2018-05-27 18:14:52,352:INFO: Experiment Progress: 5.0% -- 28/519
2018-05-27 18:14:53,431:INFO: Alcoholic Intoxication, Chronic Recall-at-100: 0.00%
2018-05-27 18:14:53,431:INFO: Experiment Progress: 5.0% -- 29/519
2018-05-27 18:14:54,149:INFO: Lung Injury Recall-at-100: 0.00%
2018-05-27 18:14:54,149:INFO: Experiment Progress: 5.0% -- 30/519
2018-05-27 18:14:54,657:INFO: Hypercalcemia Recall-at-100: 10.00%
2018-05-27 18:14:54,658:INFO: Experiment Progress: 5.0% -- 31/519
2018-05-27 18:14:55,719:INFO: Cerebrovascular accident Recall-at-100: 0.00%
2018-05-27 18:14:55,719:INFO: Experiment Progress: 6.0% -- 32/519
2018-05-27 18:14:56,876:INFO: Diaphragmatic Hernia Recall-at-100: 10.00%
2018-05-27 18:14:56,876:INFO: Experiment Progress: 6.0% -- 33/519
2018-05-27 18:14:57,415:INFO: Prostatic Intraepithelial Neoplasias Recall-at-100: 0.00%
2018-05-27 18:14:57,415:INFO: Experiment Progress: 6.0% -- 34/519
2018-05-27 18:14:58,285:INFO: Migraine Disorders Recall-at-100: 0.00%
2018-05-27 18:14:58,285:INFO: Experiment Progress: 6.0% -- 35/519
2018-05-27 18:14:58,535:INFO: Restless Legs Syndrome Recall-at-100: 0.00%
2018-05-27 18:14:58,536:INFO: Experiment Progress: 6.0% -- 36/519
2018-05-27 18:14:59,156:INFO: Brugada Syndrome (disorder) Recall-at-100: 0.00%
2018-05-27 18:14:59,156:INFO: Experiment Progress: 7.0% -- 37/519
2018-05-27 18:14:59,672:INFO: Pathological accumulation of air in tissues Recall-at-100: 20.00%
2018-05-27 18:14:59,672:INFO: Experiment Progress: 7.0% -- 38/519
2018-05-27 18:15:00,215:INFO: Craniosynostosis Recall-at-100: 0.00%
2018-05-27 18:15:00,215:INFO: Experiment Progress: 7.0% -- 39/519
2018-05-27 18:15:01,003:INFO: Head and Neck Neoplasms Recall-at-100: 0.00%
2018-05-27 18:15:01,003:INFO: Experiment Progress: 7.0% -- 40/519
2018-05-27 18:15:01,781:INFO: Brain Neoplasms Recall-at-100: 0.00%
2018-05-27 18:15:01,781:INFO: Experiment Progress: 7.0% -- 41/519
2018-05-27 18:15:02,531:INFO: Hearing Loss, Partial Recall-at-100: 0.00%
2018-05-27 18:15:02,531:INFO: Experiment Progress: 8.0% -- 42/519
2018-05-27 18:15:03,139:INFO: Chromosome Aberrations Recall-at-100: 0.00%
2018-05-27 18:15:03,139:INFO: Experiment Progress: 8.0% -- 43/519
2018-05-27 18:15:04,539:INFO: Chronic Lymphocytic Leukemia Recall-at-100: 0.00%
2018-05-27 18:15:04,539:INFO: Experiment Progress: 8.0% -- 44/519
2018-05-27 18:15:05,235:INFO: Refractive Errors Recall-at-100: 0.00%
2018-05-27 18:15:05,235:INFO: Experiment Progress: 8.0% -- 45/519
2018-05-27 18:15:05,843:INFO: Hepatitis C Recall-at-100: 0.00%
2018-05-27 18:15:05,843:INFO: Experiment Progress: 8.0% -- 46/519
2018-05-27 18:15:07,023:INFO: Mesothelioma Recall-at-100: 0.00%
2018-05-27 18:15:07,024:INFO: Experiment Progress: 9.0% -- 47/519
2018-05-27 18:15:07,234:INFO: Noise-induced hearing loss Recall-at-100: 0.00%
2018-05-27 18:15:07,234:INFO: Experiment Progress: 9.0% -- 48/519
2018-05-27 18:15:08,267:INFO: Inflammatory dermatosis Recall-at-100: 0.00%
2018-05-27 18:15:08,267:INFO: Experiment Progress: 9.0% -- 49/519
2018-05-27 18:15:09,323:INFO: Kallmann Syndrome Recall-at-100: 10.00%
2018-05-27 18:15:09,323:INFO: Experiment Progress: 9.0% -- 50/519
2018-05-27 18:15:10,120:INFO: Lipoidosis Recall-at-100: 0.00%
2018-05-27 18:15:10,121:INFO: Experiment Progress: 9.0% -- 51/519
2018-05-27 18:15:11,075:INFO: Diabetes Mellitus Recall-at-100: 0.00%
2018-05-27 18:15:11,076:INFO: Experiment Progress: 10.0% -- 52/519
2018-05-27 18:15:12,175:INFO: Fibrosis Recall-at-100: 2.50%
2018-05-27 18:15:12,175:INFO: Experiment Progress: 10.0% -- 53/519
2018-05-27 18:15:12,925:INFO: Hypercholesterolemia Recall-at-100: 0.00%
2018-05-27 18:15:12,925:INFO: Experiment Progress: 10.0% -- 54/519
2018-05-27 18:15:13,734:INFO: Microcephaly Recall-at-100: 0.00%
2018-05-27 18:15:13,734:INFO: Experiment Progress: 10.0% -- 55/519
2018-05-27 18:15:14,173:INFO: Tongue Neoplasms Recall-at-100: 0.00%
2018-05-27 18:15:14,173:INFO: Experiment Progress: 10.0% -- 56/519
2018-05-27 18:15:14,715:INFO: Common Migraine Recall-at-100: 0.00%
2018-05-27 18:15:14,715:INFO: Experiment Progress: 10.0% -- 57/519
2018-05-27 18:15:15,232:INFO: Carotid Artery Diseases Recall-at-100: 0.00%
2018-05-27 18:15:15,232:INFO: Experiment Progress: 11.0% -- 58/519
2018-05-27 18:15:16,208:INFO: Growth Disorders Recall-at-100: 3.33%
2018-05-27 18:15:16,208:INFO: Experiment Progress: 11.0% -- 59/519
2018-05-27 18:15:16,646:INFO: Absence Epilepsy Recall-at-100: 0.00%
2018-05-27 18:15:16,646:INFO: Experiment Progress: 11.0% -- 60/519
2018-05-27 18:15:17,431:INFO: Epilepsy, Temporal Lobe Recall-at-100: 0.00%
2018-05-27 18:15:17,431:INFO: Experiment Progress: 11.0% -- 61/519
2018-05-27 18:15:18,701:INFO: Memory Disorders Recall-at-100: 0.00%
2018-05-27 18:15:18,701:INFO: Experiment Progress: 11.0% -- 62/519
2018-05-27 18:15:19,312:INFO: Catalepsy Recall-at-100: 0.00%
2018-05-27 18:15:19,312:INFO: Experiment Progress: 12.0% -- 63/519
2018-05-27 18:15:20,062:INFO: Hereditary Nonpolyposis Colorectal Cancer Recall-at-100: 0.00%
2018-05-27 18:15:20,062:INFO: Experiment Progress: 12.0% -- 64/519
2018-05-27 18:15:21,058:INFO: Acute Promyelocytic Leukemia Recall-at-100: 3.33%
2018-05-27 18:15:21,058:INFO: Experiment Progress: 12.0% -- 65/519
2018-05-27 18:15:21,638:INFO: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma Recall-at-100: 0.00%
2018-05-27 18:15:21,638:INFO: Experiment Progress: 12.0% -- 66/519
2018-05-27 18:15:22,217:INFO: Gout Recall-at-100: 0.00%
2018-05-27 18:15:22,218:INFO: Experiment Progress: 12.0% -- 67/519
2018-05-27 18:15:24,096:INFO: Coronary Artery Disease Recall-at-100: 0.00%
2018-05-27 18:15:24,096:INFO: Experiment Progress: 13.0% -- 68/519
2018-05-27 18:15:25,175:INFO: Venous Thromboembolism Recall-at-100: 0.00%
2018-05-27 18:15:25,175:INFO: Experiment Progress: 13.0% -- 69/519
2018-05-27 18:15:27,449:INFO: Precancerous Conditions Recall-at-100: 0.00%
2018-05-27 18:15:27,449:INFO: Experiment Progress: 13.0% -- 70/519
2018-05-27 18:15:29,839:INFO: Crohn Disease Recall-at-100: 1.25%
2018-05-27 18:15:29,840:INFO: Experiment Progress: 13.0% -- 71/519
2018-05-27 18:15:30,608:INFO: Uterine Cervical Neoplasm Recall-at-100: 5.00%
2018-05-27 18:15:30,609:INFO: Experiment Progress: 13.0% -- 72/519
2018-05-27 18:15:31,313:INFO: Dyskinesia, Drug-Induced Recall-at-100: 15.00%
2018-05-27 18:15:31,313:INFO: Experiment Progress: 14.0% -- 73/519
2018-05-27 18:15:32,124:INFO: Ataxia, Spinocerebellar Recall-at-100: 15.00%
2018-05-27 18:15:32,124:INFO: Experiment Progress: 14.0% -- 74/519
2018-05-27 18:15:32,959:INFO: Optic Atrophy, Hereditary, Leber Recall-at-100: 35.00%
2018-05-27 18:15:32,960:INFO: Experiment Progress: 14.0% -- 75/519
2018-05-27 18:15:33,640:INFO: Liver Cirrhosis, Alcoholic Recall-at-100: 10.00%
2018-05-27 18:15:33,640:INFO: Experiment Progress: 14.0% -- 76/519
2018-05-27 18:15:34,274:INFO: Acute Lung Injury Recall-at-100: 15.00%
2018-05-27 18:15:34,274:INFO: Experiment Progress: 14.0% -- 77/519
2018-05-27 18:15:42,784:INFO: Disease Protein Prediction in the PPI Network
2018-05-27 18:15:42,785:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-27 18:15:42,785:INFO: ======================================
2018-05-27 18:15:42,785:INFO: Loading PPI Network...
2018-05-27 18:15:54,963:INFO: Loading Disease Associations...
2018-05-27 18:15:54,999:INFO: Loading PPI Matrix...
2018-05-27 18:16:32,234:INFO: Running Experiment...
2018-05-27 18:16:32,236:INFO: Experiment Progress: 0.0% -- 0/519
2018-05-27 18:16:32,939:INFO: Hydrops Fetalis, Non-Immune Recall-at-100: 0.00%
2018-05-27 18:16:32,940:INFO: Experiment Progress: 0.0% -- 1/519
2018-05-27 18:16:33,620:INFO: Psychoses, Substance-Induced Recall-at-100: 0.00%
2018-05-27 18:16:33,620:INFO: Experiment Progress: 0.0% -- 2/519
2018-05-27 18:16:34,092:INFO: Zellweger Syndrome Recall-at-100: 0.00%
2018-05-27 18:16:34,092:INFO: Experiment Progress: 0.0% -- 3/519
2018-05-27 18:16:35,365:INFO: Psoriasis Recall-at-100: 3.10%
2018-05-27 18:16:35,365:INFO: Experiment Progress: 0.0% -- 4/519
2018-05-27 18:16:35,937:INFO: Nephrotic Syndrome Recall-at-100: 5.00%
2018-05-27 18:16:35,937:INFO: Experiment Progress: 0.0% -- 5/519
2018-05-27 18:16:36,475:INFO: Nephrosis Recall-at-100: 5.00%
2018-05-27 18:16:36,475:INFO: Experiment Progress: 1.0% -- 6/519
2018-05-27 18:16:36,898:INFO: Mouth Diseases Recall-at-100: 0.00%
2018-05-27 18:16:36,898:INFO: Experiment Progress: 1.0% -- 7/519
2018-05-27 18:16:37,511:INFO: MITOCHONDRIAL COMPLEX I DEFICIENCY Recall-at-100: 6.67%
2018-05-27 18:16:37,511:INFO: Experiment Progress: 1.0% -- 8/519
2018-05-27 18:16:39,166:INFO: Substance-Related Disorders Recall-at-100: 1.00%
2018-05-27 18:16:39,166:INFO: Experiment Progress: 1.0% -- 9/519
2018-05-27 18:16:39,672:INFO: Anemia, Hemolytic Recall-at-100: 0.00%
2018-05-27 18:16:39,672:INFO: Experiment Progress: 1.0% -- 10/519
2018-05-27 18:16:42,315:INFO: Rheumatoid Arthritis Recall-at-100: 0.93%
2018-05-27 18:16:42,315:INFO: Experiment Progress: 2.0% -- 11/519
2018-05-27 18:16:42,889:INFO: Arthritis, Psoriatic Recall-at-100: 0.00%
2018-05-27 18:16:42,889:INFO: Experiment Progress: 2.0% -- 12/519
2018-05-27 18:16:43,618:INFO: Anemia Recall-at-100: 0.00%
2018-05-27 18:16:43,619:INFO: Experiment Progress: 2.0% -- 13/519
2018-05-27 18:16:44,270:INFO: Cholangiocarcinoma Recall-at-100: 8.33%
2018-05-27 18:16:44,270:INFO: Experiment Progress: 2.0% -- 14/519
2018-05-27 18:16:44,705:INFO: Neuroendocrine Tumors Recall-at-100: 0.00%
2018-05-27 18:16:44,706:INFO: Experiment Progress: 2.0% -- 15/519
2018-05-27 18:16:45,269:INFO: Malaria Recall-at-100: 5.00%
2018-05-27 18:16:45,269:INFO: Experiment Progress: 3.0% -- 16/519
2018-05-27 18:16:45,723:INFO: Hyperhomocysteinemia Recall-at-100: 0.00%
2018-05-27 18:16:45,723:INFO: Experiment Progress: 3.0% -- 17/519
2018-05-27 18:16:47,173:INFO: HIV Infections Recall-at-100: 0.00%
2018-05-27 18:16:47,174:INFO: Experiment Progress: 3.0% -- 18/519
2018-05-27 18:16:47,647:INFO: Ankylosing spondylitis Recall-at-100: 0.00%
2018-05-27 18:16:47,647:INFO: Experiment Progress: 3.0% -- 19/519
2018-05-27 18:16:49,007:INFO: Adenoid Cystic Carcinoma Recall-at-100: 0.00%
2018-05-27 18:16:49,007:INFO: Experiment Progress: 3.0% -- 20/519
2018-05-27 18:16:50,610:INFO: Juvenile arthritis Recall-at-100: 1.67%
2018-05-27 18:16:50,610:INFO: Experiment Progress: 4.0% -- 21/519
2018-05-27 18:16:51,244:INFO: Neoplasms, Experimental Recall-at-100: 0.00%
2018-05-27 18:16:51,246:INFO: Experiment Progress: 4.0% -- 22/519
2018-05-27 18:16:51,673:INFO: Neoplasms, Germ Cell and Embryonal Recall-at-100: 0.00%
2018-05-27 18:16:51,674:INFO: Experiment Progress: 4.0% -- 23/519
2018-05-27 18:16:51,975:INFO: Alopecia Areata Recall-at-100: 0.00%
2018-05-27 18:16:51,975:INFO: Experiment Progress: 4.0% -- 24/519
2018-05-27 18:16:52,400:INFO: Alopecia Recall-at-100: 0.00%
2018-05-27 18:16:52,400:INFO: Experiment Progress: 4.0% -- 25/519
2018-05-27 18:16:52,916:INFO: Bradycardia Recall-at-100: 0.00%
2018-05-27 18:16:52,916:INFO: Experiment Progress: 5.0% -- 26/519
2018-05-27 18:16:53,311:INFO: Common Variable Immunodeficiency Recall-at-100: 15.00%
2018-05-27 18:16:53,311:INFO: Experiment Progress: 5.0% -- 27/519
2018-05-27 18:16:53,848:INFO: Glomerulonephritis Recall-at-100: 0.00%
2018-05-27 18:16:53,850:INFO: Experiment Progress: 5.0% -- 28/519
2018-05-27 18:16:54,786:INFO: Alcoholic Intoxication, Chronic Recall-at-100: 0.00%
2018-05-27 18:16:54,787:INFO: Experiment Progress: 5.0% -- 29/519
2018-05-27 18:16:55,361:INFO: Lung Injury Recall-at-100: 0.00%
2018-05-27 18:16:55,362:INFO: Experiment Progress: 5.0% -- 30/519
2018-05-27 18:16:55,801:INFO: Hypercalcemia Recall-at-100: 10.00%
2018-05-27 18:16:55,801:INFO: Experiment Progress: 5.0% -- 31/519
2018-05-27 18:16:56,489:INFO: Cerebrovascular accident Recall-at-100: 0.00%
2018-05-27 18:16:56,490:INFO: Experiment Progress: 6.0% -- 32/519
2018-05-27 18:16:57,171:INFO: Diaphragmatic Hernia Recall-at-100: 10.00%
2018-05-27 18:16:57,172:INFO: Experiment Progress: 6.0% -- 33/519
2018-05-27 18:16:57,553:INFO: Prostatic Intraepithelial Neoplasias Recall-at-100: 0.00%
2018-05-27 18:16:57,553:INFO: Experiment Progress: 6.0% -- 34/519
2018-05-27 18:16:58,111:INFO: Migraine Disorders Recall-at-100: 0.00%
2018-05-27 18:16:58,111:INFO: Experiment Progress: 6.0% -- 35/519
2018-05-27 18:16:58,327:INFO: Restless Legs Syndrome Recall-at-100: 0.00%
2018-05-27 18:16:58,327:INFO: Experiment Progress: 6.0% -- 36/519
2018-05-27 18:16:58,783:INFO: Brugada Syndrome (disorder) Recall-at-100: 0.00%
2018-05-27 18:16:58,783:INFO: Experiment Progress: 7.0% -- 37/519
2018-05-27 18:16:59,177:INFO: Pathological accumulation of air in tissues Recall-at-100: 20.00%
2018-05-27 18:16:59,180:INFO: Experiment Progress: 7.0% -- 38/519
2018-05-27 18:16:59,607:INFO: Craniosynostosis Recall-at-100: 0.00%
2018-05-27 18:16:59,607:INFO: Experiment Progress: 7.0% -- 39/519
2018-05-27 18:17:00,159:INFO: Head and Neck Neoplasms Recall-at-100: 0.00%
2018-05-27 18:17:00,159:INFO: Experiment Progress: 7.0% -- 40/519
2018-05-27 18:17:00,745:INFO: Brain Neoplasms Recall-at-100: 0.00%
2018-05-27 18:17:00,746:INFO: Experiment Progress: 7.0% -- 41/519
2018-05-27 18:17:01,235:INFO: Hearing Loss, Partial Recall-at-100: 0.00%
2018-05-27 18:17:01,235:INFO: Experiment Progress: 8.0% -- 42/519
2018-05-27 18:17:01,679:INFO: Chromosome Aberrations Recall-at-100: 0.00%
2018-05-27 18:17:01,680:INFO: Experiment Progress: 8.0% -- 43/519
2018-05-27 18:17:02,489:INFO: Chronic Lymphocytic Leukemia Recall-at-100: 0.00%
2018-05-27 18:17:02,489:INFO: Experiment Progress: 8.0% -- 44/519
2018-05-27 18:17:02,975:INFO: Refractive Errors Recall-at-100: 0.00%
2018-05-27 18:17:02,977:INFO: Experiment Progress: 8.0% -- 45/519
2018-05-27 18:17:03,483:INFO: Hepatitis C Recall-at-100: 0.00%
2018-05-27 18:17:03,484:INFO: Experiment Progress: 8.0% -- 46/519
2018-05-27 18:17:04,217:INFO: Mesothelioma Recall-at-100: 0.00%
2018-05-27 18:17:04,218:INFO: Experiment Progress: 9.0% -- 47/519
2018-05-27 18:17:04,410:INFO: Noise-induced hearing loss Recall-at-100: 0.00%
2018-05-27 18:17:04,410:INFO: Experiment Progress: 9.0% -- 48/519
2018-05-27 18:17:05,440:INFO: Inflammatory dermatosis Recall-at-100: 0.00%
2018-05-27 18:17:05,440:INFO: Experiment Progress: 9.0% -- 49/519
2018-05-27 18:17:06,065:INFO: Kallmann Syndrome Recall-at-100: 10.00%
2018-05-27 18:17:06,065:INFO: Experiment Progress: 9.0% -- 50/519
2018-05-27 18:17:06,539:INFO: Lipoidosis Recall-at-100: 0.00%
2018-05-27 18:17:06,540:INFO: Experiment Progress: 9.0% -- 51/519
2018-05-27 18:17:07,129:INFO: Diabetes Mellitus Recall-at-100: 0.00%
2018-05-27 18:17:07,129:INFO: Experiment Progress: 10.0% -- 52/519
2018-05-27 18:17:07,916:INFO: Fibrosis Recall-at-100: 2.50%
2018-05-27 18:17:07,917:INFO: Experiment Progress: 10.0% -- 53/519
2018-05-27 18:17:08,622:INFO: Hypercholesterolemia Recall-at-100: 0.00%
2018-05-27 18:17:08,622:INFO: Experiment Progress: 10.0% -- 54/519
2018-05-27 18:17:09,351:INFO: Microcephaly Recall-at-100: 0.00%
2018-05-27 18:17:09,351:INFO: Experiment Progress: 10.0% -- 55/519
2018-05-27 18:17:09,755:INFO: Tongue Neoplasms Recall-at-100: 0.00%
2018-05-27 18:17:09,755:INFO: Experiment Progress: 10.0% -- 56/519
2018-05-27 18:17:10,191:INFO: Common Migraine Recall-at-100: 0.00%
2018-05-27 18:17:10,192:INFO: Experiment Progress: 10.0% -- 57/519
2018-05-27 18:17:10,688:INFO: Carotid Artery Diseases Recall-at-100: 0.00%
2018-05-27 18:17:10,688:INFO: Experiment Progress: 11.0% -- 58/519
2018-05-27 18:17:11,447:INFO: Growth Disorders Recall-at-100: 3.33%
2018-05-27 18:17:11,447:INFO: Experiment Progress: 11.0% -- 59/519
2018-05-27 18:17:11,822:INFO: Absence Epilepsy Recall-at-100: 0.00%
2018-05-27 18:17:11,822:INFO: Experiment Progress: 11.0% -- 60/519
2018-05-27 18:17:12,338:INFO: Epilepsy, Temporal Lobe Recall-at-100: 0.00%
2018-05-27 18:17:12,338:INFO: Experiment Progress: 11.0% -- 61/519
2018-05-27 18:17:13,027:INFO: Memory Disorders Recall-at-100: 0.00%
2018-05-27 18:17:13,028:INFO: Experiment Progress: 11.0% -- 62/519
2018-05-27 18:17:13,487:INFO: Catalepsy Recall-at-100: 0.00%
2018-05-27 18:17:13,487:INFO: Experiment Progress: 12.0% -- 63/519
2018-05-27 18:17:13,930:INFO: Hereditary Nonpolyposis Colorectal Cancer Recall-at-100: 0.00%
2018-05-27 18:17:13,931:INFO: Experiment Progress: 12.0% -- 64/519
2018-05-27 18:17:14,507:INFO: Acute Promyelocytic Leukemia Recall-at-100: 3.33%
2018-05-27 18:17:14,507:INFO: Experiment Progress: 12.0% -- 65/519
2018-05-27 18:17:14,981:INFO: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma Recall-at-100: 0.00%
2018-05-27 18:17:14,981:INFO: Experiment Progress: 12.0% -- 66/519
2018-05-27 18:17:15,421:INFO: Gout Recall-at-100: 0.00%
2018-05-27 18:17:15,421:INFO: Experiment Progress: 12.0% -- 67/519
2018-05-27 18:17:16,518:INFO: Coronary Artery Disease Recall-at-100: 0.00%
2018-05-27 18:17:16,520:INFO: Experiment Progress: 13.0% -- 68/519
2018-05-27 18:17:17,156:INFO: Venous Thromboembolism Recall-at-100: 0.00%
2018-05-27 18:17:17,156:INFO: Experiment Progress: 13.0% -- 69/519
2018-05-27 18:17:18,183:INFO: Precancerous Conditions Recall-at-100: 0.00%
2018-05-27 18:17:18,183:INFO: Experiment Progress: 13.0% -- 70/519
2018-05-27 18:17:19,388:INFO: Crohn Disease Recall-at-100: 1.25%
2018-05-27 18:17:19,388:INFO: Experiment Progress: 13.0% -- 71/519
2018-05-27 18:17:19,904:INFO: Uterine Cervical Neoplasm Recall-at-100: 5.00%
2018-05-27 18:17:19,904:INFO: Experiment Progress: 13.0% -- 72/519
2018-05-27 18:17:20,329:INFO: Dyskinesia, Drug-Induced Recall-at-100: 15.00%
2018-05-27 18:17:20,329:INFO: Experiment Progress: 14.0% -- 73/519
2018-05-27 18:17:20,796:INFO: Ataxia, Spinocerebellar Recall-at-100: 15.00%
2018-05-27 18:17:20,796:INFO: Experiment Progress: 14.0% -- 74/519
2018-05-27 18:17:21,232:INFO: Optic Atrophy, Hereditary, Leber Recall-at-100: 35.00%
2018-05-27 18:17:21,232:INFO: Experiment Progress: 14.0% -- 75/519
2018-05-27 18:17:21,745:INFO: Liver Cirrhosis, Alcoholic Recall-at-100: 10.00%
2018-05-27 18:17:21,745:INFO: Experiment Progress: 14.0% -- 76/519
2018-05-27 18:19:51,665:INFO: Disease Protein Prediction in the PPI Network
2018-05-27 18:19:51,665:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-27 18:19:51,666:INFO: ======================================
2018-05-27 18:19:51,666:INFO: Loading PPI Network...
2018-05-27 18:20:04,116:INFO: Loading Disease Associations...
2018-05-27 18:20:04,156:INFO: Loading PPI Matrix...
2018-05-27 18:20:37,948:INFO: Running Experiment...
2018-05-27 18:20:37,950:INFO: Experiment Progress: 0.0% -- 0/519
2018-05-27 18:20:38,502:INFO: Hydrops Fetalis, Non-Immune Recall-at-100: 0.00%
2018-05-27 18:20:38,503:INFO: Experiment Progress: 0.0% -- 1/519
2018-05-27 18:20:39,069:INFO: Psychoses, Substance-Induced Recall-at-100: 0.00%
2018-05-27 18:20:39,069:INFO: Experiment Progress: 0.0% -- 2/519
2018-05-27 18:20:39,586:INFO: Zellweger Syndrome Recall-at-100: 0.00%
2018-05-27 18:20:39,586:INFO: Experiment Progress: 0.0% -- 3/519
2018-05-27 18:20:41,448:INFO: Psoriasis Recall-at-100: 3.10%
2018-05-27 18:20:41,449:INFO: Experiment Progress: 0.0% -- 4/519
2018-05-27 18:20:41,984:INFO: Nephrotic Syndrome Recall-at-100: 5.00%
2018-05-27 18:20:41,984:INFO: Experiment Progress: 0.0% -- 5/519
2018-05-27 18:20:42,463:INFO: Nephrosis Recall-at-100: 5.00%
2018-05-27 18:20:42,463:INFO: Experiment Progress: 1.0% -- 6/519
2018-05-27 18:20:42,889:INFO: Mouth Diseases Recall-at-100: 0.00%
2018-05-27 18:20:42,890:INFO: Experiment Progress: 1.0% -- 7/519
2018-05-27 18:20:43,465:INFO: MITOCHONDRIAL COMPLEX I DEFICIENCY Recall-at-100: 6.67%
2018-05-27 18:20:43,467:INFO: Experiment Progress: 1.0% -- 8/519
2018-05-27 18:20:44,896:INFO: Substance-Related Disorders Recall-at-100: 1.00%
2018-05-27 18:20:44,896:INFO: Experiment Progress: 1.0% -- 9/519
2018-05-27 18:20:45,299:INFO: Anemia, Hemolytic Recall-at-100: 0.00%
2018-05-27 18:20:45,299:INFO: Experiment Progress: 1.0% -- 10/519
2018-05-27 18:20:47,625:INFO: Rheumatoid Arthritis Recall-at-100: 0.93%
2018-05-27 18:20:47,625:INFO: Experiment Progress: 2.0% -- 11/519
2018-05-27 18:20:48,205:INFO: Arthritis, Psoriatic Recall-at-100: 0.00%
2018-05-27 18:20:48,205:INFO: Experiment Progress: 2.0% -- 12/519
2018-05-27 18:20:48,920:INFO: Anemia Recall-at-100: 0.00%
2018-05-27 18:20:48,921:INFO: Experiment Progress: 2.0% -- 13/519
2018-05-27 18:20:49,528:INFO: Cholangiocarcinoma Recall-at-100: 8.33%
2018-05-27 18:20:49,528:INFO: Experiment Progress: 2.0% -- 14/519
2018-05-27 18:20:49,922:INFO: Neuroendocrine Tumors Recall-at-100: 0.00%
2018-05-27 18:20:49,923:INFO: Experiment Progress: 2.0% -- 15/519
2018-05-27 18:20:50,430:INFO: Malaria Recall-at-100: 5.00%
2018-05-27 18:20:50,431:INFO: Experiment Progress: 3.0% -- 16/519
2018-05-27 18:20:50,889:INFO: Hyperhomocysteinemia Recall-at-100: 0.00%
2018-05-27 18:20:50,889:INFO: Experiment Progress: 3.0% -- 17/519
2018-05-27 18:51:41,857:INFO: Disease Protein Prediction in the PPI Network
2018-05-27 18:51:41,857:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-27 18:51:41,858:INFO: ======================================
2018-05-27 18:51:41,858:INFO: Loading PPI Network...
